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ABSTRACT 
 
 
Diseases of the metabolic syndrome such as obesity, type II diabetes and atherosclerosis are 
caused by an excess accumulation of dietary lipid and are currently a major burden on 
healthcare.  The NLRP3 inflammasome is a molecular platform that leads to activation of 
caspase-1 and has received considerable attention recently regarding its role in promoting the 
inflammation associated with these diseases.  The chronic inflammation associated with these 
states is well understood but the acute inflammation has not been investigated in detail and is 
the focus of this study.  The zebrafish innate immune system functions in a similar manner to 
that of mammals and the uptake of dietary fat in the gastrointestinal tract is also strongly 
conserved.  Thus, using zebrafish larvae, a model of acute gastrointestinal inflammation 
following feeding on a fat-enriched diet has been established and characterised.  Additionally, 
the role of the NLRP3 inflammasome in the inflammation associated with feeding on such a 
diet has been investigated using pharmacological inhibitors and morpholino knockdown of 
components of this pathway.  The results demonstrate that larvae fed a cholesterol-enriched 
diet for 6h develop localized inflammation in the intestine as illustrated by the recruitment of 
myeloid cells to this region 18h following removal from the diet.  Feeding on a diet enriched 
in palmitic acid also achieves this effect, whilst an unsaturated fatty acid-enriched diet does 
not.  Reverting to a standard diet following feeding on a cholesterol-enriched diet resolves the 
localised recruitment of immune cells to the intestine.  Treatment with inhibitors targeting 
several components of the NLRP3 inflammasome blocks the recruitment of inflammatory 
cells to the intestines of larvae fed a cholesterol-enriched diet, as does treatment with a splice-
blocking morpholino against ASC, which is necessary for caspase-1 activation.  The results 
thus suggest that the acute inflammation in the intestine associated with feeding on a 
cholesterol-enriched diet is at least in part dependent on the NLRP3 inflammasome.  
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CHAPTER 1: INTRODUCTION 
 
 
Infection with pathogens, cell damage or a loss of homeostatic regulation leads to a biological 
response known as inflammation which is characterised by the migration of immune cells 
such as neutrophils and macrophages to the site of damage following the release of mediator 
molecules from resident immune cells.  Inflammation is regulated at three different levels: 
Firstly, at the cellular level in terms of the composition of cells in tissues and the behaviour of 
these cells in response to inflammatory stimuli leading to their recruitment and activation.  
Secondly, at the level of control of signalling pathways and thirdly, at the level of regulating 
gene expression (Medzhitov and Horng, 2009).  Depending on its duration, inflammation can 
be either classified as acute or chronic.  Acute inflammation shows an immediate onset and 
persists for a few days, whereas chronic inflammation shows a delayed onset and lasts for 
weeks or months.  Chronic inflammation results from a failure to resolve acute inflammation, 
which leads to tissue destruction over time.  It is a complication arising from diet-associated 
diseases such as obesity, type II diabetes and atherosclerosis which constitute the metabolic 
syndrome and are a major burden on global health.   
 
 
1.1  Acute Inflammation 
 
 
1.1.1  Inflammatory Stimuli and their Recognition 
 
 
Stimuli that incite inflammation are classified into two categories based on their origin.  The 
first class are infectious inflammatory stimuli, known as pathogen-associated molecular 
patterns (PAMPs), which are conserved structures on microorganisms necessary for their 
survival (Akira et al, 2006; Kumar et al, 2011).  Examples include lipopolysaccharide (LPS) 
in Gram negative bacteria, lipotechoic acid (LTA) in Gram positive bacteria, and lipoproteins 
and peptidoglycans present in both Gram negative and Gram positive bacteria.  Viruses also 
contain PAMPs in the form of DNA, RNA or glycoproteins (Akira et al, 2006).  PAMPs are 
recognised by pattern recognition receptors (PRRs), which are evolutionarily conserved, 
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germline-encoded receptors that are constitutively expressed in macrophages and other non-
professional immune cells.  Examples of PRRs include the transmembrane (TM) Toll-like 
receptors (TLRs) and the cytoplasmic Nod-like receptors (NLRs) (Akira et al, 2006; 
Takeuchi and Akira, 2010).  Upon recognition of PAMPs by PRRs, signalling pathways are 
activated leading to inflammatory responses that result in elimination of the infecting 
pathogen (Kumar et al, 2011).  The second class of inflammatory stimuli are non-infectious 
or sterile stimuli, known as damage-associated molecular patterns (DAMPs), which are also 
recognised by PRRs (Takeuchi and Akira, 2010).  These can take the form of pro-
inflammatory mediators released from necrotic cells following loss of integrity of the plasma 
membrane (PM), or various irritant particles (Matzinger, 2002; Rock et al, 2010).  Irritant 
particles can be either inorganic (asbestos), organic (amyloid beta (β) or amorphous (alum).  
The inflammatory response initiated against DAMPs can often fail to remove them and 
several types of DAMPs may actually be harmless (Rock et al, 2010).  Thus, the resulting 
collateral damage to the host’s tissues does more harm than good. 
 
 
1.1.2  Mediators of Acute Inflammation 
 
 
Cytokines and Chemokines 
 
Cytokines are low molecular weight proteins that are secreted from a variety of cells and 
activate intracellular signalling pathways following binding to their receptors.  Cytokines that 
play a role in promoting inflammation are known as pro-inflammatory cytokines and 
examples include interleukin-1 (IL-1), IL-6, IL-12, interferon-gamma (IFN-γ) and tumour-
necrosis factor-alpha (TNF-α).  Cytokines display synergy and redundancy in their function, 
and examples of their roles in acute inflammation are activating effector functions of immune 
cells, inducing expression of other cytokines or chemokines and enhancing expression of 
adhesion molecules on endothelial cells (ECs) (Goldsby et al, 2003).  Chemokines are small 
peptides that play a role in the migration of leukocytes from the circulation to tissues.  They 
possess a cysteine (C) motif and are classified into four categories depending on the amino 
acid sequence of the cysteine motif: the first are CXC chemokines, where two cysteine 
residues are separated by an amino acid (X).  The second are CC chemokines, where two 
cysteine residues are next to one another (Dinarello, 2000).  In the third class, there is a single 
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cysteine residue and in the fourth, two cysteine residues are separated by three amino acids 
(CX3C) (Mantovani, 1999).  Chemokines for neutrophils are of the CXC families, whereas 
monocyte chemokines are of the CC families (Yadav et al, 2010).  Chemokines show 
functional redundancy in that no chemokine acts specifically on one leukocyte population, 
and thus every leukocyte type is affected by at least one chemokine.  Additionally, 
chemokines bind to multiple receptors and the receptors are capable of binding to multiple 
ligands.  The receptors for chemokines are 7-TM domain G-protein-coupled receptors 
(GPCRs) (Mantovani, 1999).  Examples of chemokines include IL-8, monocyte 
chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 alpha (MIP-1α).  
The sources and major functions of several cytokines and chemokines involved in acute 
inflammation are summarised in Table 1.1: 
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Name Type Source(s) Function(s) References 
 
 
 
 
 
IL-1 
 
 
 
 
 
Cytokine 
 
 
 
Monocytes, 
macrophages, 
neutrophils (IL-1α and 
β). 
 
ECs (IL-1α only) 
Enhancing neutrophil survival, 
adhesion, respiratory burst and 
protease release. 
 
Enhancing cytokine production 
and phagocytosis by 
macrophages. 
 
Increasing ICAM-1 and VCAM-
1 expression on endothelial cells. 
 
Inducing chemokine production. 
 
 
 
 
 
 
Lord et al, 1991; 
Dinarello, 2009 
 
 
 
 
IL-6 
 
 
Cytokine 
 
 
ECs, macrophages 
Promoting the acute phase 
response. 
 
Inducing myeloid cell 
differentiation. 
Fiers, 1991; 
Heinrich et al, 
2003; 
Kishimoto, 2005 
 
 
 
 
IL-12 
 
 
 
 
Cytokine 
 
 
Monocytes, 
macrophages, 
neutrophils, dendritic 
cells  
 
 
 
Inducing IFN-γ production from 
natural killer (NK) cells, T cells 
and macrophages. 
Chan et al, 
1991; 
D’Andrea et al, 
1992; 
Macatonia et al, 
1995; 
Cassatella et al, 
1995; 
Munder et al, 
1998 
 
 
IFN-γ 
 
 
Cytokine 
 
 
Macrophages, NK 
cells, T cells 
Activates antimicrobial 
properties of macrophages. 
 
Increases ICAM-1 expression. 
 
Induces chemokine production. 
 
 
Billiau et al, 
1998 
 
 
 
 
TNF-
α 
 
 
 
 
Cytokine 
 
 
 
 
Activated macrophages 
Activates macrophages and 
increases their cytotoxicity. 
 
Activates neutrophils. 
 
Increases adhesion molecule 
expression on ECs. 
 
Induces chemokine expression. 
 
 
 
Fiers, 1991; 
Goldsby et al, 
2003 
IL-8 Chemokine 
Macrophages, 
neutrophils, ECs 
Neutrophil chemoattractant 
Harada et al, 
1994 
MCP-
1 
Chemokine 
Monocytes, 
macrophages, ECs 
Monocyte chemoattractant 
Yadav et al, 
2010 
MIP-
1α 
 
Chemokine 
Monocytes, 
macrophages, ECs 
Monocyte and macrophage 
chemoattractant 
 
Cook, 1996 
 
 
 
Table 1.1: Summary of the Sources and Major Functions of Several Cytokines and Chemokines Involved 
in Acute Inflammation. 
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Lipid Mediators of Acute Inflammation 
 
Lipid mediators, or eicosanoids, also play an important role in the early stages of acute 
inflammation.  There are two types of such mediators: the prostaglandins and the 
leukotrienes.  Prostaglandins enhance vascular permeability and act in either an autocrine or 
paracrine manner. They are synthesised from arachidonic acid (AA) following its release 
from the nuclear or endoplasmic reticulum (ER) membrane by type IV cytosolic 
phospholipase 2 (cPLA2).  Cyclooxygenase (COX) then converts AA into an intermediate 
prostaglandin, PGH2 (Funk, 2001).  There are two isoforms of COX: COX-1 and COX-2.  
COX-1 is responsible for the constitutive synthesis of basal levels of PGH2, whereas COX-2 
synthesises PGH2 during an inflammatory response.  PGH2 is then metabolised to mature 
prostaglandins by a range of downstream enzymes, depending on the cell type (Funk, 2001).  
Leukotrienes are produced by inflammatory cells such as neutrophils and macrophages, and 
are also synthesised from membrane-released AA.  5-lipooxygenase catalyses the synthesis of 
leukotriene A4 (LTA4) from AA and LTA4 hydrolase converts LTA4 to LTB4, which is a 
potent neutrophil chemoattractant (Funk, 2001).  The receptors for LTB4 are GPCRs of which 
there are two: B-LT1 and B-LT2.  B-LT1 is a high affinity receptor expressed on leukocytes, 
whereas B-LT2 is a low affinity receptor with a more diverse expression (Tager and Luster, 
2003).  In addition to promoting neutrophil chemotaxis, LTB4 stimulates reactive oxygen 
species (ROS) production and release of granule enzymes by neutrophils.  It also enhances 
phagocytosis of bacteria by neutrophils (Sumimoto et al, 1984; Mancuso et al, 2001; Tager 
and Luster, 2003). 
 
 
1.1.3  The Role of Macrophages and Neutrophils in Acute Inflammation 
 
 
Neutrophils 
 
Neutrophils are granulocytic immune cells which are recruited early in the inflammatory 
response and have a relatively short half-life.  However, their lifespan is prolonged by 
microbial products such as LPS, and cytokines including IL-1β, IL-6, TNF-α and IFN-γ.  
This increased survival occurs through interference of apoptosis in neutrophils and is 
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necessary for them to carry out their function in eliminating damaging agents (Colotta et al, 
1992; Mantovani et al, 2011). 
 
Neutrophils present in the circulation infiltrate sites of infection or injury following activation 
of resident macrophages.  Upon sensing danger signals, macrophages produce pro-
inflammatory cytokines such as TNF-α and IL-6, and chemokines such as IL-8 and CXCL1, 
which recruit neutrophils.  Macrophages also release matrix metalloproteases (MMPs), which 
cleave chemokines and enhance their potency (Soehnlein and Lindbom, 2010).  In response 
to TNF-α, IL-1β and IL-17 produced by resident macrophages, ECs express E and P-selectins 
on their surface.  These molecules bind to cell surface markers constitutively expressed on 
neutrophils and allow the immune cells to adhere to ECs. (Borregaard, 2010).  E and P 
selectins bind to P-selectin glycoprotein ligand-1 (PSGL-1) expressed on neutrophils and this 
binding mediates the initial contact between neutrophils and ECs.  The interaction between E-
selectin and CD44 expressed on neutrophils mediates the slower rolling of neutrophils, and 
E-selectin ligand-1 (ESL-1) co-operates with both PSGL-1 and CD44 to allow both the initial 
contact and slow rolling to occur  (Hidalgo et al, 2007).  Chemokines bound to the EC 
surface then bind to their respective receptors expressed on neutrophils and this triggers the 
activation of the β2 integrins, lymphocyte function associated antigen-1 and Mac-1.  These 
interact with intracellular cell adhesion molecule (ICAM)-1 and 2, expressed on ECs, 
allowing firm adhesion to occur (Borregaard, 2010; Williams et al, 2011).  Newly recruited 
neutrophils can roll on adherent neutrophils through interactions between L-selectin on the 
circulating neutrophils and PSGL-1 on the adherent neutrophils (Bargatze et al, 1994; 
Sperandio et al, 2003).  Following firm adhesion, extravasation of neutrophils through the 
endothelial layer occurs by which the immune cells can either pass between cell-cell 
junctions of ECs (paracellular migration) or directly through ECs (transcellular migration) 
into the underlying tissue (Zen and Parkos, 2005). 
   
A well-defined characteristic of neutrophils is their ability to generate ROS through a 
respiratory burst; an abrupt process by which molecular oxygen is reduced to more reactive 
forms (Nathan, 2006).  This is catalysed by the phagocyte NADPH oxidase (phox), which is 
an enzyme complex composed of five components; three localised in the cytosol and two at 
the PM.  Phox functions at the PM upon translocation of the cytosolic components to the PM, 
leading to assembly of the functional complex (Babior et al, 2002). 
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Neutrophils exert their effector functions through three subsets of granules, which each 
contain characteristic proteins.  Primary (azurophil) granules are characterised by 
myeloperoxidase (MPO) content, secondary (specific) granules by lactoferrin and tertiary 
(gelatinous) granules by gelatinase (Borregaard, 2010).  During extravasation, gelatinous 
granules undergo exocytosis and the released MMPs degrade the extracellular matrix (EM), 
facilitating the further entry of immune cells (Faurschou and Borregaard, 2003).  Upon 
encountering bacteria in the underlying tissue, exocytosis of specific granules occurs.   This 
leads to release of proteins such as lactoferrin, which sequesters iron required for bacterial 
survival, and LL37, which has antimicrobial properties (Nathan, 2006).  This is followed by 
exocytosis of azurophil granules resulting in the release of MPO.  MPO converts H2O2 
produced by phox into more potent ROS, such as HOBr, HOI and HOCl, which have 
enhanced microbicidal properties (Nathan, 2006).  Exocytosis of azurophil granules leads to 
the release of bacterial permeability increasing (BPI) protein, which specifically targets 
Gram-negative bacteria affecting their growth and causes damage to their inner membrane 
(Faurschou and Borregaard, 2003).  The N-terminal domain of BPI protein binds to LPS in 
the outer membrane of Gram-negative bacteria, whereas the C-terminal domain promotes 
attachment of bacteria to neutrophils, facilitating phagocytosis (Ooi et al, 1987; Iovine et al, 
1997).  Furthermore, azurophil degranulation results in the release of broad-specificity 
antimicrobial agents, termed seprocidins (Faurschou and Borregaard, 2003).  There are three 
such proteins: proteinase 3, elastase and cathepsin G, which have microbicidal properties and 
also degrade the EM.  Additionally, elastase induces the release of cytokines and chemokines 
from endothelial cells (Owen and Campbell, 1999).  Neutrophils also form extracellular traps 
(NETs) which are composed of proteins from all three types of granule, as well as chromatin.  
NETs are produced by activated neutrophils and kill bacteria extracellularly and degrade 
virulence factors (Brinkmann et al, 2004). 
 
 
Macrophages 
 
Macrophages are mononuclear phagocytes which function as a bridge between innate and 
adaptive immunity through their ability to phagocytose foreign particles and present antigenic 
peptides to lymphocytes.  Macrophages are present throughout the body and play an 
important role in surveying the surrounding tissue for damage and the presence of invading 
microorganisms (Murray and Wynn, 2011).  They also remove dead cells and toxic materials, 
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and respond to danger signals through the recognition of PAMPs and DAMPs by their PRRs.  
Macrophages possess phagocytic receptors that enable them to bind to and internalise 
opsonised particles (Murray and Wynn, 2011). 
 
Macrophages differentiate from precursor cells, termed monocytes, upon the entry of 
monocytes from the circulation into tissue.  Monocytes possess chemokine receptors and 
adhesion molecules that allow them to extravasate from the circulation into tissues during an 
inflammatory response in much the same way as neutrophils do (Geissmann et al, 2010).  
Selectin–mediated weak adhesion initially occurs between monocytes and ECs, followed by 
integrin-mediated firm adhesion as a result of chemokine stimulation and then transmigration.  
The granule components of neutrophils contained within secretory vesicles are involved in 
the attraction of monocytes to the inflamed tissue by increasing CAM expression on ECs or 
through activation of monocytes (Soehnlein et al, 2009).  One such protein is azurocidin 
(CAP37/Heparin-binding protein), which is involved in increasing expression of ICAMs and 
vascular cell adhesion molecule-1 (VCAM-1) on ECs, thereby enhancing the adhesion of 
monocytes to ECs (Lee T et al, 2003).  Azurocidin is also deposited on ECs and promotes 
monocyte arrest, as well as inducing production of IL-8, MIP-1α and TNF-α by monocytes 
(Heinzelmann et al, 2001; Soehnlein et al, 2005).  Another granule protein responsible for 
monocyte recruitment is the seprocidin, proteinase-3, which increases ICAM-1 expression on 
ECs and increases production of MCP-1 by ECs, thereby enhancing monocyte chemotaxis 
(Taekema-Roelvink et al, 2001).  An additional seprocidin, cathepsin G, cleaves CCL15 
which enhances its binding to its receptor and therefore increases monocyte chemotaxis 
(Berahovich et al, 2005).  Thus, the initial recruitment of neutrophils to a site of infected or 
damaged tissue is followed by a second wave of monocyte recruitment in response to release 
of neutrophil granule proteins.    
 
Monocytes in mice are classified into two types based on their expression of CX3CR1, Gr1 
(LY6C) and CCR2.  Monocytes which have a low expression of CX3CR1, are Gr1 and CCR2 
positive (CX3CR1
Lo
 Gr1
+
 CCR2
+
) are termed inflammatory monocytes.  However, 
monocytes that have a high expression of CX3CR1, are Gr1 and CCR2 negative (CX3CR1
Hi
 
Gr1
-
 CCR2
-
) are termed anti-inflammatory or patrolling monocytes (Geissmann et al, 2003; 
Geissmann et al, 2010).  Both types of monocytes in mice are equally abundant, whereas in 
humans, 90% of the monocytes are of the inflammatory phenotype and only 10% of the 
patrolling, non-inflammatory phenotype.  Patrolling monocytes give rise to the non-
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inflammatory tissue resident macrophages, known as alternatively activated (M2) 
macrophages, and replenish the population of these cells in the steady state (Geissmann et al, 
2003; Geissmann et al, 2010).  Inflammatory monocytes are rapidly mobilised for 
inflammation in response to MCP-1, the ligand for CCR2, and upon entry into tissues, 
differentiate into inflammatory, classically activated (M1) macrophages (Murray and Wynn, 
2011).  During differentiation from monocytes to M1 macrophages, expression of CCR2 is 
initially downregulated and then following increased levels of MCP-1 is downregulated 
further, possibly through ligand-induced downregulation (Fantuzzi et al, 1999).  CCR1 and 
CCR5 levels are also increased during differentiation together with increased responsiveness 
to MIP-1α (Kaufmann et al, 2001).  M1 macrophages are activated by LPS and IFN-γ, and 
upon activation, secrete pro-inflammatory cytokines such as TNF-α, IL-1 and IL-12 
(Mantovani et al, 2004).  Furthermore, they produce ROS, such as nitric oxide (NO) and 
superoxide, which are toxic to microorganisms.  M1 macrophages also secrete MMP2 and 
MMP9, which degrade the EM, facilitating further entry of monocytes (Mosser and Edwards, 
2008; Murray and Wynn, 2011).  A list of inflammatory mediators produced by neutrophils 
and macrophages is summarised in Table 1.2: 
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Name Function Source 
Lactoferrin Sequesters iron required for 
bacterial survival 
Neutrophils 
LL37 Antimicrobial properties Neutrophils 
MPO Converts H2O2 into more 
potent ROS 
Neutrophils 
 
 
BPI 
Affects bacterial growth, 
causes damage to their inner 
membrane and promotes 
phagocytosis of bacteria by 
neutrophils 
 
 
Neutrophils 
 
 
Proteinase 3 
Microbicidal properties, 
degrades EM, increases 
expression of ICAM-1 on 
ECs and enhances production 
of MCP-1 by ECs 
 
 
Neutrophils 
 
Cathepsin G 
Microbicidal properties, 
degrades EM and cleaves 
CCL15, enhancing monocyte 
chemotaxis 
 
Neutrophils 
 
Elastase 
Microbicidal properties,  
degrades EM and induces 
release of cytokines and 
chemokines from ECs 
 
Neutrophils 
 
 
Azurocidin 
Increases ICAM and VCAM-
1 expression on ECs, 
promotes monocyte arrest, 
induces production of IL-8, 
MIP-1α and TNF-α by 
monocytes 
 
 
Neutrophils 
TNF-α See Table 1.1 Macrophages 
IL-1 See Table 1.1 Neutrophils/Macrophages 
IL-12 See Table 1.1 Neutrophils/Macrophages 
NO Microbicidal properties Macrophages 
Superoxide Microbicidal properties Neutrophils/Macrophages 
MMP2 Degrades EM Macrophages 
MMP9 Degrades EM Macrophages 
               
 
Table 1.2: Summary of the Inflammatory Mediators Produced by Neutrophils and Macrophages. 
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1.1.4  Signalling Pathways Involved in Acute Inflammation 
 
 
The Toll-Like Receptor (TLR) Signalling Pathway 
 
TLRs are a family of PRRs expressed on macrophages, dendritic cells, B cells, T cells and 
non-immune cells such as fibroblasts and epithelial cells.  They recognise a range of 
microbial and viral PAMPs, and upon this recognition, expression of genes involved in anti-
microbial and antiviral defence is induced (Akira et al, 2006).  TLRs are type-1 TM proteins 
that possess extracellular leucine-rich repeats (LRRs) for PAMP recognition and a cytosolic 
Toll/IL-1R (TIR) domain for intracellular signalling (Kumar et al, 2011). 
 
In humans, 10 TLRs have been identified and 12 in mice, with TLRs 1 - 9 being conserved 
between the two species (Kumar et al, 2011).  TLRs 1, 2, 4, 5 and 6 are expressed at the cell 
surface and recognise a diverse range of microbial PAMPs.  TLRs 3, 7, 8 and 9 are expressed 
in intracellular vesicles such as the ER, endosomes and lyosomes and recognise nucleic acids 
from bacteria and viruses (Kawai and Akira, 2010).  TLR2 recognises components from 
bacteria, such as peptidoglycan, LTA and lipopeptides, and specificity for recognition of 
lipopeptides is conferred through formation of a heterodimer with either TLR 1 or 6 
(Takeuchi and Akira, 2010).  Each heterodimer recognises a distinct set of ligands, with 
TLR2/TLR1 recognising tri-acylated lipopeptides and TLR2/TLR6 recognising di-acylated 
lipopeptides (Jin et al, 2007; Kang et al, 2009).  TLR4 is responsible for the recognition of 
LPS and forms a complex with MD2.  Two complexes of TLR4-MD2-LPS then come 
together to form a functional homodimer (Park et al, 2009).  TLR5 binds to flagellin from 
Gram positive and Gram negative bacteria (Hayashi et al, 2001).  TLR3 recognises double 
stranded (ds) RNA from viruses and binding of dsRNA to the LRRs of TLR3 results in 
dimerisation of TLR3, leading to activation of signalling (Liu et al, 2008).   TLR7 and TLR8 
bind to single stranded (ss) RNA from RNA viruses, and TLR9 to bacterial genomic DNA 
(Hemmi et al, 2000; Heil et al, 2004).  TLRs 1, 2, 5 and 6 activate signalling pathways 
leading to induction of expression of inflammatory cytokines, whereas TLRs 7 and 9 activate 
pathways leading to induction of expression of type I interferons.  TLRs 3 and 4 are capable 
of activating pathways leading to induction of expression of both types of cytokines (Kawai 
and Akira, 2010; Kumar et al, 2011).  Table 1.3 summarises the localisation of TLRs and the 
origin of their recognised ligands: 
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Name of TLR Localisation Recognised Ligands Origin of Ligands 
TLR1/2 Cell surface Tri-acylated 
lipopeptides 
Bacteria 
TLR2 Cell surface Peptidoglycan, LTA Bacteria 
TLR3 Intracellular vesicles dsRNA Viruses 
TLR4 Cell surface LPS Bacteria 
TLR5 Cell surface Flagellin Bacteria 
TLR6/2 Cell surface Di-acylated 
lipopeptides 
Bacteria 
TLR7 Intracellular vesicles ssRNA Viruses 
TLR8 Intracellular vesicles ssRNA Viruses 
TLR9 Intracellular vesicles DNA Bacteria and Viruses 
  
 
Table 1.3: Summary of the Localisation of TLRs and the Origins of their Recognised Ligands. 
 
 
There are four adaptor proteins that associate with the TIR domain of TLRs following ligand 
binding and an induced conformational change in the domain allowing recruitment to occur: 
MyD88, TRIF, TIRAP and TRAM (Akira et al, 2006; Kumar et al, 2011).  All TLRs require 
MyD88 for their signalling except for TLR3, which recruits only TRIF.  TLRs 1, 2, 4 and 6 
also recruit TIRAP in addition to MyD88, and TLR4 recruits TRIF and TRAM in the absence 
of MyD88.  Thus, TLR4 recruits all four adaptor proteins and can signal in a MyD88-
dependent and MyD88-independent manner (Kumar et al, 2011). 
 
In MyD88-dependent signalling, MyD88 is either directly recruited to the TIR domain of 
TLRs or in the case of TLR2 and TLR4 signalling, is recruited following prior recruitment of 
TIRAP to the TIR domain (Yamamoto et al, 2002; Akira et al, 2006).  MyD88 then interacts 
with IL-1 receptor-activated kinase (IRAK) -4, which then sequentially activates IRAK-1 and 
IRAK-2 through phosphorylation.  Following this activation, the IRAKs then dissociate from 
MyD88 and interact with the E3 ubiquitin ligase, tumour necrosis factor associated factor 
(TRAF) 6 (Kawagoe et al, 2008; Takeuchi and Akira, 2010).  TRAF6 forms a complex with 
the E2 ubiquitin-conjugating enzyme complex, Ubc13 and Uev1A, which results in self-
ubiquitination of TRAF6 (Deng et al, 2000; Takeuchi and Akira, 2010).  Transforming 
growth factor-beta (TGF-β) activated protein kinase binding (TAB) 2 and TAB3 are also 
ubiquitinated and form part of a complex together with TAB1 and TGF-β activated protein 
kinase (TAK1), which leads to activation of TAK1.  TAK1 then activates a signalling 
cascade involving the mitogen activated protein (MAP) kinases extracellular signal-regulated 
kinases (ERK) 1 and 2, p38 and c-Jun N-terminal kinases (JNK).  This leads to activation of 
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transcription factor activator protein-1 (AP-1) and induction of expression of genes encoding 
pro-inflammatory cytokines (Kawai and Akira, 2010).  TAK1 also phosphorylates IκB kinase 
(IKK)-β, which is part of a complex along with IKK-α and nuclear factor kappa B (NF-κB) 
essential modulator, and this leads to phosphorylation and ubiquitin-mediated degradation of 
IκB.  NF-κB is released and translocates to the nucleus to induce expression of genes 
encoding pro-inflammatory cytokines, such as IL-1, IL-6, IL-12 and TNF-α (Medzhitov et al, 
1997; Kaisho et al, 2001; Takeuchi and Akira, 2010).   
 
In MyD88-independent signalling, TLR3 directly recruits TRIF to its TIR domain, whereas 
TLR4 requires recruitment of TRAM prior to recruitment of TRIF (Yamamoto et al, 2003a; 
Yamamoto et al, 2003b).  TRIF then associates with TRAF3 and TRAF6 through its N-
terminal TRAF-binding motifs (Takeuchi and Akira, 2010).  TRIF also has a C-terminal 
receptor-interacting protein (RIP) homotypic interaction motif which is involved in 
interacting with RIP1 (Meylan et al, 2004).  RIP1 is then ubiquitinated and together with 
TRAF6, lead to NF-κB activation in a similar manner to MyD88-dependent signalling.  
TRAF3 undergoes self-ubiquitination and activates TANK-binding kinase-1 (TBK1) and 
IKK-i, which are associated with NAK-associated protein-1 and SINTBAD (Sasai et al, 
2005; Ryzhakov and Randow, 2007; Takeuchi and Akira, 2010).  This leads to activation of 
IRF3 and IRF7 which results in their translocation to the nucleus and induction of expression 
of genes encoding type 1 interferons (Takeuchi and Akira, 2010).                   
 
 
The NLRP3 Inflammasome 
 
NLRs are a family of highly evolutionarily conserved cytoplasmic PRRs that are primarily 
expressed in immune cells such as macrophages and dendritic cells, but also in other non-
immune cells such as epithelial cells (Chen et al, 2009).  One member of this family that has 
gained a lot of attention recently is NLRP3, which forms part of a molecular platform known 
as the NLRP3 inflammasome that results in the activation and secretion of mature IL-1β.  It is 
composed of three components: NLRP3, the adaptor protein apoptosis-associated speck like 
protein containing a caspase activation and recruitment domain (ASC) and the cysteine 
protease, caspase-1 (Fig 1.1; Agostini et al, 2004).  The NLRP3 inflammasome is expressed 
in monocytes, neutrophils, dendritic cells, T and B lymphocytes, as well as epithelial cells, 
along the gastrointestinal tract.  It is also expressed in the oral cavity and oesophagus 
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(Kummer et al, 2007; Cario, 2010).  In addition to the NLRP3 inflammasome, there are other 
inflammasomes that are involved in the processing of caspase-1, which are each activated by 
different danger signals.  The NLRP1 inflammasome and the IPAF inflammasome, which do 
not require ASC, are activated by anthrax toxin and secretion signals of Gram negative 
bacteria, respectively.  The AIM2 inflammasome, which does require ASC, is activated by 
bacterial and viral DNA (Schroder and Tschopp, 2010). 
 
Various danger signals can activate the NLRP3 inflammasome, such as PAMPs, asbestos, 
ATP and crystalline particles (Tschopp and Schroder, 2010).  Several of these activators are 
internalised at the cell surface and once in the lysosome, cause destabilisation of the 
lysosomal membrane. This leads to release of the lysosomal protease, cathepsin B, which 
activates NLRP3 through an unknown mechanism (Hornung et al, 2008; Tschopp and 
Schroder, 2010).  However, not all of these danger signals activate cathepsin B, such as ATP, 
indicating an activation mechanism independent of the lysosome (Hornung et al, 2008).  All 
known activators of the NLRP3 inflammasome, however, appear to lead to the production of 
ROS although the source of ROS is currently a matter of controversy (Schroder et al, 2010; 
Tschopp and Schroder, 2010).  Studies by Dostert et al have shown that inhibition of 
NADPH oxidase with diphenylene iodonium or apocycin result in blocking production of 
mature IL-1β. However, the mitochondrial complex II inhibitor TTFA, which prevents 
mitochondrial ROS production, had no effect on production of mature IL-1β (Dostert et al, 
2008).  It was also shown that knockdown of the p22
phox
 subunit of NADPH oxidase 
decreased IL-1β secretion (Dostert et al, 2009).  Thus Dostert et al propose that the source of 
ROS is NADPH oxidase and not mitochondria (Dostert et al, 2008; Dostert et al, 2009).  In 
contrast, another study has shown that IL-1β secretion is independent of the NADPH 
oxidases Nox 1 – 4 (van Bruggen et al, 2010).  Zhou et al propose that the source of ROS 
species is derived from the mitochondria and this is shown by inhibition of complex II with 
TTFA resulting in a block in IL-1β secretion.  Furthermore, inhibition of complexes I and III, 
which results in ROS production, leads to IL-1β secretion (Zhou et al, 2011).  Complexes I, 
II and III are electron-transporting complexes that play a sequential role in the formation of 
ROS from oxygen through a series of redox reactions (Raha and Robinson, 2000).  Thus, it 
appears that whilst ROS are required for the activation of the NLRP3 inflammasome, the 
source is still debatable. 
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The generation of ROS results in thioredoxin dissociating from thioredoxin-interacting 
protein (TXNIP), allowing TXNIP to bind to NLRP3, activating it (Zhou et al, 2010).  Upon 
activation, NLRP3 oligomerises through homotypic interactions between NACHT domains 
and uses its pyrin domains (PYDs) to interact with PYDs of ASC.  ASC then recruits pro-
caspase-1 and they interact through their caspase activation and recruitment domains 
(CARDs).  This leads to auto-activation of pro-caspase-1, which then cleaves IL-1β from its 
pro-form to its active form (Schroder et al, 2010; Tschopp and Schroder, 2010).  The 
induction of expression of the pro-form of IL-1β occurs via signalling through PRRs, such as 
TLRs which generate IL-1β through NF-κB signalling (Chen et al, 2009; Stutz et al, 2009).  
Thus, two signals are required for full activation of IL-1β: the first is a priming signal 
necessary for inducing expression of the pro-form of IL-1β and a second signal resulting in 
activation of the inflammasome leading to cleavage of the pro-form of IL-1β to its active 
form.  A schematic of NLRP3 inflammasome activation is shown in Fig 1.1: 
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Figure 1.1: Schematic Representation of the Two Signal Hypothesis of NLRP3 Inflammasome Activation. 
A priming signal (Signal 1) that activates TLR signalling leads to induction of expression of pro-IL-1β in a NF-
κB-dependent manner.  Various danger signals (Signal 2) can lead to the production of ROS (1), which activates 
the NLRP3 inflammasome (2).  Several danger signals are internalised at the cell surface and once in the 
lysosome, cause rupture of the lysosomal membrane, leading to release of cathepsin B.  Cathepsin B activates 
the NLRP3 inflammasome through an unknown mechanism (3).  The end result of activation of the 
inflammasome is production of mature, active IL-1β from the pro-form in a caspase-1 dependent manner (4).  
Inset indicates colour-coded domains of the core components of the inflammasome (Figure adapted from 
Tschopp and Schroder, 2010).   
 
 
Following its release, mature IL-1β binds to its receptor IL-1RI and a heterotrimeric complex 
is formed with the co-receptor IL-1RAcP.  MyD88 is then recruited to the TIR domain of IL-
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1RI and IL-1RAcP, and recruits IRAK 4. This leads to auto-phosphorylation of IRAK4, 
resulting in recruitment of IRAKs 1 and 2 (Weber et al, 2010; Dinarello, 2011).  The 
ubiquitin E3 ligase TRAF6 is then recruited and ubiquitinates TAB2, TAB3 and TAK-1 
(Weber et al, 2010).  Following this, TAK-1 associates with TRAF6 and is phosphorylated 
leading to activation of signalling through p38 kinase and JNK.  This results in activation of 
AP-1 and its translocation to the nucleus.  TAK-1 also activates IKKB, which then 
phosphorylates IκB, leading to activation of NF-κB and its translocation to the nucleus.  AP-1 
and NF- κB then cooperatively induce expression of a variety of pro-inflammatory cytokines 
and chemokines including IL-6, IL-8, MCP-1 and IL-1β itself (Weber et al, 2010; Stienstra et 
al, 2012).   
 
 
Mitogen Activated Protein Kinase (MAPK) Signalling Pathways 
 
MAPKs are a family of Ser/Thr kinases that play an important role in inflammatory responses 
by affecting cell differentiation, proliferation and apoptosis.  MAP kinases themselves are 
activated by phosphorylation of Thr and Tyr residues by dual specificity MAP kinase kinases 
(MAPKKs), which are in turn activated through phosphorylation by MAP kinase kinase 
kinases (MAPKKKs).  There are three types of MAPKs: ERKs, JNKs and p38 (Hommes et 
al, 2003).  ERKs are activated by growth factors and mitogens, and to a lesser extent by 
cytokines and environmental stresses, whereas JNKs and p38 are involved in pathways 
activated by cytokines such as TNF-α or IL-1, or through cellular or environmental stresses 
(Ip and Davis, 1998; Zarubin and Han, 2005; Nishimoto and Nishida, 2006).  Signalling 
through ERKs results in phosphorylation of transcription factors such as Elk-1, c-Myc and c-
fos, and this results in induction of expression of genes involved in cell growth and 
proliferation (Nishimoto and Nishida, 2006; Cargnello and Roux, 2011).  Signalling through 
JNKs results in their binding to c-Jun, a member of the AP-1 family of transcription factors, 
and phosphorylating it (Hibi et al, 1993).  As well as c-Jun, JNK is also capable of 
phosphorylating other AP-1 members such as JunB, JunD and ATF2, which form part of the 
AP-1 transcriptional complex (Ip and Davis, 1998; Davis, 2000).  Phosphorylation leads to 
translocation of the AP-1 complex to the nucleus and induction of expression of genes 
encoding pro-inflammatory cytokines such as IL-1 and IL-6, as well as chemokines such as 
MCP-1 (Vukic et al, 2009).  Signalling through p38 results in activation of a range of 
transcription factors including those of the AP-1 family (Ono and Han, 2000; Zarubin and 
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Han, 2005).  Thus, several of the genes whose expression is induced through p38 signalling 
are common to that of JNK signalling, such as IL-1β, IL-6, TNF-α, MCP-1 and IL-8 (Garcia 
et al, 1998; Miyazawa et al, 1998; Goebeler et al, 1999; Marie et al, 1999).              
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1.2  Resolution of Acute Inflammation 
 
 
Resolution of inflammation is an active process that is required to prevent further tissue 
damage to the host once the inflammatory stimulus has been eradicated.  This is necessary to 
avoid chronic inflammation and potentially disease from occurring (Serhan et al, 2008; 
Soehnlein and Lindbom, 2010). 
 
As well as their role in promoting acute inflammation, lipid mediators play an important part 
in the resolution of inflammation and undergo a ‘class switch’ during the change from 
promotion of inflammation to its resolution (Levy et al, 2001).  This results in an alteration in 
production of pro-inflammatory lipid mediators such as prostaglandins and leukotrienes to 
anti-inflammatory mediators (Soehnlein and Lindbom, 2010).  One of these groups is the 
lipoxins, which are derived from AA (Serhan et al, 2008).  Lipoxins are produced by 
neutrophils following their interaction with other cells, such as platelets and epithelial cells, 
and their production by macrophages occurs following uptake of apoptotic neutrophils in a 
TGF-β-dependent manner (Freire-de-Lima et al, 2006; Soehnlein and Lindbom, 2010).  
Lipoxin A4 inhibits neutrophil entry to inflammatory sites, reduces ROS production by 
neutrophils, decreases NF-κB activation and production of pro-inflammatory cytokines and 
chemokines by neutrophils, monocytes and macrophages (József et al, 2002).  Whilst 
lipoxins reduce the transmigration of neutrophils, they promote that of monocytes (Maddox 
et al, 1997). 
 
Another group of anti-inflammatory lipid mediators are the resolvins, which are derived from 
the omega (ω)-3 unsaturated fatty acids (UFAs) eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA).  E-resolvins are derived from EPA and D-resolvins from DHA 
(Serhan et al, 2008).  E-resolvins have been shown to block neutrophil transmigration to 
inflammatory sites and inhibit TNF-α-mediated NF-κB activation (Tjonahen et al, 2006; 
Arita et al, 2007; Serhan et al, 2008).  D-resolvins also inhibit neutrophil transmigration 
(Soehnlein and Lindbom, 2010).  A third group of lipid mediators involved in the resolution 
of inflammation are the protectins, which are derived from DHA (Schwab et al, 2007).  
Protectin D1, together with resolvin E1, increases expression of CCR5 on apoptotic 
neutrophils which results in binding of CCL3 and CCL5, thus preventing further neutrophil 
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influx (Ariel et al, 2006).  Protectin D1 and resolvin E1 also promote phagocytosis of 
neutrophils (Schwab et al, 2007). 
 
The resolution of acute inflammation is dependent upon the removal of apoptotic cells by 
phagocytes.  This is to prevent cell death by necrosis from occurring and exacerbating 
inflammation further through the release of inflammatory mediators from dying cells.  To 
enable their recognition by phagocytes, apoptotic cells display ‘eat-me’ signals on their 
surface.  One of these is phosphatidylserine which binds to a phosphatidylserine receptor 
expressed on phagocytes, as well as other receptors, such as scavenger receptors and integrins 
(Grimsley and Ravichandran, 2003; Li et al, 2003).  This receptor-ligand interaction is 
required for engulfment of apoptotic cells by phagocytes.  Another ‘eat me’ signal is annexin 
A1, which is constitutively expressed in the cytoplasm of neutrophils, monocytes and 
macrophages but upon activation, translocates to the PM.  Annexin A1 then engages its 
receptor, ALXR, and activates signalling in an autocrine, paracrine or juxtacrine manner 
(Perretti and D’Acquisto, 2009).  Annexin A1 reduces neutrophil transmigration, promotes 
apoptosis of neutrophils and their phagocytosis by macrophages (Lim et al, 1998; Solito et al, 
2003; Scannell et al, 2007). 
 
A second type of signal involved in the recognition of apoptotic cells by phagocytes are 
‘find-me’ signals which are released by apoptotic cells and have chemoattractive effects on 
phagocytes (Grimsley and Ravichandran, 2003).  An example of this is lactoferrin, which is 
released by neutrophils and a variety of other apoptotic cells, and reduces neutrophil 
transmigration and activation (Bournazou et al, 2009).  Lysophosphatidylcholine, which 
results from the hydrolysis of phosphatidylcholine by PLA2 in a caspase-3-dependent 
manner, is another ‘find-me’ signal that attracts monocytes and macrophages expressing the 
receptor for lysophosphatidylcholine, G2A, on their surface to apoptotic cells (Lauber et al, 
2003).  The chemokine CX3CL1 is released from apoptotic cells in a caspase-3 dependent 
manner and attracts macrophages which express the receptor for CX3CL1, CX3CR1, on their 
surface (Truman et al, 2008).  Caspase-dependent release of nucleotides such as ATP and 
UTP from apoptotic cells has a chemoattractive effect on monocytes that express the receptor 
P2Y2 on their surface (Elliott et al, 2009). 
 
Engulfment of apoptotic leukocytes by macrophages results in a reduction in the secretion of 
pro-inflammatory cytokines such as IL-1β, IL-12 and TNF-α and chemokines such as IL-8.  
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There is also an increase in secretion of IL-10 and TGF-β, both of which are anti-
inflammatory cytokines (Voll et al, 1997; Fadok et al, 1998).  TGF-β itself reduces secretion 
of IL-8 and the pro-inflammatory cytokines, and platelet-activating factor also achieves this 
effect.  Phagocytosis of apoptotic cells increases levels of prostaglandin E2, which itself 
decreases levels of pro-inflammatory cytokines and IL-8 (Fadok et al, 1998).  Apoptotic cell 
uptake additionally reduces the expression of iNOS in macrophages and the release of NO 
(Freire-de-Lima et al, 2006).  Vascular endothelial growth factor is released following 
phagocytosis of apoptotic cells to initiate the process of tissue repair (Soehnlein and 
Lindbom, 2010). 
 
Neutrophils have been demonstrated to display retrograde transmigration from inflammatory 
sites during the resolution phase as well as undergoing apoptosis and subsequently being 
removed by phagocytosis, as described previously (Matias et al, 2006).   Inflammatory 
macrophages, however, do not undergo apoptosis and only emigrate from inflammatory sites 
to the lymphatic system (Bellingan et al, 1996).  During the resolution of acute inflammation 
in the peritoneum, β1 integrins on macrophages interact with ICAM and VCAM-1 on 
mesothelium cells and this interaction is required for their exit (Bellingan et al, 2002).  The 
β2 integrin, Mac-1, is also required for the efflux of macrophages from the peritoneum to the 
lymph nodes following inflammation and shedding of β2 integrins from macrophages in a 
metalloprotease-dependent manner is also necessary (Cao et al, 2005; Gomez et al, 2012).  
The trafficking of macrophages to lymph nodes may facilitate antigen presentation to 
lymphocytes and initiate the adaptive immune response (Cao et al, 2005).  Undifferentiated 
monocytes also emigrate to the lymph nodes and differentiate into dendritic cells where they 
carry out antigen presentation functions too (Randolph et al, 1999).  The resolution phase is 
characterised by an influx of lymphocytes; primarily B cells but also T cells and NK cells.  
These cells are not required to terminate the inflammatory response but are involved in 
protecting against secondary infection.  The signal through which lymphocytes appear is 
unknown but is proposed to be COX-2 dependent (Rajakariar et al, 2008).   
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1.3  Chronic Inflammation Associated with Metabolic Diseases 
 
 
1.3.1  Obesity 
 
 
Obesity is a disease caused by excess accumulation of fat in the body either due to dietary 
intake of fat or from rare genetic disorders.  Whilst very little is known about the acute 
inflammation associated with obesity, other than a transient influx of neutrophils to adipose 
tissue (AT) between 3 – 7 days following feeding on a high fat diet in mice, more is known 
about the chronic inflammation associated with this disease (Elgazar-Carmon et al, 2008).  In 
vivo studies have shown that chronically obese mice, both those fed on a high fat diet for 16 
weeks and those with genetic disorders fed a normal diet, display a significant upregulation 
of various inflammatory genes highly expressed on macrophages, including F4/80, ADAM8 
and CD68 when compared to mice fed a standard chow diet (Xu et al, 2003).  This 
upregulation occurs only in white adipose tissue (WAT) and not in the liver, muscle or 
spleen.  Furthermore, an infiltration of macrophages in WAT has been shown in these mice 
(Xu et al, 2003). 
 
Various in vitro studies have been carried out to understand the mechanisms leading to the 
chronic inflammation associated with obesity.  Such studies propose that TNF-α, produced by 
resident macrophages in AT, stimulates lipolysis in adipocytes through activation of ERK 
signalling (Souza et al, 2003).  This results in the release of free fatty acids (FFAs), which are 
proposed to activate signalling through MAPKs, leading to further production of TNF-α and 
thus enhancing lipolysis creating a vicious cycle (Suganami et al, 2005).  FFAs are also 
known to activate signalling through the TLR4 pathway in both adipocytes and macrophages 
resulting in activation of NF-κB (Suganami et al, 2007).  Production of TNF-α by resident 
macrophages leads to paracrine induction of MCP-1 expression in adipocytes resulting in the 
recruitment of macrophages to AT (Suganami et al, 2005).  The infiltrated macrophages in 
obese mice tend to be of a classically-activated (M1) pro-inflammatory phenotype, as 
opposed to the alternatively-activated (M2) anti-inflammatory phenotype which are abundant 
in the adipose tissue of lean mice (Lumeng et al, 2007).  This is shown by increased levels in 
expression of genes characteristic of M1 macrophages such as TNF-α and iNOS.  In contrast, 
macrophages from the AT of lean individuals show high levels of genes characteristic of the 
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M2 phenotype, such as mannose receptor C type 2, arginase 1 and IL-10 (Lumeng et al, 
2007).  The scavenger receptor CD36, which is proposed to play a role in FA uptake, 
expressed on macrophages has been shown to be necessary for the M1 phenotype of 
macrophages in AT following feeding on a high fat diet in mice (Kennedy et al, 2011).  
Infiltrated macrophages contribute further to TNF-α production, exacerbating the 
inflammation even more.  The cycle of inflammatory events occurring in adipose tissue 
during obesity is summarised in Fig 1.2:   
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Figure 1.2: Cycle of Obesity-induced Inflammation in Adipose Tissue.  Tumour necrosis factor alpha (TNF-
α), produced by resident macrophages in adipose tissue, activates lipolysis in adipocytes leading to the release of 
free fatty acids (FFAs).  Nuclear factor kappa B (NF-κB) signalling is also activated leading to the induction of 
MCP-1 expression, which recruits macrophages to the adipose tissue.  FFAs activate TLR4 signalling in 
macrophages enhancing TNF-α production and creating a vicious cycle of inflammation (Figure adapted from 
Suganami et al, 2007). 
 
 
Regulatory T (Treg) cells are a subpopulation of T cells which have immunosuppressive 
functions and are characterised by high expression levels of IL-10.  They are enriched in the 
AT of lean mice where they maintain a non-inflammatory state by controlling the Th1 
response.  However, in the AT of mouse models of obesity, numbers of Treg cells are 
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reduced (Feuerer et al, 2009).  The adipocyte-derived hormone, leptin, which controls 
nutritional status may be involved in the reduction in the Treg cell population in AT during 
obesity.  It is proposed that during obesity, the increased secretion of leptin by adipocytes 
reduces the infiltration of Treg cells into AT by decreasing their proliferation.  Increased 
leptin secretion also promotes infiltration of AT by Th1 cells, which leads to release of pro-
inflammatory cytokines by these cells and establishment of a state of inflammation in AT 
(Matarese et al, 2010).  Studies have demonstrated that leptin neutralisation with a blocking 
antibody stimulates Treg proliferation in mice, and that leptin deficient (ob/ob) and leptin 
receptor deficient (db/db) mice also show increased Treg cell proliferation (De Rosa et al, 
2007).  In vitro experiments have shown that the presence of inflammatory macrophages 
inhibits the differentiation of Treg cells (Deiuliis et al, 2011).  Thus, in AT during obesity, it 
appears that there are changes in the profiles of both macrophages and T cells, which result in 
a pro-inflammatory state.    
 
Liver X receptors (LXRs) are a family of nuclear receptors which have been demonstrated to 
reduce MCP-1 and IL-6 secretion in human adipocytes and thus antagonise the inflammation 
associated with obesity (Fernández-Veledo et al, 2009).  LXRs are also expressed in 
macrophages, but their role in adipose tissue during the inflammation associated in obesity is 
unknown.  The function of LXRs in macrophages appears to be species specific with an anti-
inflammatory effect observed in mice and a pro-inflammatory effect in humans.  In mice, 
activation of LXRs with synthetic agonists leads to a decrease in iNOS activity and 
expression as well as a reduction in expression of IL-6, IL-1β, MCP-1 and MMP-9 through 
interference with NF-κB signalling following LPS activation (Castrillo et al, 2003; Joseph et 
al, 2003).  In contrast, in human macrophages, activation of LXRs with synthetic agonists 
increases expression of MCP-1 and TNF-α following LPS stimulation.  Additionally, 
activation of LXRs enhances expression of NADPH oxidase subunits and increases activity 
of NADPH oxidase in human, but not murine, macrophages.  LXR activation also results in 
phosphorylation of JNK, ERK and p38 and increases expression of TLR4 at the 
transcriptional level through binding to the TLR4 promoter, which does not occur in mouse 
macrophages (Fontaine et al, 2007).  Given the conflicting activities of LXRs in human and 
murine macrophages, it will be interesting to see what role these nuclear receptors play in 
macrophages of mouse models of obesity compared to obese human patients.   
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1.3.2  Type II Diabetes 
 
 
The inflammation associated with obesity can lead to the development of insulin resistance in 
adipose tissue, liver and skeletal muscle, resulting in type II diabetes (Zeyda and Stulnig, 
2009).  This occurs via the activation of JNK and NF-κB signalling (Shoelson et al, 2006).  
Lipid accumulation in adipose tissue in mouse models of obesity leads to both increased 
expression and activation of NADPH oxidase, resulting in elevated levels of ROS in 
adipocytes that activate JNK and NF-κB signalling (Furukawa et al, 2004; Shoelson et al, 
2006).  Furthermore, saturated fatty acids (SFAs) can form ceramides that interfere with 
insulin signalling possibly through activation of JNK and NF-κB pathways (Straczkowski et 
al, 2004; Shoelson et al, 2006).  Ceramides also activate protein phosphatase 2A, which leads 
to inhibition of Akt/PKB, thus interfering with insulin signalling (Dobrowsky et al, 1993; 
Resjö et al, 2002).  In vivo studies have shown that obesity generates stress in the ER that 
results in activation of JNKs (Özkan et al, 2004).  ER stress also downregulates expression of 
the glucose transporter GLUT4 in adipocytes in vitro, which is required for glucose uptake in 
response to insulin signalling (Miller et al, 2007).  JNK promotes insulin resistance by 
phosphorylating insulin receptor substrate (IRS)-1 (Lee Y et al, 2003).  NF-κB, however, 
does so by inducing expression of target genes whose products promote insulin resistance 
(Shoelson et al, 2006).  LXRs improve insulin sensitivity through preventing activation of 
JNK 1/2 and thus IRS-1 phosphorylation in human adipocytes.  Additionally, activation of 
LXRs with agonists stimulates glucose uptake and promotes phosphorylation of Akt 
(Fernández-Veledo et al, 2008; Fernández-Veledo et al, 2009). 
 
 
1.3.3  Atherosclerosis 
 
 
Another inflammatory disease associated with accumulation of excess lipid in the body is 
atherosclerosis, which is characterised by the accumulation of fatty deposits in blood vessel 
walls.  This results in narrowing of the lumen which reduces blood flow and can lead to 
cardiovascular complications.  Low density lipoprotein (LDL) particles that have 
accumulated in the arterial intima become oxidised and the degree of oxidation affects the 
ability of these molecules to engage receptors (Glass and Witztum, 2001).  Partially oxidised, 
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or minimally modified (mm), LDL is still able to bind to the LDL receptor (LDLR), whereas 
extensively oxidised LDL (oxLDL) is unable to bind to the LDLR, but can engage scavenger 
receptors on macrophages (Glass and Witztum, 2001).  The oxidation of LDL is proposed to 
be due to ROS produced by ECs, macrophages and smooth muscle cells (SMCs).  Oxidation 
of LDL molecules induces activation of ECs, resulting in upregulation of expression of 
CAMs on the surface of ECs, as well as release of chemoattractants (Rocha and Libby, 2009).  
E and P selectins have been shown to be required for the formation and progression of 
atherosclerotic lesions, indicating their importance as CAMs (Dong et al, 1998).  Studies in 
mice have also demonstrated the requirement of both MCP-1 and its receptor CCR2 for the 
development of atherosclerosis (Boring et al, 1998; Gu et al, 1998).  Monocytes are recruited 
which subsequently differentiate into macrophages as a result of macrophage colony 
stimulating factor release from ECs (Rajavashisth et al, 1990).  Differentiated macrophages 
then bind to and internalise oxLDL, most likely through CD36 engagement (Febbraio et al, 
2000).  This generates lipid droplets in the macrophage cytoplasm, resulting in the 
macrophages becoming foam cells (Moore and Tabas, 2011).  An aggregation of foam cells 
leads to the formation of an atherosclerotic plaque in the blood vessel wall (Rocha and Libby, 
2009).   
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1.4  Zebrafish (Danio rerio) as Model Organisms in Immunological 
Research 
 
 
1.4.1  Advantages and Limitations of Using Zebrafish to Understand Acute Diet-
Associated Inflammation of Metabolic Diseases 
 
 
At present, much is known about the chronic inflammation associated with diseases of the 
metabolic syndrome in terms of the cell populations involved, the signalling pathways 
activated and the localisation of this inflammation in sites such as AT and the vasculature.  
However, what is known about the signalling pathways involved derives largely from 
information gained from in vitro studies.  Furthermore, there is a lack of real time in vivo 
information on the infiltration of immune cells at inflammatory sites.  Despite these 
shortcomings, the acute inflammation that occurs following feeding on a high fat diet is much 
more poorly understood in terms of the localisation of the inflammation, and the cell types 
and signalling pathways involved.  This is particularly the case for a feeding period in the 
timescale of a few hours. 
 
The zebrafish (Danio rerio) may potentially shed some light on the mechanisms of acute 
inflammation following high fat feeding due to a number of advantages it has over other 
systems.  This model organism could also provide further information on the chronic 
inflammation associated with the metabolic syndrome.  Zebrafish larvae are optically 
transparent, permitting imaging at the organismal level and facilitating localisation of 
inflammation following acute feeding.  There are a variety of transgenic strains available 
which express fluorescent proteins under promoters of immune cells.  This allows the 
localisation and behaviour of these cells to be studied in vivo at the organismal level in real 
time after an acute feeding period which cannot be carried out in mice or other mammalian 
systems.  Wholemount antibody staining can also be performed on zebrafish larvae in 
situations where there are no available transgenic strains.  In mice, this technique can only be 
applied on tissue sections and is considerably more laborious, time consuming and does not 
provide information at the organismal level.  The optical transparency of zebrafish larvae also 
allows the use of fluorogenic probes in vivo to investigate, for example, the activation of 
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signalling pathways in acute diet-associated inflammation.  In other systems, this technique 
can only be applied in vitro, limiting its applications.  Similarly, the use of small molecule 
pharmacological inhibitors to investigate signalling pathways is largely restricted to in vitro 
use in mammalian systems.  Zebrafish, however, are very amenable to this treatment as the 
inhibitors can be administered into the water.  Thus, this allows the role of signalling 
pathways involved in acute inflammation associated with a high fat diet to be investigated in 
a high-throughput manner. 
 
Morpholinos (MO) are oligonucleotides that block translation or splicing and can be used at 
the one-cell stage to transiently knock down genes in zebrafish embryos through 
microinjection (Nasevicius and Ekker, 2000).  The effects of these knockdowns on immune 
signalling pathways involved in acute diet-associated inflammation can then be studied.  
Because zebrafish produce large numbers of offspring in a clutch through rapid external 
fertilisation, the developing embryos can be utilised without sacrificing the parent.  Thus, a 
lot of embryos can be injected in a single experiment shortly after breeding the parents, which 
cannot be done in mammalian systems.  Furthermore, in mice, the process of generating null 
mutants is considerably more time consuming than the transient gene knockdown that can be 
performed in zebrafish.  The innate immune system in zebrafish develops well before full 
development of the adaptive immune system, which takes 4 – 6 weeks to fully develop (Lam 
et al, 2002; Sullivan and Kim, 2008).  Therefore, the innate immune responses can be studied 
with or without involvement of the adaptive immune system (Sullivan and Kim, 2008).  
 
As a model organism, the zebrafish itself has disadvantages.  The entire zebrafish genome 
underwent a duplication event during evolution of teleost fish, which means that functional 
redundancy may occur with certain genes (Postlethwait et al, 2000).  This may be beneficial 
when generating mutants which would otherwise be embryonic lethal but this functional 
redundancy hampers the ability to use morpholinos in gene knockdown.  This is because it is 
possible that a paralogue of the gene being knocked down can exert a compensatory effect.  
A further limitation in the use of morpholinos is that if the gene of interest is involved in the 
early stages of development, it may result in an embryonic lethal phenotype preventing its 
effects at the desired stages from being studied.  The innate immune system of zebrafish also 
differs in its ability to respond to external stimuli to that of mammals.  This is due to 
differences in the function of accessory molecules between zebrafish and mammals or a lack 
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of certain accessory molecules in zebrafish that are present in mammalian systems (Iliev et 
al, 2005). 
 
Zebrafish have been recently used to model the chronic basis of atherosclerosis.  Feeding a 
high cholesterol diet to adult fish for 8 – 12 weeks results in hypercholesteraemia, lipoprotein 
oxidation and the formation of fatty streaks in the arteries, consistent with the observations 
for mouse models of this disease (Stoletov et al, 2009).  Furthermore, feeding zebrafish 
larvae a high cholesterol diet for 2 weeks leads to oxidation of lipoproteins containing 
apolipoprotein B (apoB), consistent with mmLDL observed in mammalian models (Fang et 
al, 2010).  Larvae of transgenic strains fed a high cholesterol diet for 10 days show an 
accumulation of myeloid cells in the vascular wall (Stoletov et al, 2009).  Thus, as a model 
organism, the zebrafish is capable of replicating at least some of the features associated with 
atherosclerosis observed in mammalian systems and could potentially provide insight into the 
acute basis of these metabolic diseases. 
 
 
1.4.2  Development of the Innate Immune System in Zebrafish Through Haematopoeisis 
 
 
The innate immune system is a first line of defence against infection and the cells involved 
develop through a process known as haematopoiesis.  In vertebrates, haematopoiesis occurs 
in two successive waves, known as primitive (embryonic) and definitive (adult) (Warga et al, 
2009).  Primitive haematopoiesis in zebrafish occurs in two distinct sites of the lateral 
mesoderm: the development of erythroid and endothelial precursors occurs in the posterior 
lateral plate mesoderm (P-LPM), which forms the intermediate cell mass (ICM), whereas the 
development of myeloid cells occurs in the anterior lateral plate mesoderm (A-LPM), which 
forms the posterior blood island (PBI) (Dooley et al, 2005).  Primitive haematopoiesis is 
controlled by the action of various transcription factors.  One of these is Pu.1, which plays an 
important role in the development of myelomonocytes and granulocytes (Scott et al, 1994; 
McKercher et al, 1996).  Pu.1 is known to function downstream of the early haematopoietic 
genes Cloche, Etsrp and Scl and is first expressed at around 12 hours post fertilisation (hpf) 
in the A-LPM, followed by expression in the ICM at around 22 hpf (Bennett et al, 2001; 
Ward et al, 2003; Rhodes et al, 2005; Bukrinsky et al, 2009).  Pu.1 is initially expressed in 
erythro-myeloid progenitors and plays an important role in suppressing erythropoiesis in the 
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A-LPM by antagonising the function of Gata1, which is necessary for promoting 
erythropoiesis (Rhodes et al, 2005).  At the same time, Pu.1 is involved in driving 
myelopoiesis through promoting the expression of markers of myeloid cells, such as MPO, L-
plastin and Lysozyme C (LyzC).  Studies have demonstrated that Pu.1 morphant embryos 
display a reduced expression of MPO, L-plastin and LyzC, and Gata1 morphants an enhanced 
expression of MPO and L-plastin compared to uninjected controls (Rhodes et al, 2005).   
MPO is expressed in granulocytes and is detected initially at 18 hpf within the ICM.  MPO 
expressing cells spread over the yolk sac of the embryo and by 3 days post fertilisation (dpf) 
are present in the anterior yolk sac, posterior ICM and PBI (Bennett et al, 2001).  L-plastin, 
an actin-binding protein expressed in both macrophages and neutrophils, is first detected at 
18 hpf in the anterior yolk sac and by 28 hpf is expressed in the posterior ICM.  Its expression 
however, is greatly reduced by 5dpf (Bennett et al, 2001, Matias et al, 2009).  LyzC, like L-
plastin, is expressed in both neutrophils and macrophages and first appears at approximately 
20hpf in the anterior yolk sac.  At around 30hpf, it is detected in the ICM (Berman et al, 
2005).  A schematic representation of haematopoiesis in zebrafish is shown in Fig 1.3: 
 
         
 
 
Figure 1.3: Schematic Representation of the Events of Primitive Haematopoiesis in Zebrafish Leading to 
Myeloid and Erythroid Differentiation.  Initial expression of genes indicated in hpf.  (Figure adapted from 
Rhodes et al, 2005 and Bukrinsky et al, 2009) 
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1.4.3  In Vivo Real Time Imaging of Zebrafish Immune Cells in Response to 
Inflammatory Stimuli 
 
 
The immune response following acute wounding injury has been investigated in detail in 
zebrafish and takes advantage of transgenic strains expressing fluorescent proteins under the 
promoters of immune cells.  Studies have shown that up to a period of 6h following tailfin 
injury in larvae, there is an increase in the number of neutrophils, marked by green 
fluorescent protein (GFP) expressed under the MPO promoter, to the wounded tail.  There is 
then a subsequent decrease such that by 24h, resolution of the inflammatory response has 
occurred through retrograde chemotaxis of neutrophils back to the vasculature (Matias et al, 
2006).  Other groups have demonstrated that resolution of this neutrophil response can occur 
through apoptosis in a caspase-dependent manner, suggesting two mechanisms of resolution 
(Renshaw et al, 2006; Loynes et al, 2010).  Myeloid cells marked by GFP expression under 
the LyzC promoter show a peak accumulation in a JNK-dependent manner at a wounded tail 
4 – 6h post injury and retrograde resolution occurs 6 – 8h post injury (Zhang Y et al, 2008).  
Studies simultaneously investigating the roles of macrophages and neutrophils have shown 
that neutrophils migrate more quickly than macrophages do to the injury site but 
macrophages remain at the site for longer and phagocytose apoptotic neutrophils.  Such work 
has been carried out using two fluorescent proteins, one under a neutrophil promoter and the 
other under a macrophage promoter to track cells (Ellet et al, 2011). 
 
Real time imaging of fluorescent immune cells has also been used to examine chemically-
induced inflammation.  Treatment of larvae for 3 days with trinitrobenzene sulphonic acid 
(TNBS) results in an accumulation of neutrophils in the intestine which have migrated from 
the caudal haematopoietic tissue (CHT) (Oehlers et al, 2011).  It has additionally been shown 
that fluorescent LyzC and MPO cells migrate from the CHT and PBI to the midline of the tail 
and trunk in a ROS-dependent manner in response to copper sulphate treatment which 
damages neuromasts.  The cells first appear 20 minutes after treatment and numbers begin to 
decrease approximately 2 – 3h post-treatment, such that by 6h resolution has occurred in a 
COX-dependent manner (d’Alençon et al, 2010). 
 
Thus, real time imaging of the behaviour of immune cells in several models of inflammation 
has been used to examine both the onset and resolution of inflammation in vivo, taking 
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advantage of the optical transparency of this model organism.  As the signals that lead to 
macrophage and neutrophil emigration from inflammatory sites during the resolution phase 
of inflammation are currently not well understood, the ability to image these cell populations 
in vivo may provide insight into this.  Furthermore, neither the onset nor the resolution of 
acute inflammation associated with a high-fat diet is well understood and so this property of 
zebrafish can be exploited to understand these processes better.  This may have potential 
therapeutic benefit in preventing the development of diseases such as obesity, diabetes and 
atherosclerosis, which result from an initial acute inflammation phase that fails to resolve.        
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1.5  Uptake and Processing of Dietary Fat 
 
 
Dietary fat primarily takes the form of triacylglycerols (TAG) and is hydrolysed to fatty acids 
(FAs) and diacylglycerols (DAG) by lipases in the intestinal lumen (Tso et al, 2004; Niot et 
al, 2009).  There are three proteins expressed on the apical surface of absorptive intestinal 
epithelial cells, also termed enterocytes, that are thought to be involved in the uptake of FAs, 
but with controversial involvement: plasma membrane fatty acid-binding protein (FABPpm), 
CD36 and fatty acid transport protein 4 (FATP4) (Masson et al, 2010).  The role of FABPpm 
is questionable given that its amino acid sequence is identical to that of mitochondrial 
aspartate amino-transferase, a protein that itself is not involved in fatty acid uptake (Stump et 
al, 1993).  There is conflicting evidence in the literature about the involvement of CD36 as 
studies investigating impaired function of CD36 on long chain FA uptake showed either no 
effect on uptake or a reduced uptake (Goudriaan et al, 2002; Nauli et al, 2006; Nassir et al, 
2007).  FATP4 was initially thought to be involved in long chain FA uptake as studies 
demonstrated that stable overexpression of FATP4 enhanced uptake of palmitic acid and 
reduced expression of FATP4 affected FA uptake by enterocytes (Stahl et al, 1999).  
However, more recent studies have indicated that FATP4 was localised to the ER membrane, 
thus bringing its proposed role as a FA uptake protein into question (Milger et al, 2006).  
FATP4 has also been shown to display acyl coA synthetase activity suggesting an alternative 
function of the protein.  This may involve converting FAs to FA-CoAs, thereby reducing the 
intracellular FA concentration and promoting FA entry through a mechanism of mass entry if 
there are sufficient FAs in the lumen (Hall et al, 2005; Milger et al, 2006).  Thus, it appears 
that CD36 is the only transport protein that may have a plausible potential role in FA uptake 
into enterocytes.  It is possible that FAs initially bind to CD36 and then once in close 
proximity to the PM, enter through passive diffusion (Lynes and Widmaier, 2011).        
         
Another major component of dietary fat is cholesterol which, like FAs, is also taken up by 
enterocytes and first incorporated into mixed micelles to enhance solubility in the intestinal 
lumen (Ros, 2000; Masson et al, 2010).  The uptake protein Niemann-Pick C1-Like 1 
(NPC1L1), which is expressed at the apical domain of enterocytes, is responsible for the 
uptake of cholesterol from the intestinal lumen into the enterocyte (Altmann et al, 2004).    
The localisation of NPC1L1 within the cell is dependent upon the cholesterol content of the 
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cell.  When there is an abundance of cholesterol, NPC1L1 resides in the endocytic 
compartment, but upon cholesterol depletion, NPC1L1 is recycled to the PM (Yu et al, 2006).  
It is proposed that NPC1L1 binds to cholesterol using a predicted N-terminal sterol-sensing 
domain (Betters and Yu, 2010).  The uptake of cholesterol by NPC1L1 is likely through 
clathrin-mediated endocytosis and it is thought that NPC1L1 dissociates from cholesterol 
during the endocytic stages (Ge et al, 2008; Betters and Yu, 2010).  Two other proteins 
expressed at the apical domain of enterocytes are ATP-binding cassette G5 (ABCG5) and 8 
(ABCG8), which are involved in the efflux of excess dietary cholesterol from the enterocyte 
back into the intestinal lumen (Masson et al, 2010).  The expression of proteins involved in 
the uptake of cholesterol by enterocytes is controlled by the activity of LXRs, which are 
activated by oxidised derivatives of cholesterol, known as oxysterols (Zhao and Dahlman-
Wright, 2010).  Activation of LXRs decreases expression of NPC1L1, but increases 
expression of ABCG5, ABCG8 and ABCA1, thus reducing cholesterol uptake and promoting 
cholesterol efflux (Yu et al, 2003; Duval et al, 2006; Zhao and Dahlman-Wright, 2010). 
 
FAs are then processed in the enterocytes to produce TAG, which are then combined with 
apoB48 through the action of microsomal transfer protein (MTP) (Wetterau et al, 1997; Niot 
et al, 2009).  Following its uptake, cholesterol is esterified and the resulting cholesterol esters 
(CEs) are also combined with apoB lipoproteins through MTP (Lee et al, 2000; Iqbal et al, 
2008).  The association of TAG, CEs and apoB lipoproteins leads to the formation of 
chylomicrons (CMs) which are then subsequently transported in the blood to peripheral 
tissues.  Additionally, a small proportion of FAs that are not processed into TAG are secreted 
from enterocytes as FFAs and some free cholesterol is combined with ApoA1 to form high 
density lipoproteins (HDLs) in a process mediated by ABCA1. (Masson et al, 2010).  The FA 
content of CMs is released into AT and muscle, and the resulting CM remnants are taken up 
by the liver through endocytosis (Havel, 1998; Rader and Daugherty, 2008).  The CEs are 
then combined with TAG, phospholipids and apoB100 to form very low density lipoproteins 
(VLDLs), which are subsequently processed to LDLs.  LDLs are taken up by cells to release 
intracellular free cholesterol following hydrolysis in the lysosome (Rhainds and Brisette, 
1999; Brewer, 2000; Daniels et al, 2009).           
 
Zebrafish, like mammals, feed on a diet that contains lipids, express similar proteins involved 
in the transport of dietary fat, and process this fat in essentially the same way as mammals do.  
Dietary FAs are present in the plasma immediately after feeding and as TAG-enriched CMs 
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following processing in the intestine.  Dietary fat is transported from the intestine to the liver 
and in association with lipoproteins, as in mammals (Hölttä-Vuori et al, 2010).  MTP has 
been characterised in zebrafish and is highly expressed in the anterior intestine, consistent 
with this location being the site of lipid uptake in zebrafish (Marza et al, 2005).  The 
expression levels of MTP also increase in response to feeding on a fat-enriched diet, which is 
consistent with similar findings reported in other organisms (Marza et al, 2005; Schlegel and 
Stainier, 2006).  NCP1L1 is conserved in zebrafish and has been shown to be involved in 
cholesterol uptake (Clifton et al, 2010).  A zebrafish orthologue of mammalian Ang2, a 
protein involved in vesicular trafficking of lipids through the Golgi of enterocytes, termed fat 
free has been characterised (Ho et al, 2006).  Lipoproteins such as ApoE, have also been 
characterised in zebrafish (Babin et al, 1997). 
 
Thus, it appears that zebrafish are a useful model organism for the study of dietary fat uptake 
and processing.  Therefore, in combination with their applications in immunological research, 
they can potentially be used to investigate the gastrointestinal inflammatory response 
associated with feeding on a fat-enriched diet.  As zebrafish possess an intestine such as that 
in mammals, this allows the accumulation of cells in this region of the organism to be studied 
following fat feeding.  Furthermore, the localised inflammation in the intestine following 
feeding on a fat-enriched diet has not been studied in detail before at either the acute or the 
chronic stage.    
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1.6  Aims 
 
 
The aims of this thesis are: 
 
 To establish and characterise zebrafish as a model for gastrointestinal inflammation 
following acute feeding on a fat-enriched diet. 
 
 To investigate the role of the NLRP3 inflammasome in the inflammation associated 
with acute feeding on a fat-enriched diet. 
 
 To attempt to generate a stable transgenic line of zebrafish that possesses an ablated 
population of immune cells. 
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CHAPTER 2: MATERIALS AND METHODS 
 
 
2.1  Strains of Zebrafish (Danio rerio) Used and Their Maintenance  
 
The strains of zebrafish used and their source are listed in Table 2.1:  
 
Name of Strain Source 
Wild Type (WT) AB Tübingen (Germany) 
Pu.1 GFP University of Sheffield (UK) 
LyzC GFP University of Bristol (UK) 
LyzC dsRed University of Bristol (UK) 
Tra/Nac Cancer Research Institute (UK) 
 
 
Table 2.1: Strains of Zebrafish Used and Their Source. 
 
 
Fish were maintained according to standard practices and all procedures conformed to UK 
Home Office requirements as per the Animals (Scientific Procedures) Act 1986.  Prior to 
experimental procedures, larvae were initially reared in system water containing 3 x 10
-5 
% 
methylene blue (Sigma) as an antifungal agent and 30mg/L 1-phenyl 2-thiourea (Sigma) to 
prevent melanisation.  
 
 
2.2  Preparation of the Experimental Diets 
 
1g of cholesterol (C75209; Sigma) or the SFAs, palmitic acid (P5585-10G; Sigma) and 
myristic acid (M3128-10G; Sigma), was dissolved in 10ml diethyl ether (Sigma) to create a 
10% solution.  For preparing the unsaturated fatty acids (UFAs), linoleic acid (L1376-5G; 
Sigma) and oleic acid (01008-5G; Sigma), 1ml of the fatty acids was added to 9ml ether to 
create a 10% solution.  In all cases, 400µl was then added to 0.5g of standard zebrafish larval 
food (ZM; ZM Systems) to create an 8% diet.  400µl of diethyl ether was added to 0.5g of ZM 
to serve as a control diet.  The diets were then left overnight for the ether to evaporate and 
then the following day, were ground up into fine particles using a pestle and mortar (Adapted 
from Stoletov et al, 2009).  All diets were stored at 4°C until required.   
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2.3  Feeding of Zebrafish Larvae 
 
For studies on rates of ingestion and gastrointestinal transit, 6 dpf larvae were placed in a 
3cm dish with system water containing 1.0µm polystyrene microspheres conjugated to YFP 
(excitation 505nm/emission 515nm; Invitrogen) at a dilution of 2 x 10
7 
microspheres/ml.  
Larvae were allowed to feed for 4h at 28°C.  For fat feeding experiments, 6 dpf larvae were 
placed in system water containing clotted cream used at a 1:10 dilution (6.25% fat, 0.22% 
carbohydrate and 0.16% protein) and were fed for 6h at 28°C (Schlegel and Stainier, 2006; 
Kadereit et al, 2008).  Larvae were also fed skimmed milk of an equivalent protein 
concentration to the cream, double cream containing 6.25% fat or were unfed for 6h.  
Additionally, 6dpf larvae were fed cholesterol, palmitic acid, myristic acid, linoleic acid and 
oleic acid (all at 8%) or a standard diet (ZM), prepared as described previously, for 6h at 
28°C.  Specific details of the timings of the feedings are described in the Results Sections. 
 
 
2.4  Epifluorescent Microscopy 
 
Larvae were anaesthetised in 0.016% MS222 (Sigma) and imaged using QCapture Pro 
software on an Olympus CKX41 epifluorescent microscope fitted with a QImaging QICAM 
camera, and FITC and TRITC filters.  Specific details of the timings of imaging are described 
in the Results Sections.   
 
 
2.5  Staining of Larvae 
 
2.5.1  Fixation of Zebrafish Larvae 
 
Larvae were fixed overnight in 4% paraformaldehyde (Polysciences Inc) at 4°C.  
 
2.5.2  MPO Activity for Granulocyte Staining 
 
Following fixation, the larvae were washed once in phosphate-buffered saline with 0.1 % 
Tween (Sigma) (PBST) and then once in wash buffer (1 × Trizmal buffer (Sigma), 0.01% 
Tween and H2O) for 5 minutes each.  The larvae were then stained for 30 minutes at 37°C in 
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stain solution (0.015% H2O2 AnalaR) and 1.5mg/ml diaminobenzidine (DAB) substrate 
(Sigma) in wash buffer), followed by two washes in PBST for 5 minutes (Matias et al, 2006). 
Stained larvae were imaged using Leica Application Suite software on a Leica MZ16F 
microscope.  Cell numbers were counted in a blinded manner. 
 
2.5.3  Whole Mount Immunofluorescent Staining of Myeloid Cells in Zebrafish Larvae 
with an Anti-L-plastin Antibody 
 
Following fixation, larvae were washed twice for 5 minutes in PBS and then once for 5 
minutes in de-mineralised (DM) H2O.  They were then permeabilised in acetone (Sigma) for 
7 minutes at -20°C.  Following this, they were rinsed in DM H2O for 30 seconds and then 
incubated in blocking solution (5% donkey serum (Sigma), 1% dimethylsulphoxide (DMSO; 
Sigma) and 0.1% Tween in PBS) for 30 minutes.  Larvae were subsequently incubated 
overnight at 4°C in rabbit anti-zebrafish L-plastin antibody (Gift from Paul Martin, 
University of Bristol, UK) diluted 1:500 in blocking solution.  The following day, larvae were 
washed three times for 20 minutes in PBST and then twice for 20 minutes in blocking 
solution.  They were then incubated for 4h at room temperature in secondary donkey anti-
rabbit immunoglobulin G (IgG) conjugated to TRITC (Stratech) used at 15µg/ml in blocking 
solution.  Following this, larvae were washed four times for 20 minutes each in PBST and 
then imaged using an epifluorescent microscope, as previously described.  Cell numbers were 
counted in a blinded manner. 
 
2.5.4  Whole Mount DAB Staining of Myeloid Cells in Zebrafish Larvae with an Anti-L-
plastin Antibody 
 
Larvae were stained as described above, but following washes in PBS and prior to 
permeabilisation in acetone, were incubated in peroxidase solution (0.5% H2O2 in PBS) for 
20 minutes to block endogenous peroxidase activity.  Additionally, larvae were incubated 
instead in a secondary goat anti-rabbit IgG conjugated to horseradish peroxidise (HRP) 
(Jackson Immunoresearch) used at 4µg/ml in block solution containing 5% goat serum 
(Sigma), 1% DMSO and 0.1% Tween in PBS.  Following the final washes in PBST, larvae 
were incubated for 30 mins in 0.3mg/ml DAB in PBS, followed by incubation for 10 minutes 
in 0.3mg/ml DAB and 0.05% H2O2 in PBS.  Larvae were then washed twice for 5 minutes in 
PBST and then stored at 4°C.     
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2.6  Paraffin Embedded Sectioning of Larvae 
 
Larvae were embedded in a 3% agar block and then through wax processing, transferred to a 
paraffin block (performed by Lorraine Lawrence).  5µM transverse sections were cut using a 
rotary microtome and placed onto glass slides, which were left to dry overnight.  The 
following day, sections were stained with haematoxylin and then mounted with coverslips 
(haematoxylin staining performed by Lorraine Lawrence).  Stained sections were imaged 
using Axiovison Rel 4.7 software on a Leica MPS 60 microscope fitted with an Axiocam 
HRc camera.  
 
 
2.7  Confocal Microscopy 
 
Larvae were imaged on a Zeiss LSM-510 inverted confocal microscope fitted with an argon 
488 laser and a helium/neon 543 (He/Ne 543) laser.   
 
 
2.8  Small Molecule Inhibitor Treatment of Larvae 
 
5 dpf WT larvae were treated with 12.5µg/ml or 25µg/ml ezetimibe (Sequoia Research Ltd) 
overnight, followed by feeding the next day.  6 dpf WT larvae were treated for 30 minutes 
with caspase-1 and 5 inhibitor N-Acetyl WEHD-al (Sigma), cathepsin B inhibitor Ca-074-Me 
(Calbiochem) and NADPH oxidase inhibitor VAS-2870 (Enzo Life Sciences), followed by 
feeding, as previously described.  The inhibitors were administered into the water and were 
present for the duration of the experiment.  Inhibitors were initially used at a range of 
concentrations to determine an optimum concentration, and then further experiments were 
carried out using the optimum concentration and with an appropriate vehicle control. 
 
 
2.9  Treatment of Larvae with the Fluorogenic NADPH Oxidase Probe 
 
6 dpf WT larvae were treated for 1 hour with 50µM fluorogenic NADPH oxidase probe 
Acetyl-pentafluorobenzenesulfonyl fluorescein (Calbiochem) or an equivalent volume of 
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DMSO (Niethammer et al, 2009).  This was followed by a 10 minute feeding period after 
which larvae were anesthetised and imaged under an epifluorescent microscope, as 
previously described. 
 
 
2.10  Treatment of Larvae with Fluorogenic Caspase-1 Substrate and 
Inhibitor 
 
For experiments with the fluorogenic caspase-1 substrate Z-YVAD-AFC (Enzo Life 
Sciences), 6 dpf WT larvae were treated for 1 hour with the substrate used at concentrations 
of 10µM, 40µM and 100µM.  Following this treatment period, larvae were anaesthetised and 
imaged on a Zeiss Axiovert 200 wide-field fluorescent microscope fitted with a CFP filter 
using Improvision Volocity Software. 
 
For experiments with the fluorochrome inhibitor of caspase-1 (FLICA), FAM-YVAD-FMK 
(Immunochemistry Technologies, LLC), 6 dpf WT larvae were fed for 6h.  After this feeding 
period, larvae were removed from the diet and at varying time points following removal, 
were incubated for 30 mins at 28°C in 1x FLICA.  This was followed by a 30 minute wash in 
PBS, and after this larvae were anaesthetised and imaged under an epifluorescent microscope, 
as previously described (Adapted from Yeh et al, 2008).    
 
 
2.11  Morpholino Treatment of Larvae 
 
6 dpf WT larvae were treated with a splice-blocking MO that targets the exon 1 – intron 1 
boundary sequence of zebrafish ASC, a translation blocking MO that blocks the translation 
initiation site of ASC, a specificity control MO containing mismatched base-pairs from the 
splice-blocking morpholino and a standard control MO (Gene-Tools).  All MO were 
conjugated to carboxyfluorescein and administered into the water for 24h.  After this period, 
the larvae were fed, as described previously in the presence of the MO.  A range of 
concentrations of the splice-blocking morpholino were initially used, followed by further 
experiments using the optimum concentration and the other MO at this concentration also. 
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For MO delivery by micro-injection, WT embryos were injected at the single-cell stage into 
the yolk sac using a Narishige IM300 Microinjector (performed by Harriet Taylor).  0.1mM 
concentrations of splice-blocking morpholino, translation-blocking MO (both targeting 
zebrafish ASC) and standard fluorescent control MO were injected.  2h post injection, 
embryos were screened on the basis of the presence of carboxyfluorescein in the dividing 
cells.  Embryos that displayed this fluorescence in the dividing cells only were retained and at 
6 dpf, were fed, as described previously.  A list of the MO used and their sequences is shown 
in Table 2.2: 
 
 
Name of Morpholino Sequence (5’-3’) 
ASC Splice-blocking CAATTGCACTTACATTGCCCTGTGT 
ASC Translation-blocking GGTGCTCCTTGAAAGATTCCGCCAT 
ASC Specificity Control for Splice-blocking CAATTCCAGTTAGATTGCCGTGTCT 
Standard Control CCTCTTACCTCAGTTACAATTTATA 
 
 
Table 2.2: Names and Sequences of Morpholinos Used and Their Sequences. 
 
 
2.12  RNA Extraction from WT Larvae 
 
Larvae were killed by anaesthetic overdose in 0.4% MS222 and then had their intestines 
dissected using forceps with the remaining carcases also being kept.  20 intestines were 
assimilated into a pool and the 20 remaining carcases were split into 4 pools of 5 carcases.  
Tissue was stored in lysis buffer containing β-mercaptoethanol and RNA was extracted using 
a MagMax 96 Total RNA Isolation Kit according to the manufacturer’s instructions 
(Ambion).  Following this, cDNA was synthesised using the following reaction mixture 
(100µl): 85ng RNA, 1 x reaction buffer, 1 x random primers, 1 x dNTPs, reverse 
transcriptase (all available from Applied Biosystems) and H2O.  The reaction conditions were 
a 10 minute incubation at 25°C, followed by 2h at 37°C. 
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2.13  Quantitative Real Time PCR (q-RT PCR) 
 
For TaqMan reactions, the mixture (10µl) was prepared using 1µl cDNA, 0.5µl probe (20x), 
5µl mastermix (2x) (Applied Biosystems) and 3.5µl H2O.  For SYBR green reactions, the 
mixture was prepared using 1µl cDNA, 0.5µl forward (FWD) primer (0.5µM), 0.5µl reverse 
(REV) primer (0.5µM), 5µl mastermix (Applied Biosystems) and 3µl H2O.  Reactions were 
carried out in either duplicate or triplicate, depending on the gene and were run on an ABI 
7500 Fast Real Time PCR System machine.  The following cycling conditions were used: 1 
cycle of 95°C for 20 seconds, followed by 40 cycles of 95°C for 3 seconds and 60°C for 30 
seconds.  A list of genes and the type of reaction run is shown in Table 2.3: 
 
 
Name of Gene Type of Reaction Taqman Assay Code / SYBR Green 
Primer Sequences 
ASC TaqMan Dr03125114_m1 
TNF-α TaqMan Dr03126850_m1 
IL-17 TaqMan Dr03141653_m1 
IFN-1 TaqMan Dr03100938_m1 
m-17 TaqMan Dr03098117_g1 
Lta TaqMan Dr03109563_m1 
IL-10 TaqMan Dr03103209_m1 
IL-12a TaqMan Dr03127924_m1 
Cxcl1 TaqMan Dr03436643_m1 
Cxcl12 TaqMan Dr03119119_m1 
IL-15 TaqMan Dr03077605_m1 
 
IL-8 
 
SYBR Green 
FWD: 
TGTGTTATTGTTTTCCTGGCATTTC 
REV:  
CTGTAGATCCACGCTGTCGC 
 
EF1a (Housekeeping) 
 
SYBR Green 
FWD: 
GGAGATTGCCGCATTGTTGAG 
REV: 
CAGCAAAGCGACCAAGAGGAG 
Actin (Housekeeping) TaqMan Dr03432610_m1 
18S (Housekeeping) TaqMan 4308329 
  
 
Table 2.3: A List of Genes Analysed by qRT-PCR Along with the Type of Reaction Used. 
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2.14 Plasmid Vector Maps 
 
 
 
 
 
Figure 2.1: Schematic Representation of the 14XUAS CFP-NTR Plasmid Vector.  Sites for restriction 
enzymes that cut the vector once only are shown.  Vector map provided by Jeff Mumm, Medical College of 
Georgia, USA.    
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Figure 2.2: Schematic Representation of the pTol(2.4kb LyzC)eGFP Plasmid Vector.  Restriction sites are 
shown in bold and italic.  Tol2L and Tol2R indicate minimal Tol2 transposable elements. PolyA indicates a 
polyadenylation sequence (Figure adapted from Kitaguchi et al, 2009).  
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Figure 2.3: Schematic Representation of the CS-TP Plasmid Vector.  TPase indicates the Tol2 transposase 
cDNA sequence, P-CMV, the cytomegalovirus promoter and SV40 pA, a SV40 polyadenylation sequence.  
Restriction sites and their positions of cutting within the sequence are shown.  Figure taken from the Kawakami 
Lab website http://kawakami.lab.nig.ac.jp/map2.html (Koichi Kawakami Laboratory, National Institute of 
Genetics, n.d). 
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2.15  PCR Amplification of the CFP-NTR Ablation Cassette 
 
The cyan fluorescent protein-nitroreductase (CFP-NTR) ablation cassette from the 14XUAS 
CFP-NTR plasmid vector (Gift from Jeff Mumm, Medical College of Georgia, USA) was 
amplified by PCR using the following reaction mixture: 1x reaction buffer (Promega), 
200µM dNTPs (Promega), FWD primer (5’ – 3’; 
CAGTGATACACCATGGACGAATTCCGGTCGCCACCATGGT; 0.1µM, 0.5µM and 
1µM; Sigma), REV primer (5’ – 3’; 
GTTCTAGAGGCTCGAGACCCGCTAAATCTTCAACCTGGGA; 0.1µM, 0.5µM and 
1µM; Sigma), 3mM MgCl2 (Promega), Pfu (Promega), H2O and approximately 2ng DNA.  
The cycling conditions were: 1 cycle of 95°C for 90 seconds, 35 cycles of 95°C for 30 
seconds, 63°C for 45 seconds and 72°C for 3 minutes, and 1 cycle of 72°C for 7 minutes.  
The reaction was run on a Programmable Thermal Controller – 100 PCR machine.  
 
 
2.16  Restriction Digest of the pTol(2.4kbLyzC)eGFP Plasmid Vector 
 
Approximately 3µg of pTol(2.4kb LyzC)eGFP (Gift from Atsuo Kawahara, National 
Cardiovascular Center Research Institute, Japan) was digested with NcoI in Reaction Buffer 
3 (New England Biolabs (NEB)) to linearise the vector.  The digested product was then 
column purified according to the manufacturer’s instructions (Qiagen).  Following this, a 
second digest of the linearised vector was carried out using XhoI in reaction buffer 2 (NEB) to 
excise the GFP from the vector.  The digested product was column purified.  Restriction 
digests were carried out at 37°C for 4h and 100ng of DNA from the digestion reactions was 
run on a 1% agarose gel. 
 
 
2.17  Recombination of the Digested Vector and PCR-amplified Insert 
Using the Infusion Kit 
 
100ng of vector and 46.7ng of insert were used in the reaction according to the 
manufacturer’s instructions (Clontech).  Following the reaction, 2.5ng and 10ng of DNA 
from the reaction mixture was added to 50µl of Library Efficiency DH5α cells (Invitrogen) 
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along with control reactions supplied with the kit.  The cells were left on ice for 30 minutes 
and then heat shocked for 20 seconds at 42°C.  They were then put back on ice for 2 minutes.  
Following this, 950µl of pre-warmed Luria-Bertani (LB) media (Sigma) was added to the 
cells and they were incubated at 37°C for 90 minutes.  10µl and 90µl volumes were then 
spread onto LB-agar (Sigma) plates containing 100µg/ml of ampicillin (Sigma).    
 
 
2.18  Overnight Growth of Bacterial Colonies 
 
Positive clones were picked and grown in 5ml LB media containing 100µg/ml ampicillin.  
The following day, DNA was miniprepped from the bacterial cultures according to the 
manufacturer’s instructions (Qiagen). 
 
 
2.19  Restriction Digest of the Recombined Vector and Insert 
 
To confirm the presence of the CFP-NTR ablation cassette in the pTol(2.4kb LyzC) vector, 
250ng of miniprepped DNA was digested with EcoRV in Reaction Buffer 3 (NEB) along 
with 1x BSA (Promega) for 4h at 37°C.  100ng of the digestion reaction was run on a 1% 
agarose gel. 
 
 
2.20  Sequencing of the pTol(2.4kbLyzC)CFP-NTR Plasmid Vector to 
Confirm the Presence of the CFP-NTR Ablation Cassette 
 
The pTol(2.4kb LyzC)CFP-NTR plasmid vector was sent for sequencing at Beckman Coulter 
Genomics using four overlapping reverse primers (Sigma) along with an in-house M13R 
primer used to sequence the final 400bp of the CFP-NTR ablation cassette.  Table 2.4 gives 
the sequences for the four overlapping primers and the position of the start site of the primer 
in the CFP-NTR sequence:  
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Sequence of Primer (5’-3’) Position of the Start Site in the Sequence 
GAAGATGGTGCGCTCCTGGACGTA 300 
GGCGAGCTGCACGCTGCCGTCCTC 540 
CTTAGTGGAATGACGCTTTAAGGC 780 
CCAGACATCCTCCATCGCGGTTTT 1020 
 
 
Table 2.4: Sequences of the Overlapping Primers Used and the Position of Their Start Sites in the CFP-
NTR Sequence. 
 
 
2.21  Synthesis of mRNA from the Tol2 cDNA 
 
The pCS-TP plasmid vector containing the Tol2 cDNA (Gift from Koichi Kawakami, 
National Institute of Genetics, Japan) was digested for 6h at 37°C with NotI in Reaction 
Buffer 3 (NEB) to linearise the plasmid vector.  Following this, mRNA was synthesised from 
the Tol2 cDNA within the linearised vector using the SP6 mMessage mMachine kit 
according to the manufacturer’s instructions (Ambion). 
 
 
2.22  Co-injection of pTol(2.4kb LyzC)CFP-NTR Plasmid Vector with Tol2 
mRNA into Embryos at the Single-cell Stage 
 
A DNA/RNA solution containing 25ng/µl of pTol(2.4kb LyzC)CFP-NTR plasmid vector and 
25ng/µl of Tol2 mRNA was injected into WT and Tra/Nac embryos at the single-cell stage 
using a Narishige IM300 Microinjector (performed by Harriet Taylor).  Larvae were screened 
at 3 dpf for the presence of CFP positive LyzC cells using Improvision Volocity software on 
a Zeiss Axiovert 200 wide-field fluorescent microscope fitted with a CFP filter. 
 
 
2.23  Generation and Screening of F1 Larvae   
 
F1 larvae were produced by crossing injected adult F0 founder fish with age-matched WT or 
Tra/Nac fish.  F1 larvae were screened for the presence of CFP positive LyzC cells through a 
tail transection experiment, whereby 3 dpf F1 larvae, LyzC GFP larvae and LyzC dsRed 
larvae were anaesthetised and had their tails transected.  Larvae were then allowed to recover 
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through transfer to fresh water.  5h post transection, larvae were anaesthetised and imaged 
under a Zeiss Axiovert 200 wide-field fluorescent microscope fitted with CFP, GFP and 
rhodamine-TRITC filters for the presence of LyzC positive cells in the wounded tails. 
 
 
2.24  Whole Kidney Marrow (WKM) Extraction from Adult Zebrafish 
 
Adult fish were killed by anaesthetic overdose and then had their kidneys removed using 
forceps.  The tissue was homogenised in PBS containing 10% foetal calf serum (Sigma) to 
obtain a single cell suspension.  The resulting suspension was centrifuged at 1300 rpm for 4 
minutes and the supernatant removed.  The remaining pellet was then resuspended in PBS 
and kept on ice. 
 
 
2.25  Analysis of WKM by Flow Cytometry 
 
Tissue samples were analysed by flow cytometry on a BD LSR Fortessa machine using 
FACS DIVA software with a 405/450 excitation/emission channel and a 488/530 
excitation/emission channel (performed by Fränze Progratzky). 
 
 
2.26  Image Processing and Analysis 
 
Acquired images were processed and analysed using ImageJ and Volocity software. 
 
 
2.27  Statistical Analysis 
 
Statistical analysis was performed for parametric data sets with two groups using a t-test or a 
paired t-test.  For non-parametric data sets with two groups, a Mann-Whitney test or a 
Wilcoxon matched pairs test was used.  For parametric data sets with more than two groups, a 
one-way analysis of variance (ANOVA) was used, followed by a Bonferroni post test.  For 
non-parametric data sets with more than two groups, a Kruskall-Wallis test was used, 
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followed by a Dunn’s post test.  P values of less than 0.05 were deemed statistically 
significant. 
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CHAPTER 3: ESTABLISHING AND CHARACTERISING 
ZEBRAFISH AS A MODEL FOR GASTROINTESTINAL 
INFLAMMATION FOLLOWING ACUTE FEEDING ON A 
FAT-ENRICHED DIET 
 
 
3.1  Introduction 
 
 
Whilst the process by which uptake of FAs into intestinal epithelial cells occurs is similar for 
all FAs, the inflammatory effects associated with different types of FAs vary.  It is known 
that SFAs have pro-inflammatory properties in the context of the chronic inflammation 
associated with obesity and type II diabetes through activation of TLR4 and MAPK 
signalling (Suganami et al, 2005; Suganami et al, 2007).  UFAs, however, are often non-
inflammatory or anti-inflammatory and this has been demonstrated in a number of in vitro 
studies.  Whilst SFAs such as palmitic acid or lauric acid have been shown to induce COX-2 
expression in macrophages, UFAs such as linoleic acid or oleic acid, failed to do so.  
Additionally, lauric acid induced iNOS and IL-1α expression in an NF-κB-dependent 
manner, whereas UFAs inhibited NF-κB activation and also blocked LPS-induced expression 
of COX-2, iNOS and IL-1α (Lee et al, 2001).  Palmitic acid and lauric acid increased 
expression of the monocyte chemokine, IP-10 in macrophages, but linoleic acid and oleic 
acid were unable to do so (Neville et al, 1997; Laine et al, 2007).  Oleic acid and linoleic acid 
have also been shown to antagonise the effects of palmitic acid (Weigert et al, 2004; 
Kennedy et al, 2009).  However, a study by Ciapaite et al has shown that oleic acid can cause 
NF-κB activation just as palmitic acid can in human umbilical vein endothelial cells (Ciapaite 
et al, 2007). Thus, it appears that the effects of oleic acid may vary depending on cell or 
tissue type.  
 
The ω-3 UFAs, DHA and EPA, in particular, have well characterised anti-inflammatory roles 
and have been shown to inhibit IL-1β and TNF-α production by monocytes, and IL-6 and IL-
8 production by ECs (De Caterina et al, 1994; Khalfoun et al, 1997; Chu et al, 1999).  DHA 
has also been demonstrated to decrease E-selectin, ICAM-1 and VCAM-1 expression on ECs, 
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and reduce the ability of monocytes to adhere to the endothelium (De Caterina et al, 1994; De 
Caterina and Libby, 1996).  In vivo studies have shown that switching to a diet enriched in ω-
3 UFAs for 5 weeks following a 15 week feeding period on a high fat diet in mice results in a 
phenotypic switch from M1 to M2 macrophages in AT compared to mice continually fed the 
high fat diet.  The expression levels of M1 inflammatory genes such as IL-6, TNF-α, MCP-1, 
IL-1β and iNOS were also reduced upon switching diets.  However, the expression levels of 
M2 anti-inflammatory genes such as arginase 1 and IL-10 were increased (Oh et al, 2010).  
Thus, the content of dietary fat affects its inflammatory properties.  Western diets 
increasingly contain a high level of saturated fat and are therefore pro-inflammatory in 
comparison to healthier diets rich in ω-3 UFAs, which are anti-inflammatory.  A large 
majority of the studies comparing the effects of SFAs and UFAs have been performed in 
vitro and would require in vivo verification.  The zebrafish presents itself as a highly valuable 
system for examining this in more detail owing to its use for in vivo imaging at the 
organismal level.       
 
As well as the similarity in the manner in which zebrafish process dietary fat to mammals, the 
zebrafish intestine is very similar to that of mammals in terms of both its structure and 
development.  Both contain an epithelium layer that projects into the lumen, comprising the 
mucosa.  Additionally, both the zebrafish and mammalian intestines are composed of a layer 
of inner circular and outer longitudinal smooth muscle, comprising the muscularis (Wallace 
et al, 2005).  Cell renewal in the zebrafish intestine is also very similar to that in mammals 
and epithelial cell proliferation is regulated by the microbiota, as in mammals (Uribe et al, 
1997; Rawls et al, 2004; Crosnier et al, 2005).  However, whilst mammals acquire the 
microbiota in the womb prior to birth, zebrafish are colonised after hatching between 48 - 72 
hpf, once they are no longer protected by their chorions (Bates et al, 2006).  Despite the 
similarities between the zebrafish and mammalian digestive tracts, there are major 
differences.  One of these is that the mammalian intestine is comprised of two distinct organs: 
a small intestine involved in nutrient absorption, and a large intestine involved in water and 
ion uptake.  In contrast, the zebrafish intestine is a continuous structure extending from the 
mouth to the anus (cloaca) (Wallace et al, 2005).  The zebrafish intestine also lacks a 
submucosa region, which is present in the mammalian intestine and contains blood vessels, 
lymphatics and enteric nerves.  Another difference is that in mammals, the epithelium forms 
finger-like projections called villi that extend into the lumen, whereas in zebrafish these 
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projections are broad and irregular (Wallace et al, 2005).  The differences in structure 
between the adult mammalian and zebrafish intestines are shown in Fig 3.1: 
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Figure 3.1: Differences in the Structure and Organisation of the Mammalian (A) and Zebrafish (B) 
Intestines.  The mammalian intestine contains a submucosa layer (yellow) that is absent in that of the zebrafish.  
Additionally, the epithelial projections in the mammalian intestine are finger-like, whereas they are more broad 
and irregular in the zebrafish intestine (Figure adapted from Wallace et al, 2005).   
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The zebrafish intestine is comprised of two regions: the anterior intestine, or intestinal bulb 
(IB), and the posterior intestine (PI).  The two regions carry out distinct roles in the 
processing and absorption of ingested food.  The IB is involved in lipid absorption and this is 
highlighted by the enriched expression of intestinal fatty acid binding protein (I-FABP) in 
this region of 5 dpf, 7 dpf and 9 dpf larvae (Her et al, 2004; Crosnier et al, 2005).  The 
anterior portion of the PI is involved in protein absorption and the posterior portion of the PI 
near the cloaca in water absorption and ion uptake (Crosnier et al, 2005).  Essentially, the 
roles of the IB and the anterior portion of the PI are similar to that of the mammalian small 
intestine, and the role of the posterior portion of the PI is similar to that of the mammalian 
large intestine.   
 
The primitive zebrafish intestine initially arises at 26 – 30 hpf from endodermic tissue 
running from what will form the mouth to the site of where the cloaca will develop.  From 30 
– 52 hpf, formation of the intestinal lumen occurs, which begins in the IB and progresses 
caudally to the PI (Ng et al, 2005).  Following this, the intestine then develops in two stages: 
an expansion stage characterised by rapid cell proliferation and a differentiation stage 
(Wallace et al, 2005).  The epithelium of the intestine undergoes a phase of rapid 
proliferation until approximately 74 hpf, whereby there is a decline in proliferation uniformly 
in all regions of the intestine and junctional complexes have now fully formed between 
epithelial cells (Wallace et al, 2005).  After 74 hpf, epithelial cells adopt a columnar shape 
and undergo polarisation, with the nuclei being localised at the base of the cell (Ng et al, 
2005).  Enteric neurones and smooth muscle progenitor cells both first appear at 
approximately 50 hpf and follow a coincidental differentiation program from about 74 hpf 
(Wallace et al, 2005).  Hormone-producing enteroendocrine cells first appear at 
approximately 52 hpf in the PI and then appear later in the IB (Ng et al, 2005).  At 74 hpf, 
mucus-secreting goblet cells first start to appear primarily in the PI, before differentiating at 
around 100 hpf (Crosnier et al, 2005; Ng et al, 2005; Wallace et al, 2005).  The cloaca opens 
at around 98 hpf and the lumen in the IB enlarges at this time too.  Epithelial folds begin to 
develop in the IB at around 96 hpf and continue until approximately 120 hpf, whereby a fully 
functional intestine has developed (Ng et al, 2005).  Between 6 dpf and 8 dpf, there is an 
increase in the number of neutrophils in the intestine as a result of microbial colonisation 
during this period.  This is necessary to establish a homeostatic population of neutrophils in 
the intestine (Bates et al, 2007). 
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3.2  Aim 
 
 
The aim of this Chapter was to establish and characterise zebrafish as a model for acute 
gastrointestinal inflammation following feeding on a fat-enriched diet.  This was achieved in 
the following ways: 
 
 
 Feeding zebrafish larvae a fat-enriched diet and observing the recruitment of various 
populations of immune cells to the intestine. 
 
 Observing the localisation of immune cells within different regions of the intestine 
following feeding on a fat-enriched diet and examining this in more detail using 
histological sectioning. 
 
 Detecting changes in expression of pro-inflammatory cytokines and chemokines 
following feeding on a fat-enriched diet. 
 
 Investigating the effect of switching from a fat-enriched diet to a standard diet on the 
accumulation of immune cells in the intestine.  
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3.3  Results 
 
 
3.3.1  Structure and Histology of the Zebrafish Larval Intestine 
 
 
 
             
   
 
Figure 3.2: Anatomy of the Zebrafish Larval Intestine at 7 dpf.  (A) Low magnification image of a live 7 
dpf zebrafish larva.  (B) Intestinal bulb (IB) and (C) posterior intestine (PI) of a fixed 7 dpf zebrafish larva.  
Areas of the IB and PI outlined by a black box are enlarged in (D) and (E), respectively.  The intestine is 
outlined in red, (A), (B) and (C), the swim bladder depicted by a red arrow and the eye by a green arrow, (A) 
and (B).  Larvae are oriented sagitally from anterior (left) to posterior (right).  Scale bar (white) represents 1mm, 
black represents 0.4mm and red represents 0.1mm.  Data shown for n = 1 experiments (number of times 
experiment was performed). 
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The zebrafish larval intestine (Fig 3.2, outlined in red) at 7 dpf is composed of two parts: the 
anterior (IB) (Fig 3.2B and D) and the posterior intestine (PI) (Fig 3.2C and E).  The entire 
area outlined in red is the region in which the immune cells are counted in subsequent 
experiments. 
 
In order to further examine the detailed histological structure of the zebrafish larval intestine, 
transverse sections were taken of both the IB and PI in paraffin-embedded 7 dpf larvae.  
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Figure 3.3: Morphology of the Zebrafish Larval Intestine at 7 dpf.  7 dpf WT larvae were fixed in 4% 
paraformaldehyde overnight at 4°C and then one group was not subjected to immunohistochemistry (no Ab) (A) 
and (B).  Another was stained with a secondary IgG antibody conjugated to HRP raised in goat, followed by 
staining with DAB to check for check for non-specific staining of the secondary antibody (C) and (D).  A final 
group was stained with a primary antibody against zebrafish L-plastin raised in rabbit, followed by staining with 
the secondary antibody, and then with DAB (E) and (F).  Larvae were then embedded in a paraffin block and 
5µM sections were cut using a rotary microtome, followed by staining with haematoxylin.  Panels (A), (C) and 
(E) represent sections taken from the IB and panels (B), (D) and (F) represent sections taken from the PI.  
Stained L-plastin positive cells are indicated with an arrow (E) and (F).  l denotes lumen, g goblet cells, e 
epithelial layer and m muscularis.  Scale bar (black) represents 20µM and red represents 10µM.  Data shown for 
n = 1 experiments (number of times experiment was performed). 
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There are three identifiable regions in both the IB and PI: the innermost lumen (l), the 
epithelial layer (e) and the outermost muscularis (m) (Fig 3.3).  Additionally, goblet cells (g) 
are absent in the IB (Fig 3.3A, C and E) but present in the PI (Fig. 3.3B), although not across 
the entire length of the PI.  This is shown by some sections in this region lacking goblet cells 
(Fig 3.3D and F).  Staining larvae with a primary antibody against zebrafish L-plastin in 
combination with the secondary antibody and DAB gave positive staining of myeloid cells 
(Fig 3.3E and F, arrows).  Staining zebrafish larvae with the secondary antibody followed by 
DAB, gave no positive staining indicating absence of both endogenous peroxidase activity in 
the larvae and non-specific staining of the secondary antibody (Fig 3.3C and D).   
 
 
3.3.2  Accumulation of Immune Cells in the Zebrafish Larval Intestine in Response to 
an Enriched Fat Diet 
  
 
Differences in Rates of Ingestion and Transit of Fluorescent Microspheres by Zebrafish 
Larvae 
 
As zebrafish larvae are capable of feeding from 5 dpf onwards, it was important to verify that 
they were able to swallow and ingested material would pass down the digestive tract.  
Fluorescent microspheres were thus used as a marker for following feeding.  6 dpf embryos 
were fed fluorescent microspheres for 4h.  After this feeding period (0h post feeding), larvae 
were selected on the basis of whether or not they had ingested a sufficient number of 
microspheres to fill the IB.  Those with sufficient numbers of microspheres were washed, 
anaesthetised and imaged.  Larvae were also imaged at 4h and 20h post feeding. 
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Figure 3.4: Accumulation and Localisation of Ingested Fluorescent Microspheres by Zebrafish Larvae.  6 
dpf larvae were fed fluorescent microspheres for 4h.  Following this, (0h post feeding), a selection of larvae 
were washed, anaesthetised and imaged.  Larvae were also similarly imaged at 4h and 20h post feeding.  (A) 
Accumulation of green microspheres in a larva after feeding for 4h (0h post feeding).  (B) Localisation of 
microspheres in a larva 4h post feeding.  (C) Clearance of microspheres from the intestine in a larva 20h post 
feeding.  The swim bladder is depicted by a red arrow.  Larvae are oriented sagitally from anterior (left) to 
posterior (right).  Representative images are shown.  Scale bar represents 0.5 mm.  Data shown for n = 1 
experiments (number of times experiment was performed). 
 
 
There was sufficient accumulation of fluorescent microspheres to fill the IB of approximately 
75% of 6 dpf larvae 0h post feeding (Fig 3.4A).  At 4h post feeding, the microspheres were 
still present in the intestines of the larvae, but there were variations in the localisation within 
the intestine.  Approximately 50% of the larvae showed a localisation pattern as in Fig 3.4B, 
with the microspheres having progressed along the length of the IB.  The remaining 50% 
showed a localisation pattern as in Fig 3.4A, with the microspheres displaying the same 
localisation at 0h, indicating no progress along the IB.  At 20h post feeding, approximately 
90% of the larvae had passed the microspheres out of their systems (Fig 3.4C).  Collectively, 
these results demonstrate that 6dpf zebrafish larvae are capable of swallowing, but show 
variations in the transit of the microspheres along their intestines. 
 
 
Accumulation of Granulocytes in the Intestine of Zebrafish Larvae in Response to an 
Enriched Fat Diet 
 
To study the effect of a fat-enriched diet on the number of granulocytes found in the intestine, 
larvae were fed for 6h either clotted cream, milk of an equivalent protein concentration or 
were unfed.  Larvae were then stained for MPO activity, a marker of these immune cells, and 
numbers of cells were counted in the intestine. 
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Figure 3.5: Accumulation of Granulocytes in the Intestines of Zebrafish Larvae Fed a Fat-enriched Diet.  
6 dpf WT larvae were fed either clotted cream containing 6.25% fat, milk of an equivalent protein concentration 
to the cream or were unfed for 6h.  Then they were fixed overnight at 4°C and then stained for MPO activity of 
granulocytes.  (A) Unfed larva, (B) larva fed cream and (C) larva fed milk.  The red box highlights the area of 
interest, with the intestine outlined in white and the swim bladder depicted by an arrow.  MPO positive 
granulocytes are stained black and examples are highlighted with a black open arrowhead.  Larvae are oriented 
sagittaly from anterior (left) to posterior (right).  Scale bar represents 0.5 mm.  Representative images are 
shown.  Comparison of the numbers of granulocytes in the intestines of individual larvae (D) and mean numbers 
of granulocytes (E) in the intestines under the various feeding conditions.  Statistical significance was 
determined using a Kruskall-Wallis test followed by a Dunn’s post test.  *** denotes p < 0.001 and ** p < 0.01.  
Error bars represent 95% confidence intervals.  Data shown for n = 2 experiments (number of times experiment 
was performed).   
 
 
Successful staining in each experiment of the cell type was verified by presence in the blood 
island, the principal region for haematopoiesis in the larvae.  The number of granulocytes in 
the intestine showed a statistically significant increase of ~ 1.5 fold in larvae fed cream 
compared to unfed larvae (Fig 3.5D and E).  As larvae fed milk did not show this significant 
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accumulation, the protein component alone of the cream is not responsible for this effect (Fig 
3.5D and E).    Taken together, the results show that feeding zebrafish larvae an enriched fat 
diet results in a significant accumulation of granulocytes in the intestine. 
 
 
Accumulation of Pu.1 Expressing Cells Peaks at 12h After a 6h Feed on a Fat Enriched Diet 
and Subsides by 27h After Feeding 
 
To examine the effects of acute fat feeding on the accumulation of immune cells in the 
intestines of larvae over a period of time after feeding for 6h, larvae were anaesthetised at 3h 
intervals and imaged over a 27h period after feeding and removal from the cream (Fig 3.6). 
This experiment took advantage of transgenic zebrafish, which express GFP under the 
influence of the Pu.1 promoter.  Pu.1 is a transcription factor that drives myelopoiesis and is 
an early marker of myeloid cells (Scott et al, 1994; McKercher et al, 1996). 
 
 
 
 
 
 
 
Figure 3.6: Design of the Acute Fat Feeding Time Course of 6 dpf Pu.1 GFP Larvae.  Larvae were either 
fed double cream or were unfed for 6h.  At the end of this period (6h + 0h), larvae were removed from the cream 
and placed in system water.  Numbers of Pu.1 expressing cells accumulating in the intestines of cream fed and 
unfed larvae were counted at 3h intervals after removal from the cream.   
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Figure 3.7: Accumulation of Pu.1 Expressing Cells Peaks at 12h After a 6h Feed on a Fat Enriched Diet 
and Subsides by 27h After Feeding.  6 dpf Pu.1 GFP transgenic larvae were either fed double cream 
containing 6.25% fat or were unfed for 6h.  Double cream was found to disperse into the water more uniformly 
than clotted cream following its administration.  After this feeding period, larvae were removed from the diet 
and at 3h intervals post removal, numbers of GFP positive cells were counted in anaesthetised larvae.  Mean 
numbers of GFP positive cells in the intestines of larvae at 3h intervals from the diet.  Statistical significance 
was determined using a t-test or a Mann-Whitney test comparing between unfed and cream fed larvae at each 
time point.  *** denotes p < 0.001, ** p < 0.01 and * p < 0.05.  Error bars represent 95% confidence intervals.  
Data shown for n = 1 experiments (number of times experiment was performed). 
 
 
During the time course there was a slight increase in the number of GFP positive cells in the 
intestines of unfed larvae, suggesting an increase in cell numbers with increasing age.  
Immediately after removal (0h), there was approximately twice the number of cells in the 
intestines of larvae fed cream compared to the unfed control.  Cell numbers increased in 
cream-fed larvae until a peak was reached 12h after removal from the cream (~ 9 cells).  
After this peak, there was a decrease in the number of cells until they reached the level of the 
unfed control 27h after removal from the cream (~ 4 cells).  There was a statistically 
significant difference in the cell numbers in larvae fed cream compared to unfed controls 
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from 0h to 15h after removal from the cream, at which point the significance was lost (Fig 
3.7).  These results show that the number of GFP positive cells in the intestines of larvae fed 
cream increases until a peak is reached 12h after removing the larvae from the cream and this 
is followed by a subsequent decline.  27h after removing the larvae from the cream, the 
inflammatory effect of feeding an enriched fat diet appears to subside. 
 
 
Accumulation of Myeloid Cells in the Intestines of Larvae fed a Fat-enriched Diet for 6h 
Peaks at 18h Following Removal from the Diet 
 
Having seen an accumulation of Pu.1 expressing cells in the intestines of larvae fed a fat-
enriched diet, the behaviour of other myeloid cell populations was then investigated.  Two 
such markers of myeloid cells were LyzC and L-plastin, which are expressed in both 
neutrophils and macrophages but are expressed later in development than Pu.1 (Bennett et al, 
2001; Berman et al, 2005).  A transgenic line of zebrafish expressing dsRed under the 
influence of the LyzC promoter was used along with WT larvae that were stained with an 
antibody against L-plastin.  Larvae were fed for 6h on either a fat-enriched diet or were unfed 
and at various time points following removal from the diet, numbers of dsRed positive cells 
were counted in the intestine.  At these same time points, WT larvae were fixed, stained and 
of L-plastin positive cells were enumerated. 
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Figure 3.8: Accumulation of Myeloid Cells in the Intestines of Larvae fed a Fat-enriched Diet for 6h 
Peaks at 18h Following Removal from the Diet.  6 dpf LyzC dsRed and WT larvae were fed double cream or 
were unfed for 6h.  At various time points following removal from the diet, numbers of dsRed positive cells 
were counted in the intestines of LyzC dsRed larvae.  At the same time points following removal from the diet, 
WT larvae were fixed, stained with an antibody against zebrafish L-plastin and numbers of L-plastin positive 
cells were counted in the intestine.  Mean numbers of dsRed positive cells under the LyzC promoter (A) and L-
plastin positive cells (B) in the intestines of larvae fed either cream or unfed over the time course.  Statistical 
significance was determined using a t-test or a Mann-Whitney test comparing between cream-fed larvae and 
unfed larvae at each time point.  *** denotes p < 0.001, ** p < 0.01 and * p < 0.05.  Error bars represent 95% 
confidence intervals.  Data for n = 1 experiments (number of times experiment was performed).   
  
 
Feeding a fat-enriched diet in the form of cream resulted in an increase in the number of 
dsRed positive cells and L-plastin positive cells until 18h following removal from the diet, 
when a peak was reached (~19 and ~26 cells, respectively).  At 24h following removal from 
the diet, there was a decrease in the number of cells to a level approximately equal to that of 
the unfed control.  The differences in the numbers of both dsRed and L-plastin positive cells 
at 0h, 6h, 12h and 18h after removal from the diet were statistically significant compared to 
the unfed groups at these time points.  The fold changes between the cream-fed and unfed 
larvae at these time points were also approximately the same for L-plastin and dsRed positive 
cells.  However, there were slightly higher numbers of L-plastin positive cells compared to 
the numbers of dsRed positive cells for the unfed group as a result of the resident population 
of L-plastin positive cells in the intestine being higher than that of the dsRed positive cells.  
Consequently, L-plastin positive cells accumulated in greater numbers than dsRed positive 
cells following feeding on a fat-enriched diet (Fig 3.8).  Collectively, these results 
demonstrate that the number of myeloid cells accumulating in the intestine following feeding 
on a fat-enriched diet increases until a peak is reached at 18h, after which there is a decline 
and the fold change between cream-fed and unfed larvae is the same for both L-plastin and 
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dsRed positive cells at the respective time points.  Additionally, there are a slightly higher 
number of resident L-plastin positive cells present in the intestine compared to dsRed positive 
cells and these cells consequently accumulate in slightly greater numbers following feeding 
on a fat-enriched diet.     
 
 
3.3.3  Accumulation of Immune Cells in the Zebrafish Larval Intestine in Response to a 
Cholesterol-enriched Diet 
 
 
Feeding a Cholesterol-enriched Diet has a Similar Effect to Feeding Cream in both the 
Kinetics of the Accumulation of Pu.1 Positive Cells in the Intestine and Numbers of Cells 
 
After establishing that feeding 6 dpf larvae an enriched fat diet in the form of cream results in 
a localised accumulation of immune cells to the intestines of larvae, the next step was to use a 
more refined diet enriched in single components which were present in cream.  Due to the 
crude nature of the cream, in that the fat element was very heterogeneous in terms of its 
composition, it was necessary to see whether or not such individual components were capable 
of achieving the same inflammatory effect as the cream.  Thus, such components may 
potentially be responsible for the effect observed with the cream.  Pu.1 GFP larvae were fed 
either cream, a standard diet (ZM), ZM enriched in cholesterol, palmitic acid, or myrsitic 
acid, or were unfed for 6h.  At various time points following feeding, numbers of GFP 
positive cells were counted in the intestines of the larvae.         
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Figure 3.9: Effect of Feeding Various Components of Cream on the Accumulation of GFP Positive Cells 
in the Intestines of Larvae.  6 dpf Pu.1 GFP larvae were fed double cream, standard diets (ZM) enriched in 
palmitic acid, myristic acid, or cholesterol, ZM or were unfed for 6h (Cholesterol and fatty acids used at a 
concentration of 8%).  At various time points following removal from the diet, the larvae were anaesthetised and 
numbers of GFP positive cells were counted in the intestine.  The graph shows the comparison of the numbers 
of GFP positive cells in the intestines of the larvae fed the various diets at several time points following removal 
from the diets.  Error bars represent 95% confidence intervals.  Data for n = 1 experiments (number of times 
experiment was performed). 
 
 
Feeding larvae a diet enriched in cholesterol resulted in a significant accumulation of GFP 
positive cells in the intestines of these larvae compared to unfed larvae.  The kinetics of the 
cell recruitment and the numbers of cells recruited was similar between larvae fed a 
cholesterol-enriched diet and those fed cream with both effects peaking at 12h following 
removal from the diets.  At this time point, there were approximately 2.5x the number of cells 
in the intestines of larvae fed these two diets compared to unfed larvae.  Larvae fed a palmitic 
acid-enriched diet also showed a significant accumulation of cells.  However, this peaked at 
  3.  Establishing and Characterising the Model 
92 
 
18h following removal from the diet, with the numbers at 12h being lower than both cream 
and cholesterol.  Feeding larvae a myristic acid-enriched diet resulted in a peak recruitment 
of cells at 18h following removal from the diet, but unlike the effect of a palmitic acid-
enriched diet, this was not significantly different to unfed larvae.  Larvae that were fed ZM 
showed a very similar accumulation of cells to that of unfed larvae, indicating that the 
standard diet alone has no inflammatory effect and that any effect seen is due to cholesterol 
or palmitic acid (Fig 3.9).  These results show that cholesterol has a similar effect to cream in 
terms of both the kinetics and the numbers of accumulated cells in the intestine. 
 
 
L-Plastin Positive Cells Show the Greatest Accumulation in the Intestine Following Feeding 
on a Cholesterol-enriched Diet 
 
After observing that feeding larvae on a cholesterol-enriched diet resulted in an accumulation 
of Pu.1 expressing cells in the intestine, the effect of feeding such a diet on other immune cell 
populations was studied.  WT and transgenic strains of larvae expressing GFP under the Pu.1 
or LyzC promoter were fed and at various time points post-feeding, numbers of immune cells 
were quantified in the intestines of transgenic larvae and WT larvae fixed and stained for 
MPO and L-plastin.    
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Figure 3.10: Comparison of the Kinetics of the Accumulation of Different Immune Cell Populations in the 
Intestine Following Feeding on a Cholesterol-enriched Diet.  6 dpf WT, Pu.1 GFP or LyzC GFP larvae were 
fed either 8% cholesterol enriched standard diet (ZM) or ZM for 6h.  At various time points following removal 
from the diet, the numbers of MPO positive cells (A), Pu.1 GFP cells (B), L-Plastin positive cells (C) and LyzC 
GFP cells (D) were counted in the intestine.  MPO positive cells were counted in WT larvae that had been fixed 
and stained for MPO activity in granulocytes.  L-Plastin positive cells were counted in WT larvae that had been 
fixed and antibody stained.  Statistical significance was determined using a t-test or a Mann-Whitney test 
comparing between cholesterol-fed and ZM-fed groups at each time point.  ** denotes p < 0.01 and * denotes p 
< 0.05.  Error bars represent 95% confidence intervals.  Data shown for n = 1 experiments (number of times 
experiment was perfomed).    
 
 
Feeding larvae a cholesterol-enriched diet resulted in an accumulation of all four populations 
of immune cells in the intestine compared to larvae fed a standard diet.  There was also an 
increase in the number of immune cells in the ZM-fed group for all of the populations 
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through the time course, suggesting an age-related increase.  However, the rate of increase of 
immune cells for each successive time point in the cholesterol-fed groups was greater than 
the rate of increase in the ZM-fed groups. This indicates that the accumulation over time 
following feeding on a cholesterol-enriched diet was due to a recruitment of immune cells 
over time and not an initial recruitment at 0h post removal, followed by an age-related 
increase (Fig 3.10).  The peak accumulation of MPO positive cells and cells expressing GFP 
under the Pu.1 promoter (Pu.1 GFP cells) occurred at 12h post-removal (~ 9 cells and ~ 8 
cells, respectively; Fig 3.10A and B), whereas the peak accumulation of L-plastin positive 
cells and cells expressing GFP under the LyzC promoter (LyzC GFP cells) occurred at 18h 
post-removal (~ 28 cells and ~ 15 cells, respectively; Fig 3.10C and D).  Additionally, the 
numbers of recruited L-plastin positive cells following cholesterol feeding were the highest of 
all of the immune cell populations throughout the time course and showed the greatest level 
of statistical significance across the time course compared to the numbers of the ZM-fed 
larvae (Fig 3.10C). 
 
After 12h, there was a reduction in the numbers of MPO positive and Pu.1 GFP cells in 
cholesterol-fed larvae, such that by 24h, the numbers were approximately the same as that of 
the ZM-fed control (~ 5 cells and ~ 4 cells, respectively, Fig 3.10A and B).  After 18h, there 
was a reduction in the numbers of L-plastin positive and LyzC GFP cells in cholesterol-fed 
larvae, such that by 24h post-removal, the numbers of LyzC GFP cells were approximately 
equal to that of ZM-fed larvae (~ 10 cells; Fig 3.10C and D).  However, although the number 
of L-plastin positive cells was reduced at 24h following removal from the diet, they still 
appeared to be higher than that of the ZM-fed larvae (~ 22 cells compared to ~ 17; Fig 
3.10D).  Across the ZM-fed groups, L-plastin positive cells also showed the greatest numbers 
indicating a higher resident population of L-plastin positive cells in the intestine compared to 
the other immune cell populations (Fig 3.10C).  These results demonstrate that L-plastin 
positive cells show the greatest accumulation of the four immune cell populations following 
feeding on a cholesterol-enriched diet and cell numbers peak at 18h post-removal.  
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A Diet Enriched in 8% Cholesterol Gives the Greatest Accumulation of L-Plastin Positive 
Cells in the Intestine 
 
Given that an 8% cholesterol diet resulted in a similar response to cream in terms of the 
accumulation of Pu.1 positive cells in the intestine, it was then necessary to determine 
whether this was the optimum concentration of cholesterol to use as an enriched diet.  In 
order to do this, 6 dpf larvae were fed a range of concentrations of cholesterol or ZM made 
up both in the presence and absence of ether, the solvent in which the diets are prepared, for 
6h.  This was to exclude the possibility of an inflammatory effect associated with ether in the 
diets, although it evaporates from the diets prior to their use.  18h after removal from the diet, 
the larvae were fixed and stained and L-plastin positive cells were enumerated in the 
intestine. 
 
 
 
 
 
Figure 3.11: A Diet Enriched in 8% Cholesterol Gives the Greatest Accumulation of L-Plastin Positive 
Cells in the Intestine.  6 dpf WT larvae were fed either a standard diet (ZM) prepared with or without ether or a 
cholesterol-enriched diet containing various concentrations of cholesterol from 2% - 10% for 6h.  18h following 
removal from the diet, larvae were fixed, stained and numbers of L-plastin positive cells were counted in the 
intestine.  Comparison of cell numbers in individual larvae (A) and mean numbers of cells (B) in larvae fed 
either ZM or cholesterol.  Statistical significance was determined using a one-way ANOVA followed by a 
Bonferroni post test.  *** denotes p < 0.001 and * p < 0.05.  Error bars represent 95% confidence intervals.  
Data shown for n = 2 experiments (number of times experiment was performed).    
 
 
Feeding larvae a diet enriched in a range of concentrations of cholesterol resulted in a dose-
dependent increase in the number of L-plastin positive cells accumulating in the intestine up 
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to an 8% concentration.  A 10% diet gave a similar number of cells (~ 19) as an 8% diet, 
indicating that a peak is reached at an 8% concentration.  Feeding larvae a diet enriched in 
4%, 8% or a 10% concentration of cholesterol resulted in a statistically significant 
accumulation of cells compared to ZM-fed larvae, with 8% and 10% giving the greatest level 
of significance (p < 0.001) (Fig 3.11B).  Furthermore, feeding larvae ZM prepared either in 
the presence or absence of ether gave approximately the same number of cells (~ 11), 
indicating that the ether has no inflammatory effect, as expected.  These results show that a 
diet enriched in 8% cholesterol is sufficient to give the peak accumulation of L-plastin 
positive cells in the intestine. 
 
 
Treating Cholesterol-Fed Larvae with Ezetimibe Reduces the Number of L-Plastin Positive 
Cells Accumulating in the Intestine 
 
Whether the uptake of cholesterol was required for the accumulation of immune cells in the 
intestine to occur was then investigated.  This involved the use of a drug, ezetimibe, which is 
an inhibitor of the cholesterol transport protein NPC1L1, thus preventing cholesterol uptake 
by intestinal epithelial cells (Betters and Yu, 2010).  Larvae were pre-treated with ezetimibe 
or DMSO and then fed a cholesterol-enriched or palmitic acid-enriched diet for 6h.  Numbers 
of L-plastin positive cells were counted in larvae fixed and stained 18h after removal from 
the diet. 
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Figure 3.12: Treating Cholesterol-Fed Larvae with Ezetimibe Prevents L-Plastin Positive Cells from 
Accumulating in the Intestine.  5 dpf WT larvae were pre-treated overnight with either ezetimibe, or an 
equivalent volume of DMSO, or untreated.  The following day, one group of untreated larvae were fed a 
standard diet (ZM) and an untreated group and the treated groups were fed a cholesterol-enriched diet or 
palmitic acid-enriched diet for 6h, whilst in the presence of the drug.  18h following removal from the diet, but 
still in the presence of ezetimibe, larvae were fixed, stained and numbers of L-plastin positive cells were 
counted in the intestines.  Comparison of cell numbers in individual larvae (A) and mean numbers of cells (B) in 
larvae treated with 12.5µM or 25µM ezetimibe, or an equivalent volume of DMSO to the concentrations of 
ezetimibe used (low or high being equivalent to 12.5µM or 25µM, respectively), or untreated under the different 
feeding conditions.  Comparison of cell numbers in individual larvae (C) and mean numbers of cells (D) in 
larvae treated with 25µM ezetimibe or DMSO or untreated under the different feeding conditions.  Statistical 
significance was determined using a Kruskall-Wallis test followed by a Dunn’s post test.  *** denotes p < 0.001 
and * p < 0.05.  Error bars represent 95% confidence intervals.  Data shown for n = 2 experiments (A) and (B), 
and n = 1 experiments (C) and (D) (numbers of times experiments were performed). 
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Treating larvae with 25µM ezetimibe, followed by feeding a cholesterol-enriched diet 
resulted in a reduction in the number of L-plastin positive cells accumulating in the intestine 
compared to cholesterol-fed larvae exposed to an equivalent volume of DMSO to that of 
25µM ezetimibe (~ 7 - 8 compared to ~ 13 - 14).   However treatment with 12.5µM ezetimibe 
had no effect (Fig 3.12A and B).  Larvae fed a palmitic acid-enriched diet exposed to 25µM 
ezetimibe showed no reduction in cell numbers compared to larvae pre-treated with DMSO, 
as expected.  This indicates that palmitic acid is taken up independently of NPC1L1 and 
validates the specificity of ezetimibe in blocking cholesterol uptake only (Fig 3.12C and D).  
Taken together, these results suggest that the uptake of cholesterol may be required for the 
recruitment of L-plastin positive cells to the intestine following feeding on a cholesterol-
enriched diet. 
 
 
3.3.4  Localisation of L-Plastin Positive Cells Within the Zebrafish Larval Intestine 
 
 
L-plastin Positive Cells Tend to Accumulate in the Posterior Intestine of Larvae Fed a 
Cholesterol-enriched Diet 
 
Establishing that acute feeding of a cholesterol-enriched diet to 6dpf larvae resulted in an 
accumulation of a variety of immune cell populations in the intestines, of which L-plastin 
positive cells showed the greatest response, the finer localisation of this population of cells 
within the intestine was examined.  Larvae were fed a cholesterol-enriched diet or ZM and 
numbers of L-plastin positive cells were quantified in the IB and PI of the larvae. 
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Figure 3.13: L-plastin Positive Cells Tend to Accumulate in the Posterior Intestine of Larvae Fed a 
Cholesterol-enriched Diet.  6 dpf WT larvae were fed either a standard diet (ZM), or a cholesterol-enriched 
diet for 6h.  18h following removal from the diet, larvae were fixed, stained and numbers of L-plastin positive 
cells in the intestine were counted.  Examples of L-plastin positive cells are depicted with a white arrow and the 
intestine is outlined in white.  IB denotes the intestinal bulb (A) and (C), and PI posterior intestine (B) and (D).  
Larvae are oriented sagitally from anterior (left) to posterior (right).  Scale bar represents 0.4mm.   Comparison 
of cell numbers in the entire intestines of individual larvae (E) and mean numbers of cells (G) in the entire 
intestines of larvae fed either ZM or cholesterol.  Comparison of cell numbers in the IB and PI of individual 
larvae (F) and mean numbers of cells (H) in the IB and PI of larvae fed either ZM or cholesterol.  Statistical 
significance was determined using a Wilcoxon matched pairs test (E) and (G) or a Kruskall-Wallis test followed 
by a Dunn’s post test (F) and (H).  *** denotes p < 0.001.  Error bars represent 95% confidence intervals.  Data 
shown for n = 2 experiments (number of times experiment was performed). 
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The majority of L-plastin positive cells accumulating in the intestines of larvae fed a 
cholesterol-enriched diet tended to do so in the PI with only a relatively small number in the 
IB.  Numbers in the IB appeared to be similar between ZM-fed and cholesterol-fed larvae but 
there were considerably more cells accumulating in the PI of cholesterol-fed larvae compared 
to ZM-fed larvae. (Fig 3.13A – D).  When quantifying the numbers of L-plastin positive cells 
in the entire intestines of cholesterol-fed larvae compared to ZM-fed larvae, there were 
approximately twice the number of cells in the intestines of larvae fed a cholesterol-enriched 
diet compared to larvae fed ZM (Fig 3.13E and G).  When quantifying the number of cells in 
the IB and PI of cholesterol and ZM-fed larvae, there were no significant differences in cell 
numbers in the IB between the two diets.  However, there was a significant difference of 
approximately three-fold in the PI of larvae fed the two diets (Fig 3.13F and H).  These 
results demonstrate that the majority of L-plastin positive cells accumulating in the intestines 
of larvae fed a cholesterol-enriched diet do so in the PI and there is relatively little 
accumulation in the IB. 
 
 
L-plastin Positive Cells are Localised in the Muscularis of the Intestine for Both Cholesterol 
and ZM-fed Larvae 
 
Given that the majority of cells were localised in the PI, the next step was to determine the 
localisation of these cells within the histology of the intestine.  Fixed and stained larvae were 
embedded in paraffin and 5µM sections were cut. 
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Figure 3.14: L-plastin Positive Cells are Localised in the Muscularis of the Intestine for Both Cholesterol 
and ZM-fed Larvae.  6 dpf WT larvae were either fed a standard diet (ZM) or a cholesterol-enriched diet for 
6h.  18h after removal from the diet, larvae were fixed and antibody stained followed by DAB staining.  Stained 
larvae were then embedded in a paraffin block and 5µM sections were cut using a rotary microtome, followed 
by staining with haematoxylin.  Panels (A) and (C) represent sections taken from the intestinal bulb (IB) and 
panels (B) and (D) represent sections taken from the posterior intestine (PI).  Stained L-plastin positive cells 
(brown) are indicated with an arrow.  l denotes lumen, g goblet cells,  e epithelial layer and m muscularis.  Scale 
bar (black) represents 20µM and red represents 10µM.  Data shown for n = 1 experiments (number of times 
experiment was performed).  
 
 
L-plastin positive cells (arrows) in the intestines of larvae fed ZM were localised in the 
muscularis layer of the gut for both the IB and PI (Fig 3.14A and B).  In the intestines of 
larvae fed a cholesterol-enriched diet, the cells were also distributed in the muscularis for 
both the IB and PI (Fig 3.14C and D).  However, there were approximately two cells per 
section in the PI for cholesterol-fed larvae compared to one cell for ZM-fed larvae, consistent 
with the significant difference in this region (Fig 3.14B and D).  Additionally, a greater 
number of PI sections from cholesterol-fed larvae contained cells than those from ZM-fed 
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larvae, as expected.  The morphology of the guts between ZM-fed and cholesterol-fed larvae 
was the same for both the IB and PI.  These results show that there is no change in 
localisation of recruited L-plastin positive cells in the intestine after feeding a cholesterol-
enriched diet compared to the resident population in the ZM-fed group.  The localised 
inflammation associated with feeding on a cholesterol-enriched diet also does not affect the 
morphology of the intestine compared to feeding on ZM.    
 
 
3.3.5  Analysis of Cytokine and Chemokine Transcripts Following Feeding on a 
Cholesterol-enriched Diet 
 
 
To further study the pro-inflammatory effect of feeding a cholesterol-enriched diet to 
zebrafish larvae, changes in expression of cytokines and chemokines in response to a 
cholesterol-enriched diet were analysed.  Larvae were fed for 4h and immediately after 
feeding, had their intestines dissected and the remaining carcasses also kept.  RNA was 
extracted and cDNA synthesised and analysed by qRT-PCR for expression of a variety of 
cytokines and chemokines (Table 3.1). 
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Name of Gene Result 
TNF-α Undetected 
IL-17 Undetected 
IFN-1 Undetected 
Lta Undetected 
M-17 Undetected 
IL-10 Undetected 
IL-12a Undetected 
Cxcl1 Detectable but no difference 
Cxcl12 Detectable but no difference 
IL-15 Detectable but no difference 
IL-8 Detectable but no difference 
   
   
Table 3.1: Analysis of Transcripts for Various Cytokines and Chemokines Following Feeding a 
Cholesterol-enriched Diet.  6 dpf larvae were fed either a cholesterol-enriched diet or standard diet (ZM) for 
4h and following this, had their intestines dissected with the remaining carcasses also kept.  RNA was extracted 
from the tissue and cDNA synthesized and analysed by qRT-PCR for cytokine and chemokine expression.  
Undetected refers to a gene that gave a CT of above 35 or was stated as beyond the level of detection.  
Detectable but no difference refers to a gene that gave a detectable CT but there was no difference in expression 
between the cholesterol and ZM-fed larvae in both the intestines and remaining carcasses.  Data shown for n = 1 
experiments (number of times experiment was performed). 
 
 
11 cytokines and chemokines were analysed for expression changes by qRT-PCR, but 7 out 
of the 11 were beyond the level of detection.  Of the remaining four that were detectable, 
there was no difference in expression levels in any of these between the cholesterol-fed and 
ZM-fed groups in both the intestines and remaining carcasses (Table 3.1). 
 
Changes in IL-8 expression between the two feeding conditions over a time course were then 
measured. 
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Figure 3.15: Analysis of IL-8 Expression Following Feeding for a Variety of Time Periods.  6 dpf WT 
larvae were fed either a cholesterol-enriched diet or a standard diet (ZM) for 1h, 2h, 4h or 6h.  At the end of 
these time points, larvae had their intestines dissected and the remaining carcasses also kept.  RNA was 
extracted from pooled intestines (20 intestines/pool) and from one pool of carcases (5 carcasses/pool) for each 
condition, and cDNA was synthesised.  Expression levels of IL-8 were determined by qRT-PCR, normalised to 
EF1a and readings were calibrated to a group of larvae that were killed immediately prior to the start of feeding 
(Unfed 0h).  Comparison of changes in IL-8 expression in the intestine (A) and remaining carcasses (rest) (B) 
during feeding on either ZM or a cholesterol-enriched diet.  CT values for IL-8 in both the intestines and 
remaining carcasses ranged between 29-30.  CT values for EF1α both in the intestines and remaining carcasses 
ranged between 18-19.  Data shown for n = 1 experiments (number of times experiment was performed). 
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There appeared to be a reduction in IL-8 expression in cholesterol-fed larvae compared to 
unfed larvae at 0h in both the intestines and remaining carcasses after feeding for 1h.  The 
level of expression then seemed to slightly decrease in the intestines and very slightly 
increase in the remaining carcasses after feeding for 2h.  After a 4h feed, there was an 
increase in expression in both the intestines and remaining carcasses.  After a 6h feed, the 
level of expression decreased slightly in the intestines and remained the same in the 
remaining carcasses.  The trend observed for changes in IL-8 expression throughout the time 
course is very similar in both the intestines and remaining carcasses of ZM-fed larvae with 
only small fluctuations in expression between time points (Fig 3.15).  There were also 
differences in the level of expression in the intestine between cholesterol and ZM-fed larvae 
with expression levels being ~ 1.3 fold lower in cholesterol-fed larvae compared to ZM-fed 
larvae, except after a 4h feed where levels of expression were ~ 1.5 fold higher in cholesterol-
fed larvae.  In the remaining carcasses, expression levels were lower in cholesterol-fed larvae 
compared to ZM-fed larvae (~2 fold at 1h and ~ 1.2 fold at 2h and 6h), except after 4h, where 
levels were ~ 1.3 fold higher.  However, these differences are not biologically relevant.  IL-8 
expression levels were also normalised to other housekeeping genes, but also showed no 
meaningful differences between cholesterol-fed and ZM-fed larvae.     
      
 
3.3.6  Unsaturated Fatty Acids do not Cause a Significant Accumulation of Immune 
Cells in the Intestines of Larvae unlike a Saturated Fatty Acid 
 
 
The data so far has shown that feeding larvae on a palmitic acid-enriched diet resulted in an 
accumulation of immune cells in the intestine compared to ZM-fed larvae (Fig 3.9).  Given 
that palmitic acid is SFA, the effect of feeding a diet enriched in unsaturated fatty acids was 
studied.  Larvae were fed diets enriched in palmitic acid or the UFAs, linoleic acid and oleic 
acid, or ZM for 6h.  18h after removal from the diet, larvae were fixed and stained for L-
plastin positive cells. 
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Figure 3.16: Unsaturated Fatty Acids do not Cause a Significant Accumulation of L-plastin Positive Cells 
in the Intestines of Larvae Unlike Palmitic Acid.  6 dpf WT larvae were fed either a standard diet (ZM), or 
diets enriched in either palmitic acid, linoleic acid or oleic acid for 6h.  18h following removal from the diet, 
larvae were fixed and stained, and numbers of L-plastin positive cells were counted in the intestines.  
Comparison of cell numbers in individual larvae (A) and mean numbers (B) in larvae fed either ZM or varying 
concentrations of palmitic acid. Comparison of cell numbers in individual larvae (C) and mean numbers (D) in 
larvae fed either ZM or the FA-enriched diets (8%).  Statistical significance was determined using a Kruskall-
Wallis test followed by a Dunn’s post test (A) and (B) or a one-way ANOVA followed by a Bonferroni post test 
(C) and (D).  *** denotes p < 0.001, ** p < 0.01 and * p < 0.05.  Error bars represent 95% confidence intervals.  
Data shown for n = 2 experiments (number of times experiment was performed). 
 
 
Feeding larvae a palmitic acid-enriched diet resulted in a dose-dependent increase in the 
number of L-plastin positive cells in the intestine compared to ZM-fed larvae up to an 8% 
concentration, as was the case with cholesterol.  Beyond 8%, the response formed a plateau 
with 10% giving a similar number of cells to 8% (~ 17 - 18 cells).  Feeding larvae a diet 
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enriched in 4%, 8% or a 10% concentration of palmitic acid resulted in a statistically 
significant accumulation of cells compared to ZM-fed larvae, with 8% giving the greatest 
level of significance (p < 0.001).  Feeding larvae ZM prepared either in the presence or 
absence of ether gave approximately the same number of cells in the intestine (~ 12), 
indicating that the ether had no inflammatory effect, as expected.  In contrast to the 
inflammatory effect observed with palmitic acid, the unsaturated fatty acids, linoleic acid and 
oleic acid, failed to show a significant increase in the number of L-plastin positive cells in the 
intestine compared to ZM (Fig 3.16C and D).  These results demonstrate that a SFA, such as 
palmitic acid, can induce a localised accumulation of L-plastin positive cells in the intestine, 
but UFAs are unable to do so. 
 
As UFAs did not cause a statistically significant increase in the number of L-plastin positive 
cells in the intestine, unlike palmitic acid, the behaviour of another cell population over a 
time course was investigated.  Larvae were fed the same diets but at various time points post-
feeding, GFP cells under the LyzC promoter were enumerated in the intestines of 
anaesthetised larvae. 
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Figure 3.17:  Unsaturated Fatty Acids do not Cause a Significant Accumulation of LyzC GFP Cells in the 
Intestines of Larvae Unlike Palmitic Acid Over a Time Course.  6 dpf LyzC GFP larvae were fed diets 
enriched in palmitic acid, linoleic acid, oleic acid or a standard diet (ZM) for 6h.  At various time points 
following removal from the diet, the larvae were anaesthetised and numbers of GFP positive cells were counted 
in the intestines.  The graph shows the comparison of the mean numbers of GFP positive cells in the intestines 
of the larvae fed the various diets at several time points following removal from the diets.  Statistical 
significance was determined using a Kruskall-Wallis test followed by a Dunn’s post test.  *** denotes p < 
0.001, ** p < 0.01 and * p < 0.05 and indicate statistical significance between palmitic acid and ZM.  Error bars 
represent 95% confidence intervals.  Data shown for n = 1 experiments (number of times experiment was 
performed). 
 
 
Feeding larvae a palmitic acid-enriched diet resulted in an increase in the accumulation of 
GFP positive cells in the intestine up to 18h post removal (~ 21 cells), after which the 
numbers of cells decreased.  There was a statistically significant difference in cell numbers 
between palmitic acid and ZM at 0h, 12h and 18h post-removal, with the greatest difference 
at 18h post removal (p < 0.001).  In contrast, both linoleic acid and oleic acid fail to show a 
significant difference in the numbers of cells compared to ZM at any point in the time course 
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(Fig 3.17).  These results thus show that UFAs do not cause a significant accumulation of 
GFP positive cells in the intestine, at least at the concentrations used, and this is consistent 
with the result from the previous experiment with the effect on L-plastin cell accumulation in 
the intestine. 
 
 
3.3.7  Reversion to a Standard Diet Following Enriched Fat Feeding Leads to 
Accelerated Resolution of Inflammation 
 
 
Switching to a Standard Diet Following High Fat Feeding Results in a Reduction in the 
Number of Pu.1 GFP Cells Accumulating in the Intestine 
 
The results have demonstrated that feeding a diet enriched in either saturated fat or 
cholesterol results in a localised accumulation in the number of immune cells in the intestine 
compared to either unfed larvae or larvae fed a standard diet.  The number of immune cells 
also peaks at a specific time point following removal from the diet after which there is a 
decline in the number of cells.  However, the effect of switching to a standard diet following 
acute feeding of a fat enriched or cholesterol-enriched diet had not been been examined.  6 
dpf Pu.1 GFP larvae were fed either cream or were unfed for 6h.  Following removal from 
the diet, one group of cream-fed and unfed larvae were fed a standard diet whereas another 
group were unfed.  0h, 12h and 18h after switching diets, numbers of GFP positive cells were 
counted in the intestine. 
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Figure 3.18: Switching to a Standard Diet Following Feeding on a Fat-enriched Diet Results in a 
Reduction in the Number of Pu.1 GFP Cells Accumulating in the Intestine.  6dpf Pu.1 GFP larvae were 
either fed double cream for 6h or were unfed.  Immediately after this feeding and upon removal, one group of 
unfed and one group of cream fed larvae were given ZM (Unfed ZM and Cream ZM, respectively), whilst 
another group of unfed and cream fed larvae were not (Unfed Unfed and Cream Unfed, respectively).  Numbers 
of GFP positive cells were counted in the intestines of larvae at 0h, 12h and 18h after switching the diets.  
Comparison of the cells numbers in individual larvae under different feeding conditions at 0h (A), 12h (B) and 
18h (C) after switching the diets.  Comparison of the mean number of cells in larvae under the different feeding 
conditions at 0h (D), 12h (E) and 18h (F) after switching the diets.  Statistical significance was determined 
using a Wilcoxon matched pairs test (A) and (D) or a Kruskall-Wallis test followed by a Dunn’s post test (B) 
and (E), and (C) and (F).  *** denotes p < 0.001 and ** denotes p < 0.01.  Error bars represent standard 95% 
confidence intervals.  Data shown for n = 4 experiments for 0h and 18h, and n = 2 experiments for 12h (number 
of times experiments were performed).   
 
 
There were approximately twice the number of GFP positive cells accumulating in the 
intestines of larvae fed cream compared to those unfed immediately after feeding, confirming 
the result shown in Fig 3.7 (Fig 3.18A and D).  12h after removing the larvae from the cream, 
there was an increase in the number of GFP positive cells compared to the numbers observed 
immediately removing larvae from the cream (Fig 3.18B and E).  However, there was no 
significant effect of switching to a standard diet following an acute fat diet at this stage (Fig 
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3.18B and E).  18h after removing the larvae from the cream and switching to a standard diet, 
there was a significant reduction in the number of cells compared to larvae fed an enriched fat 
diet and then starved (~ 5 cells compared to ~ 8; Fig 3.18F).  This reduction resulted in a 
similar number of cells present in the intestine to that of the unfed control.  These results 
show that feeding a standard diet following a high fat diet causes a more rapid reduction in 
the number of cells than observed with no refeeding. 
 
 
Switching to a Standard Diet Following Feeding on a Cholesterol-enriched Diet Results in a 
Reduction in the Number of Pu.1 GFP Cells Accumulating in the Intestine  
 
After observing that switching to a standard diet following feeding on a fat-enriched diet 
resulted in an accelerated reduction in the number of Pu.1 GFP positive cells in the intestine 
compared to no refeeding, the next step was to see if this were the case with feeding on a 
cholesterol-enriched diet.  Pu.1 GFP larvae were fed as in the previous experiment, except 
cholesterol was used instead of cream. 
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Figure 3.19:  Switching to a Standard Diet Following Feeding on a Cholesterol-enriched Diet Results in a 
Reduction in the Number of Pu.1 GFP Cells Accumulating in the Intestine.  6 dpf Pu.1 larvae were fed 
either a cholesterol-enriched diet or were unfed for 6h.  After this feeding period, one group of unfed larvae 
were fed a standard diet (ZM) whilst another group were unfed.  Additionally, one group of cholesterol-fed 
larvae were left unfed and another group were fed ZM.  12h and 18h after switching diets, numbers of GFP 
positive cells were counted in the intestines of anaesthetised larvae.  Comparison of the cell numbers in 
individual larvae (A) and (B), and mean numbers (C) and (D) at 12h and 18h after switching diets under the 
different feeding conditions.  Statistical significance was determined using a Kruskall-Wallis test followed by a 
Dunn’s post test.  ** denotes p < 0.01.  Error bars represent 95% confidence intervals.  Data shown for n = 1 
experiments (number of times experiment was performed). 
 
 
Cholesterol-fed larvae that were not fed a standard diet after the 6h feeding period showed 
approximately twice the number of GFP positive cells in the intestine compared to unfed 
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larvae 12h after switching diets.  There was a trend towards a reduction in the number of cells 
following switching to ZM after feeding on a cholesterol-enriched diet compared to larvae 
that were fed a cholesterol-enriched diet and starved afterwards, but it was not statistically 
significant (Fig 3.19A and C).  18h following switching diets, there was a stronger trend 
towards a reduction in the number of cells in larvae fed ZM compared to those that were 
starved after a cholesterol feed in comparison to 12h, but it was also not statistically 
significant (Fig 3.19B and D).  Taken together, these results indicate that switching to a 
standard diet following feeding on a cholesterol-enriched diet shows a trend towards a 
reduction at both 12h and 18h post-switching. 
 
 
Switching to a Standard Diet Following Feeding on a Cholesterol-enriched Diet Results in a 
Reduction in the Number of L-Plastin Positive Cells Accumulating in the Intestine 
 
The effect of switching diets on another population of immune cells was thus investigated in 
order to establish if there was a similar effect to that on Pu.1 GFP cells and whether this 
effect was stronger with potentially higher numbers of immune cells in the cholesterol-fed 
groups that were starved after the initial feed.  Therefore, L-plastin expressing cells were 
chosen as the immune cell population to study given that such cells show the greatest 
accumulation in response to feeding on a cholesterol-enriched diet.  Larvae were fed either a 
cholesterol-enriched diet or were unfed for 6h.  After this feeding period, cholesterol-fed 
larvae were either fed a further cholesterol-enriched diet or ZM or unfed for 12h or 18h.  
Unfed larvae were either fed ZM or unfed for 12h or 18h.  Larvae were fixed and stained at 
12h and 18h post-switching. 
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Figure 3.20:  Switching to a Standard Diet Following Feeding on a Cholesterol-enriched Diet Results in a 
Reduction in the Number of L-Plastin Positive Cells Accumulating in the Intestine.  6 dpf WT larvae were 
fed either a cholesterol-enriched diet or were unfed for 6h.  After this feeding period, one group of unfed larvae 
were fed a standard diet (ZM) whilst another group were unfed.  Additionally, one group of cholesterol-fed 
larvae were left unfed, another group were fed a cholesterol-enriched diet and a final group were fed ZM.  12h 
and 18h after switching diets, larvae were fixed, stained and numbers of L-plastin positive cells were counted in 
the intestines.  Comparison of the cell numbers in individual larvae at 12h and 18h after switching diets (A) and 
(B), and mean numbers of cells in larvae at 12h and 18h after switching diets (C) and (D).  Statistical 
significance was determined using a Kruskall-Wallis test followed by a Dunn’s post test.  ** denotes p < 0.01.  
Error bars represent 95% confidence intervals.  Data shown for n = 2 experiments (number of times experiment 
was performed). 
 
 
There was an increase in the number of L-plastin positive cells accumulating in the intestines 
of cholesterol-fed larvae that are either left unfed or fed a further cholesterol-enriched diet 
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12h after switching diets compared to unfed larvae.  There was also no difference in the cell 
numbers of larvae that were fed a further diet enriched in cholesterol compared to those that 
were left unfed after the initial cholesterol-enriched feed (~ 20 cells).  This shows that a 
prolonged cholesterol feed does not induce an enhanced effect than the initial 6h feed.   
However, switching to ZM following a cholesterol-enriched feed resulted in a trend towards a 
decrease in the number of cells compared to cholesterol-fed larvae that were left unfed or fed 
a further diet enriched in cholesterol 12h after switching diets (~ 17 – 18 cells; Fig 3.20A and 
C).  18h after switching diets, there was an increase in cell numbers in larvae that were 
switched to a second cholesterol-enriched diet or were left unfed compared to 12h after 
switching diets.  There was also no difference in the number of cells accumulating in the 
intestines of larvae that were switched to a second cholesterol-enriched diet compared to 
those that were left unfed 18h after switching diets (~ 22 – 23 cells).  However, there was a 
statistically significant decrease in cell numbers in larvae switched to ZM after the initial 
cholesterol feed compared to those that were fed a further cholesterol-enriched diet or were 
left unfed (~ 16 cells; Fig 3.20B and D).  Collectively, these results demonstrate that 
switching from a cholesterol-enriched diet to a standard diet results in a reduction in the 
number of L-plastin positive cells accumulating in the intestine.  Additionally, feeding a 
prolonged diet enriched in cholesterol does not result in an increase in the number of cells 
accumulating in the intestine compared to an initial 6h feed. 
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3.4  Discussion 
 
 
In brief, the results have demonstrated that acute feeding of zebrafish larvae a diet enriched in 
either cholesterol or saturated fat results in a significant accumulation of myeloid cells in the 
intestines compared to control larvae.  However, a diet enriched in UFAs does not have this 
effect.  The results also show that of the cell populations examined, L-plastin expressing cells 
display the greatest level of accumulation in the intestine and peak 18h after removal from 
the diet.  These cells accumulate primarily in the PI but show the same localisation in the 
histology of the intestine in both cholesterol-fed and ZM-fed larvae.  Treatment with 
ezetimibe reduces the recruitment of L-plastin positive cells to the intestine following feeding 
on a cholesterol-enriched diet.  Finally, switching from a fat-enriched diet to a standard diet 
results in an accelerated resolution of the inflammatory effect.     
 
 
3.4.1  Differences in Rates of Ingestion and Transit of Fluorescent Microspheres by 
Zebrafish Larvae. 
 
The variations in the passage of ingested material along the digestive tract are consistent with 
observations reported by Field et al, who also showed that there are variations in transit times 
across the intestine of 7dpf larvae (Fig 3.4).  In this study, by 24h post feeding, the majority 
of larvae have cleared a fluorescent tracer consisting of powdered larval feed and yellow-
green fluorescent 2.0m polystyrene microspheres from their intestine, but a small number 
still contain this tracer.  Field et al also show that approximately 50% of the larvae that were 
fed the tracer had actually ingested it after 2h of feeding (Field et al, 2009).  This indicates 
that whilst larvae are capable of feeding at this age, not all of them ingest material at the same 
rate nor does the ingested material progress along the digestive tract at the same rate in those 
that have fed.  This could account for the variability observed in numbers of immune cells 
recruited to the intestines of larvae within the same treatment group as it is possible that 
larvae which have ingested a greater amount of a fat-enriched diet display a higher number of 
recruited cells than those that have ingested less. 
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3.4.2  A Fat-Enriched Diet Results in the Localised Recruitment of Leukocytes to the 
Intestine 
 
The observed recruitment of leukocytes to the intestines of larvae following feeding on a fat-
enriched diet has never, to our knowledge, been observed before.  It also represents a process 
of inflammation associated with enriched-fat feeding that has not, to our knowledge, been 
previously investigated.  The ability of the SFA, palmitic acid, to cause a significant 
accumulation of myeloid cells in the intestines of larvae is consistent with its well-established 
pro-inflammatory effects.  In contrast, the inability of the UFAs, oleic acid and linoleic acid, 
to do so is also supported by their anti-inflammatory properties in the literature (Fig 3.16 – 
3.17).  Palmitic acid impairs insulin signalling and induces production of ceramide and 
synthesis of DAG in C2C12 myotubes.  It has also been demonstrated to activate NF-κB and 
MAPK signalling pathways in adipocytes leading to induction of MCP-1 expression, 
resulting in the recruitment of monocytes to adipose tissue (Ajuwon and Spurlock, 2005; 
Takahashi et al, 2008).  Palmitic acid causes inflammation in WAT through oxidative stress, 
ROS production and protein kinase C signalling, whereas oleic acid antagonises the 
inflammatory effects of palmitic acid (Kennedy et al, 2009).  Murine 3T3-L1 adipocytes 
treated with palmitic acid display increased TNF-α expression and secretion, and reduced 
expression and secretion of the anti-inflammatory cytokine IL-10.  Oleic acid, however, fails 
to increase TNF-α expression or secretion (Bradley et al, 2008).  Linoleic acid has been 
shown to antagonise the activation of NF-κB and IL-6 expression caused by palmitic acid in 
human myotubes (Weigert et al, 2004).  Additionally, treatment of macrophages in vitro with 
linoleic acid results in decreased levels of IL-6 and MCP-1 compared to palmitic acid (Wang 
et al, 2009).  Mice that are deficient in TLR4 are protected from the inflammatory effects of 
feeding on a high palmitic acid diet, indicating that palmitic acid exerts its effects through 
TLR4 signalling (Davis et al, 2008).  However, the mechanism by which palmitic acid 
achieves this inflammatory effect in the larval intestine may be different.  This is especially 
given that zebrafish lack CD14 and MD-2 and thus are unable to signal through TLR4 (Iliev 
et al, 2005).        
 
The accumulation of cells expressing dsRed or GFP under the LyzC promoter and L-plastin 
expressing cells in the intestines of larvae fed a fat-enriched diet confirmed a possible 
involvement of monocytes and macrophages.  This is due to these two populations of cells 
showing a greater difference in numbers between fat fed and control diet fed larvae than 
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MPO positive cells.  If the response to feeding on a fat-enriched diet was solely neutrophil-
driven, then the difference in numbers of L-plastin positive and LyzC dsRed or GFP positive 
cells between between the two diets would be similar to that of the MPO positive cells.  L-
plastin marks both macrophages and neutrophils as shown by studies demonstrating the 
presence of both L-plastin positive cells with MPO expression and those lacking MPO 
expression, the former being neutrophils and the latter being macrophages (Meijer et al, 
2008; Matias et al, 2009).  An explanation for the differences in numbers of L-plastin 
positive cells and dsRed or GFP positive cells in the intestine is that whilst L-plastin and 
LyzC are both markers of macrophages and neutrophils, L-plastin may encompass a greater 
population of cells.  This is supported by findings by made by Hall et al who demonstrated 
that whereas all LyzC expressing cells also express L-plastin, not all L-plastin positive cells 
express LyzC (Hall et al, 2007).  Thus, L-plastin encompasses both LyzC expressing cells (L-
plastin
+
 LyzC
+
) and other non-LyzC expressing cells (L-plastin
+
 LyzC
-
).  Given that both L-
plastin and LyzC encompass the majority of neutrophils, as shown by their colocalisation 
with MPO expression, the L-plastin
+
 LyzC
- 
cells are most likely macrophages.  Therefore, L-
plastin is a more selective marker of macrophages than LyzC (Hall et al, 2007; Meijer et al, 
2008; Matias et al, 2009). 
 
A study of acute inflammation in response to tailfin injury in zebrafish larvae by Loynes et al 
revealed that the peak accumulation of macrophages follows that of neutrophils and that 
macrophages remained at the injury site for longer (Loynes et al, 2010).  This is consistent 
with the observed peak accumulation of L-plastin positive cells occuring after that of MPO 
positive cells and taking longer to resolve following feeding on a cholesterol-enriched diet 
(Fig 3.10A and C).  Although LyzC GFP cells also show a peak accumulation after MPO 
positive cells do, the resolution of this accumulation occurs more rapidly than that of L-
plastin cell accumulation and is consistent with LyzC not being as selective a marker of 
macrophages as L-plastin (Fig 3.10A, C and D).  Loynes et al also found that macrophages 
phagocytose neutrophils that have undergone apoptosis at the site of injury (Loynes et al, 
2010).  It is possible that the macrophages being recruited to the intestine following feeding 
on a cholesterol-enriched diet may be carrying out the same role.  At 18h post-removal, there 
is a reduction in the number of MPO positive cells, suggesting a resolution of the neutrophil 
response and a coincidental peak accumulation of L-plastin positive cells.  Thus, the L-plastin 
positive cells accumulating at this time point may be anti-inflammatory M2 macrophages, in 
addition to pro-inflammatory M1 macrophages that may have accumulated earlier.  Studies in 
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zebrafish have identified markers of M1 and M2 macrophages, TNF-α and arginase, 
respectively, which colocalise with L-plastin indicating the possibility of pro-inflammatory 
and anti-inflammatory macrophages in this model organism (Feng et al, 2010). 
 
The involvement of macrophages in chronic inflammation associated with metabolic 
disorders is well characterised.  In atherosclerosis, the immune cells that are recruited to the 
sites of vascular lesions are primarily macrophages (Glass and Witztum, 2001).  In mouse 
models of chronic obesity, there is an infiltration of macrophages in the adipose tissue of 
mice fed a high fat diet compared to mice fed a standard diet.  There is also an upregulation 
of macrophage-enriched genes upon feeding a high fat diet (Xu et al, 2003).  However, very 
little is known about the acute inflammation associated with feeding on a fat-enriched diet.  
Neutrophil recruitment to AT has been observed as early as 3 days of feeding on a high fat 
diet and persists until 7 days.  By 14 days of feeding, neutrophils are no longer detected, 
suggesting a transient infiltration.  Macrophages, though, are not observed in great numbers 
until several weeks of feeding (Xu et al, 2003; Elgazar-Carmon et al, 2008).  Thus, the 
involvement of macrophages in the acute stages of feeding on a fat-enriched diet has not been 
previously documented.  These results, however, do suggest a potential involvement of 
macrophages in the localised inflammatory response in the intestine to acute feeding on a fat-
enriched diet after a period of a few hours. 
 
 
3.4.3  Cholesterol Uptake into Intestinal Epithelial Cells May be Required for Localised 
Inflammation to Occur 
 
The results suggest that the uptake of cholesterol by intestinal epithelial cells may be required 
for the inflammatory effect observed upon feeding on a cholesterol-enriched diet (Fig 3.12).  
NPC1L1 is expressed predominantly in intestinal epithelial cells and hepatocytes, but is also 
expressed in macrophages, albeit at a much lower level (Seedorf et al, 2004).  In human 
macrophages, expression is approximately 0.3 – 0.5% of that in the liver and intestine.  It has 
also been demonstrated that ezetimibe blocks oxLDL uptake by macrophages, presumably 
through inhibition of Class II scavenger receptors (Seedorf et al, 2004).  This is consistent 
with macrophages not having a characterised role in cholesterol uptake and any effect of 
ezetimibe in macrophages would likely be on another target than NCP1L1.  However, in the 
context of acute fat feeding, it is unlikely that the observed effect of ezetimibe is on blocking 
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oxLDL uptake by macrophages due to the relatively short timescale of the feeding period 
within which formation of oxLDL would be not expected.  This is consistent with 
observations that vascular lesions resulting from oxLDL uptake by macrophages take a 
period of weeks to develop in zebrafish (Stoletov et al, 2009).  Given that in order for 
cholesterol to form LDLs, it needs to first be taken up by intestinal epithelial cells and 
processed by the body, it is more likely that ezetimibe is acting on NPC1L1 on intestinal 
epithelial cells than on macrophage-expressed scavenger receptors in the context of an acute 
fat feeding period. 
 
It has been proposed that intracellular accumulation of cholesterol in the liver through uptake 
by NPC1L1 results in ER stress which leads to activation of p38.  This accumulation also 
results in production of ROS by mitochondria, leading to activation of JNK and can progress 
to insulin resistance through downregulation of Akt activity (Nomura et al, 2009).  Ezetimibe 
treatment, however, has been shown to decrease expression of NADPH oxidases, IL-6, TNF-
α and IL-1β in the livers of rats fed a high fat diet in comparison to untreated animals fed on 
such a diet.  In hepatocytes in vitro stimulated with free cholesterol, ezetimibe treatment 
decreases ROS production and reduces activation of JNK and p38 compared to free 
cholesterol-stimulated hepatocytes in the absence of ezetimibe (Nomura et al, 2009).  It is 
possible that ezetimibe treatment of larvae may reduce the accumulation of L-plastin positive 
cells in the intestine compared to untreated larvae by a decrease in expression levels of IL-1β 
and NADPH oxidase in intestinal epithelial cells.  This is supported by intestinal epithelial 
cells being known to express both IL-1β and NADPH oxidase and both of whose expression 
levels are affected by ezetimibe treatment in hepatocytes (Waterhouse and Stadnyk, 1999; 
Flores et al, 2010). 
 
In rabbits fed a hyperlipidaemic diet, ezetimibe treatment results in a reduced expression of 
MCP-1 and reduction in activation of NF-κB (Gómez-Garre et al, 2009).  Atheroscelerotic 
plaques are smaller in size and have a lower macrophage content in ezetimibe-treated animals 
than untreated ones.  Ezetimibe treatment has also been shown to decrease monocyte 
transmigration in vitro. (Gómez-Garre et al, 2009).  The observation of a reduced 
transmigration of monocytes following ezetimibe treatment is consistent with lower numbers 
of L-plastin positive cells in the intestines of ezetimibe-treated larvae.  This is because the 
accumulation of L-plastin positive cells in the intestine is likely due to transmigration of cells 
from outside the intestine.  It is possible that MCP-1 may be involved in the recruitment of L-
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plastin positive cells to the intestine due to its expression being reduced following ezetimibe 
treatment in vivo in rabbit models of atherosclerosis, suggesting cholesterol induces MCP-1 
expression.  MCP-1 has been also shown to be expressed in intestinal epithelial cells 
(Reinecker et al, 1995). 
 
 
3.4.4  Pro-inflammatory Cytokines and Chemokines do not Show Detectable Differences 
in Changes in Expression Between Cholesterol-Fed and ZM-fed Larvae 
 
IL-8 functions as a potent chemoattractant primarily for neutrophils, but also to a lesser 
extent for monocytes (Oppenheim et al, 1991; Gerszten et al, 1999).  It is expressed in the 
zebrafish intestine along with its receptors, CXR1 and CXR2 (Oehlers et al, 2010).  IL-8 
transcript levels have been demonstrated to be upregulated as measured by qRT-PCR 
following treatment with a variety of inflammatory stimuli.  Bacterial infection of 4 dpf 
zebrafish larvae with Listonella anguillarum for 6h resulted in an approximate 2.5 fold 
increase in IL-8 expression levels in the whole body compared to untreated controls.  LPS 
treatment increased expression levels in the intestine by 2.5 fold and treatment of 3 dpf larvae 
with TNBS for 3 days resulted in an increase in expression levels by 4 fold in the whole body 
compared to untreated controls (Oehlers et al, 2010).  In a further study by Oehlers et al, a 
significant upregulation of IL-8 expression was observed in the intestines of larvae but not in 
the remaining carcasses following 3 days of treatment of 3 dpf larvae with TNBS (Oehlers et 
al, 2011).  Thus, it appears that changes in expression levels of IL-8 in response to 
inflammatory stimuli are detectable by qRT-PCR both in the intestine and remaining 
carcasses. 
 
It appears odd that the results in Fig 3.15 do not show biologically relevant increases in IL-8 
expression levels in at least the intestines of cholesterol-fed larvae compared to ZM-fed 
larvae.  This is especially unusual given that even immediately after a 6h feeding period, 
there is an accumulation of immune cells in the intestines of larvae fed either cream or a 
cholesterol-enriched diet, suggesting that migration of immune cells to the intestine has 
begun.  Thus, it would be expected that there should be an increase in expression levels of IL-
8 prior to the accumulation of myeloid cells.  IL-8 has been shown to be upregulated in 
obesity and its production in human adipocytes is induced by TNF-α (Kobashi et al, 2009).  
Circulating levels of IL-8 have also been shown to be elevated in obese human patients (Kim 
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et al, 2006).  Thus, IL-8 has been demonstrated to be involved in the chronic inflammation 
associated with a high fat diet and both neutrophils and macrophages are involved in the 
inflammation associated with a high fat diet, albeit with different kinetics (Xu et al, 2003; 
Elgazar-Carmon et al, 2008).  Taken together, this evidence supports a potential involvement 
of IL-8 in the acute inflammation associated with feeding on a fat-enriched or cholesterol-
enriched diet that is not observed in the data.  It is, however, possible that the localised 
inflammation in the intestine is occurring independently of IL-8 and that another chemokine 
may be involved in immune cell accumulation, despite IL-8 having a well-established role in 
chronic diet-associated inflammation. 
 
Several other cytokines and chemokines that were tested for expression changes by qRT-PCR 
upon feeding a cholesterol-enriched diet were undetected or showed no difference in 
expression levels between the intestines and remaining carcasses of cholesterol-fed or ZM-
fed larvae (Table 3.1).  A number of these tested cytokines have been shown to be involved 
in the chronic inflammation associated with obesity.  TNF-α, which was not detected, plays 
an important role in stimulating lipolysis in AT and activating NF-κB signalling leading to 
production of MCP-1.  TNF-α is also an activator of JNK signalling, which results in insulin 
resistance (Souza et al, 2003; Suganami et al, 2005; Shoelson et al, 2006).  M-17, which was 
also not detected, is a member of the IL-6 family and elevated levels of IL-6 expression are 
observed in obese mice (Harkins et al, 2004).  Furthermore, co-culture of pre-adipocytes with 
monocytes in vitro leads to an upregulation in IL-6 expression in pre-adipocytes, suggesting a 
paracrine effect of monocytes on IL-6 expression in pre-adipocytes (Couturier et al, 2012).  
Another undetected cytokine was the anti-inflammatory IL-10, which is a characteristic 
marker of M2 macrophages and is downregulated in adipose tissue during obesity as the 
proportion of M1 macrophages increases (Lumeng et al, 2007).  Thus, it is possible that this 
cytokine would show a decreased expression in cholesterol-fed larvae compared to ZM-fed 
larvae. 
 
CXCL1 is an example of a chemokine that was detected but showed no difference in 
expression levels between cholesterol-fed or ZM-fed larvae.  Like IL-6, CXCL1 expression 
has been shown to be upregulated in pre-adipocytes following co-culture with monocytes 
(Couturier et al, 2012).  CXCL1 is both a neutrophil and macrophage chemoattractant that is 
expressed in intestinal epithelial cells (Masumoto et al, 2006).  Given that there is an 
observed accumulation of myeloid cells to the intestines of cholesterol-fed larvae, the 
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inability to detect TNF-α, and CXCL1 showing no difference between the two feeding 
conditions is not consistent.  TNF-α promotes macrophage chemotaxis by activating MCP-1 
expression and CXCL1 is itself a chemokine for both neutrophils and macrophages.  Thus, 
both of these two cytokines would be expected to be involved in the inflammation observed 
with feeding a cholesterol-enriched diet.  However, as is the case with IL-8, the localised 
immune cell accumulation in the intestine may be occurring independently of TNF-α and 
CXCL1, despite their established roles in chronic inflammation associated with obesity.   
 
Oehlers et al also investigated changes in expression of TNF-α in the same study as IL-8 
expression.  They found that bacterial infection resulted in a 3 fold increase in expression 
levels in whole larvae compared to untreated controls.  LPS treatment resulted in a 2 fold 
increase in TNF-α expression levels in the intestine and TNBS exposure in a 7 fold increase 
in expression levels in the whole body compared to untreated controls (Oehlers et al, 2010).  
In a subsequent study investigating the effects of TNBS exposure, Oehlers et al found that 3 
days of treatment of 3dpf larvae with TNBS resulted in a significant increase in TNF-α levels 
in the remaining carcasses but no change in the intestine (Oehlers et al, 2011).  These studies, 
together with the measurements of IL-8 expression, provide further evidence that it is 
possible to detect cytokine expression in both the bodies and intestines of larvae. 
 
A potential explanation for the lack of observed detection of cytokines in the intestines of 
larvae may be due to the intestine being a very heterogeneous population of cells.  This 
means that the amount detected in certain cell populations could potentially be diluted out by 
a non-detectable signal in other cell populations.  This may then result in an overall non-
detectable signal.  The same may be true for expression in the remaining carcasses with only 
a small proportion of the carcass giving a detectable signal.  This explanation can also 
account for cytokines that were detectable but showed no difference in expression levels in 
the intestine between cholesterol-fed and ZM-fed larvae.  There may have been an increased 
expression in certain populations of cells in the intestine that was diluted out by an 
unchanged expression in other cell populations in cholesterol-fed larvae.  Thus, the overall 
expression levels would be the same for both the cholesterol-fed and ZM-fed larvae.  A 
possible explanation for no change in expression levels in the remaining carcasses may be 
due to potential changes in expression levels of the cytokines being limited only to the 
intestine, consistent with a localised inflammation in this region.  Thus, expression levels in 
the remaining carcasses would be unaffected.  Given the inability to detect certain cytokines 
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and chemokines in zebrafish or to detect differences in expression, wholemount in situ 
hybridisation (WISH) can be used as an alternative method, as discussed further in Chapter 6. 
 
 
3.4.5  Reversion to a Standard Diet Following Enriched Fat Feeding Leads to 
Accelerated Resolution of Inflammation Possibly Due to the Anti-Inflammatory Effects 
of Omega-3 Fatty Acids 
 
ZM is enriched in ω-3 FAs and these may be a component of the standard diet that is 
responsible for the observed reduction in immune cell numbers in the intestine following 
switching to such a diet.  ω-3 FAs are converted to protectins and resolvins, which block 
neutrophil transmigration and promote their phagocytosis, thus enabling the resolution of 
inflammation (Schwab et al, 2007; Serhan et al, 2008; Soehnlein and Lindbom, 2010).  It is 
possible that protectins and resolvins may cause an initial reduction in numbers of neutrophils 
acuumulating in the intestine following a switch to ZM.  It has also been demonstrated in 
vitro that ω-3 FAs are converted to oxo-derivatives by COX-2 in activated macrophages and 
these derivatives are capable of suppressing IL-6 and MCP-1 expression.  Additionally, the 
oxo-derivatives suppressed expression of iNOS and functioned as agonists of peroxisome 
proliferator receptor-γ (PPARγ) (Groeger et al, 2010).  Thus, oxo-derivatives of ω-3 FAs 
have anti-inflammatory properties and may be involved in the accelerated resolution of 
inflammation upon switching to a ZM diet following feeding on a fat-enriched or cholesterol-
enriched diet.  In support of this, it is likely that there is a presence of activated macrophages 
in the intestines of cholesterol-fed larvae which can convert the ω-3 FAs present in ZM into 
oxo-derivatives and thus resolve the inflammation caused by the feeding of a cholesterol-
enriched diet.   
 
Feeding mice a diet enriched in ω-3 FAs for 5 weeks results in an increase in the expression 
levels of PPARγ, GLUT4 and IRS-1, thus leading to improved insulin sensitivity.   
Intraperitoneal injection of resolvins into mice also results in enhanced expression of PPARγ, 
GLUT4 and IRS-1 (González-Périz et al, 2009).  Thus, both ω-3 FAs and their metabolites 
are capable of improving insulin sensitivity, highlighting their anti-inflammatory properties.  
Studies by Oh et al have identified GPR120 as the receptor through which ω-3 FAs exert 
their anti-inflammatory effects, which is highly expressed on M1 macrophages and 
adipocytes (Oh et al, 2010).  In vitro, ω-3 FAs have been shown to inhibit phosphorylation of 
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JNK and IKKB in both macrophages and adipocytes.  It is likely that this occurs through 
GPR120 signalling inhibiting TAB1 and preventing its interaction with TAK1, which is 
necessary for activation of both JNK and NF-κB signalling (Oh et al, 2010). 
 
Feeding mice a high fat diet for 15 weeks and then switching one group of mice to an ω-3 
FA-enriched diet for 5 weeks, whilst continuing another group on a high fat diet for 5 weeks 
results in improved insulin sensitivity and lipid metabolism in the ω-3 FA-fed group 
compared to the high fat diet-fed group.  Mice fed the diet enriched in ω-3 FAs also displayed 
a decrease in levels of F4/80 expression and reduced macrophage chemotaxis (Oh et al, 
2010).  Expression levels of IL-6, CD11c and MCP-1 were all reduced in the ω-3 FA-fed 
group compared to the high fat diet-fed group.  Furthermore, there was a reduction in 
expression of genes characteristic of M1 macrophages and an increase in expression levels of 
genes characteristic of M2 macrophages upon feeding a diet enriched in ω-3 FAs (Oh et al, 
2010).  This indicates that ω-3 FAs are able to induce a switch in macrophage phenotype 
from pro-inflammatory to anti-inflammatory.  Thus, perhaps it is possible that the ω-3 FAs in 
ZM are capable of exerting their anti-inflammatory properties in the intestine and 
accelerating resolution of the inflammatory effect of a fat enriched or cholesterol-enriched 
diet without themselves being converted into oxo-derivatives, or protectins and resolvins.  
This is supported by the observed potential involvement of macrophages in the acute 
response in the intestine, which may express GPR120 and thus allow signalling through the 
receptor through binding of ω-3 FAs.  Therefore, the observed reduction in immune cell 
numbers in the intestines of larvae that are fed a standard diet following feeding on a fat-
enriched or cholesterol-enriched diet may be mediated through the action of ω-3 FAs on M1 
macrophages or products of ω-3 FAs metabolism being processed by activated macrophages. 
 
 
3.4.6  Conclusion 
 
In conclusion, feeding zebrafish larvae a fat-enriched diet results in a localised recruitment of 
both neutrophils and potentially macrophages to the intestine.  It also appears that the peak 
accumulation of neutrophils precedes that of macrophages following feeding on a 
cholesterol-enriched diet.  The results suggest that the uptake of cholesterol into intestinal 
epithelial cells may be required for acute inflammation in the intestine to occur.  This could 
possibly be due to cholesterol uptake increasing expression of NADPH oxidase or IL-1β, 
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both of which are expressed in intestinal epithelial cells and whose expression levels are 
reduced by blocking cholesterol uptake in other studies.  A long chain SFA such as palmitic 
acid is capable of causing a localised accumulation of myeloid cells in the intestine, whereas 
UFAs are unable to likely due to their anti-inflammatory nature.  Finally, switching to a 
standard diet following feeding on a fat-enriched diet results in an accelerated resolution of 
the inflammatory effect.  This is possibly due to the anti-inflammatory effects of ω-3 FAs in 
the standard diet on macrophages, or processing of ω-3 FAs to anti-inflammatory derivatives 
by macrophages. 
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CHAPTER 4:  INVESTIGATING THE ROLE OF THE NLRP3 
INFLAMMASOME IN THE INFLAMMATION ASSOCIATED 
WITH FEEDING ON A FAT-ENRICHED DIET 
 
 
4.1  Introduction 
 
 
As described in Chapter 1, the NLRP3 inflammasome is activated by a variety of danger 
signals, including components of dietary fat.  Recently, it has been shown that crystalline 
particles of cholesterol are capable of activating the NLRP3 inflammasome in vitro.  When 
LPS-primed mouse macrophages are treated with cholesterol crystals, the crystals are taken 
up through phagocytosis and activate the NLRP3 inflammasome in a cathepsin B-dependent 
manner (Duewell et al, 2010; Rajamäki et al, 2010).  Incubation of unprimed macrophages 
with oxLDL results in internalisation of this material and crystalline particles forming in the 
phagolysosomal compartment, ultimately leading to the release of mature IL-1β.  It is 
possible that the crystals form from the action of cholesterol ester hydrolases converting 
cholesteryl esters from the oxLDL to free cholesterol (Duewell et al, 2010).  As oxLDL is 
capable of priming cells for NLRP3 inflammasome activation through binding to the TLR4/6 
heterodimer and co-receptor CD36, and is capable of being converted into crystalline 
particles of cholesterol, there is no requirement for priming with LPS.  This is because 
oxLDL alone is capable of providing both signals required for full NLRP3 inflammasome 
activation (Stewart et al, 2010).  The SFA, palmitate, has also recently been shown to induce 
IL-1β secretion from bone marrow-derived macrophages in the presence of LPS in an NLRP3 
inflammasome-dependent manner.  The mechanism by which this occurs is independent of 
the lysosome and therefore cathepsin B, but requires the production of ROS.  The unsaturated 
fatty acid oleate is unable to do so, however (Wen et al, 2011). 
 
The NLRP3 inflammasome is implicated in a variety of metabolic diseases with activation of 
caspase-1 and release of IL-1β being contributing factors underlying the development and 
progression of these diseases.  Obesity is associated with an increase in ceramide, SFAs, ROS 
and ATP, all of which are activators of the inflammasome (Lukens et al, 2011).  Caspase-1 
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activity has been shown to be increased in both diet-induced and genetic mouse models of 
obesity, with the resulting increase in activity in AT and liver leading to impaired insulin 
signalling and promotion of β cell apoptosis in the pancreas (Stienstra et al, 2010; 
Vandanmagsar et al, 2011).  This leads to insulin resistance and development of type II 
diabetes.  During type II diabetes, islet amyloid polypeptide (IAPP) is secreted by β cells and 
deposited in the pancreas.  IAPP activates caspase-1 in an NLRP3 and lysosome dependent 
manner further exacerbating defective insulin signalling and enhanced β cell apoptosis.  The 
priming of the NLRP3 inflammasome is due to partially oxidised, or mmLDL, and glucose 
metabolism.   This indicates a role of dietary intake in providing the first signal for induction 
of IL-1β expression (Masters et al, 2010).  In atherosclerosis, crystalline particles of 
cholesterol are deposited in the lesions relatively early during the development of the disease 
and their localisation correlates with that of macrophages as disease development progresses.  
Additionally, LDLR KO mice reconstituted with bone marrow deficient in components of the 
NLRP3 inflammasome showed decreased lesion size (Duewell et al, 2010).  Given that these 
particles are capable of activating the NLRP3 inflammasome in vitro, the inflammasome may 
play a role in development and progression of atherogenesis in vivo (Duewell et al, 2010; 
Rajamäki et al, 2010).      
 
In zebrafish, an orthologue of mammalian caspase-1, termed Caspy, has been characterised, 
which displays 54% similarity to its mammalian counterpart.  As in mammals, Caspy 
interacts with the zebrafish orthologue of ASC (zASC) and this interaction is required for 
activity of Caspy (Masumoto et al, 2003).  Caspy has been demonstrated to cleave IL-1β in 
zebrafish primary leukocytes in vitro following Francisella noatunensis infection (Vojtech et 
al, 2012).  Cathepsin B has also been characterised in zebrafish (Zhang T et al, 2008).  
Furthermore, members of the NADPH oxidase family have been identified, including 
phagocyte NADPH oxidase, Nox2, expressed in macrophages and neutrophils, and Duox, 
expressed in intestinal epithelial cells (Flores et al, 2010; Brothers et al, 2011).  Thus, it 
appears that zebrafish possess many of the components required for signalling through the 
NLRP3 inflammasome and this pathway may play a role in the accumulation of immune cells 
in the gut following acute feeding on an enriched fat diet.   
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4.2  Aim 
 
 
The aim of this Chapter was to investigate the role of the NLRP3 inflammasome in the 
inflammation associated with feeding on a fat-enriched diet.  This was approached in the 
following ways: 
 
Using (1) pharmacological inhibitors, (2) fluorogenic tools such as a H2O2 probe or a 
caspase-1 substrate and (3) splice-blocking morpholinos to target various components 
involved in signalling through the NLRP3 inflammasome, the effect on acute inflammation in 
the intestine following feeding on a fat-enriched diet was investigated.  Fig 4.1 indicates the 
targets (red) of pharmacological inhibition and MO knockdown: 
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Figure 4.1: Components of the NLRP3 Inflammasome that were Targeted by Pharmacological Inhibition 
and MO Knockdown.  Names of inhibitors are shown in bold and specificities in italic (Figure adapted from 
Tschopp and Schroder, 2010).    
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4.3  Results 
 
 
4.3.1  Pharmacological Inhibition of Cathepsin B Activity Reduces the Accumulation of 
L-Plastin Positive Cells in the Intestines of Cholesterol-fed, but not Palmitic Acid-fed 
Larvae 
 
 
In order to study the role of cathepsin B induced by a cholesterol-enriched diet, a 
pharmacological inhibitor of cathepsin B, Ca-074-Me, was used.  Ca-074 has been shown to 
bind to Cys 29 in the active site of bovine cathepsin B and irreversibly inhibits its activity 
(Yamamoto et al, 1997).  Larvae were fed cholesterol-enriched or palmitic acid-enriched 
diets in the presence of the drug and following this, L-plastin positive cells in the intestine 
were enumerated in fixed and stained larvae. 
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Figure 4.2: Pharmacological Inhibition of Cathepsin B Activity Reduces the Accumulation of L-Plastin 
Positive Cells in the Intestines of Cholesterol-fed, but not Palmitic Acid-fed, Larvae.  6 dpf WT larvae were 
pre-treated with the cathepsin B inhibitor, Ca-074-Me, or DMSO of an equivalent volume, or were untreated for 
30 mins.  Following this, they were then fed for 6h whilst in the presence of the drug or DMSO.  18h after 
removal from the diets but in the presence of the drug, larvae were fixed, stained, and numbers of L-plastin 
positive cells were counted in the intestines.  Comparison of the numbers of cells in individual larvae (A) and 
mean numbers of cells in larvae (B) fed either a standard diet (ZM) or a cholesterol-enriched diet and treated 
with varying concentrations of Ca-074-Me.  Comparison of the numbers of cells in individual larvae (C) and 
mean numbers of cells in larvae (D) fed either ZM or a cholesterol-enriched diet and treated with 100µM Ca-
074-Me or DMSO, or untreated.  Comparison of the numbers of cells in individual larvae (E) and mean 
numbers of cells in larvae fed either ZM, or diets enriched in either cholesterol or palmitic acid (PA) and treated 
with 100µM Ca-074-Me, or DMSO or untreated (F).  Statistical significance was determined using a Kruskall-
Wallis test followed by a Dunn’s post test.  *** denotes p < 0.001, and * p < 0.05.  Error bars represent 95% 
confidence intervals.  Data shown for n = 1 experiments (A) and (B), (E) and (F), and n = 2 experiments (C) 
and (D) (numbers of times experiments were performed). 
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Treating larvae with a range of concentrations of Ca-074-Me resulted in a dose-dependent 
reduction in the accumulation of L-plastin positive cells in the intestines of larvae fed a 
cholesterol-enriched diet.  100µM was statistically significant (p < 0.05) whereas 10µM and 
25µM were not.  Additionally, exposure to an equivalent volume of DMSO to 100µM did not 
reduce the inflammatory infiltrate compared to untreated larvae (Fig 4.2A and B).  ZM-fed 
larvae exposed to 100µM showed no reduction in cell numbers compared to ZM-fed larvae 
that were treated with DMSO. However, cholesterol-fed larvae showed a statistically 
significant reduction between these two groups, validating the effect observed in the previous 
titration experiment (Fig 4.2A – D).  In contrast, this concentration had no inhibitory effect 
on the numbers of cells in larvae on a palmitic acid-enriched diet as compared to DMSO-
treated larvae (Fig 4.2E and F).  Taken together, these results indicate that pharmacological 
inhibition of cathepsin B activity results in a reduction in the number of L-plastin positive 
cells accumulating in the intestines of larvae fed a cholesterol-enriched diet, but not a 
palmitic acid-enriched diet.  This suggests that the manner in which palmitic acid induces an 
accumulation of L-plastin positive cells in the intestine occurs independently of cathepsin B 
activity. 
 
 
4.3.2  Pharmacological Inhibition of NADPH Oxidase Activity Reduces the 
Accumulation of L-Plastin Positive Cells in the Intestines of Cholesterol-fed Larvae 
 
 
Since NADPH oxidases are expressed in zebrafish intestinal epithelial cells and are a 
potential source of ROS capable of activating NLRP3 (Dostert et al, 2008; Dostert et al, 
2009; Flores et al, 2010), larvae were pre-treated with a range of concentrations of the 
NADPH oxidase inhibitor, VAS-2870, or the appropriate controls and fed with cholesterol in 
the presence of the drug.  The numbers of L-plastin positive cells were evaluated as described 
previously. 
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Figure 4.3: Pharmacological Inhibition of NADPH Oxidase Activity Reduces the Accumulation of L-
Plastin Positive Cells in the Intestines of Cholesterol-fed Larvae.  6 dpf WT larvae were pre-treated with a 
range of concentrations of the NADPH oxidase inhibitor, VAS-2870, or DMSO of an equivalent volume to the 
highest concentration of inhibitor, or were untreated for 30 mins.  Following this, they were then either fed a 
standard diet (ZM) or a cholesterol-enriched diet for 6h whilst in the presence of the drug or DMSO.  18h 
following removal from the diet but in the presence of the drug, larvae were fixed, stained, and numbers of L-
plastin positive cells were counted in the intestine.  Comparison of the numbers of cells in individual larvae (A) 
and mean numbers of cells in larvae (B) fed either ZM or a cholesterol-enriched diet and  treated with varying 
concentrations of VAS-2870, or DMSO, or untreated.  Statistical significance was determined using a one way 
ANOVA followed by a Bonferroni post test.  *** denotes p < 0.001 and ** p < 0.01.  Error bars represent 95% 
confidence intervals.  Data shown for n = 2 experiments (number of times experiment was performed). 
 
 
A dose-dependent reduction in the number of L-plastin
 
positive cells recruited to the 
intestines of larvae fed a cholesterol-enriched diet was observed following treatment with 
VAS-2870, with the greatest level of statistical significance seen with 1µM VAS-2870 (p < 
0.001).  However, such a reduction was not observed upon exposure to DMSO of an 
equivalent volume to 1µM (~ 17 cells).  No reduction in cell numbers occurred following 
treatment with all concentrations of inhibitor in larvae fed ZM compared to untreated or 
DMSO-treated larvae (all ~ 8 – 9 cells; Fig 4.3).  These results thus indicate that 
pharmacological inhibition of NADPH oxidase activity reduces the number of L-plastin 
positive cells accumulating in the intestines of larvae fed a cholesterol-enriched diet. 
 
Given that NADPH oxidase activity appears to be involved in the inflammation, the next step 
was to attempt to visualise this activity through the use of a fluorogenic H2O2 probe.  H2O2 is 
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a ROS that is produced by NADPH oxidases and larvae were pre-treated with this probe, fed 
and then imaged (Nathan, 2006).  Larvae pre-treated with DMSO showed no detectable 
fluorescence in the intestine (Fig 7.1A; Appendix).  However, in all of the feeding 
conditions, the level of fluorescence intensity of the probe was the same indicating no 
difference in H2O2 production upon feeding a cholesterol-enriched diet compared to feeding 
ZM or unfed larvae (Fig 7.1B – D; Appendix).  As DMSO treatment displayed no 
fluorescence, this indicates that the fluorescence observed in the intestines of larvae pre-
treated with the probe was due to the effect of the probe and not autofluorescence associated 
with DMSO or autofluorescence in the intestine itself.  These results thus suggest that it is not 
possible to distinguish between the fluorescence intensity of the probe in larvae fed ZM, a 
cholesterol-enriched diet or unfed larvae.  
 
 
4.3.3  Pharmacological Inhibition of Caspase-1 Activity Reduces the Accumulation of L-
Plastin Positive Cells in the Intestines of Cholesterol-fed and Palmitic Acid-fed Larvae 
 
 
The role of caspase-1, a component of the inflammasome itself downstream of cathepsin B 
and NADPH oxidase, was then studied.  Caspase-1 is involved in the processing of IL-1β to 
its mature, cleaved form and an orthologue of which has been characterised in zebrafish 
(Masumoto et al, 2003; Schroder et al, 2010; Tschopp and Schroder, 2010).  Experimental 
groups were set up as described for experiments using the cathepsin B inhibitor, but in this 
case using a reversible, competitive caspase-1 and 5 inhibitor, N-Acetyl WEHD-al (Rano et 
al, 1997). 
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Figure 4.4: Pharmacological Inhibition of Caspase-1 Activity Reduces the Accumulation of L-Plastin 
Positive Cells in the Intestines of Cholesterol-fed and Palmitic Acid-Fed Larvae.  6 dpf WT larvae were 
pre-treated with the caspase-1 and 5 inhibitor, N-Acetyl WEHD-al, or were untreated for 30 mins.  Following 
this, they were then fed for 6h whilst in the presence of the drug.  18h following removal from the diet but in the 
presence of the drug, larvae were fixed, stained, and numbers of L-plastin positive cells were counted in the 
intestines.  Comparison of the numbers of cells in individual larvae (A) and mean numbers of cells in larvae (B) 
fed either a standard diet (ZM) or a cholesterol-enriched diet and treated with varying concentrations of N-
Acetyl WEHD-al.  Comparison of the numbers of cells in individual larvae (C) and mean numbers of cells in 
larvae (D) fed either ZM or a cholesterol-enriched diet and treated with 100µM N-Acetyl WEHD-al or 
untreated.  Comparison of the numbers of cells in individual larvae (E) and mean numbers of cells in larvae (F) 
fed either ZM, a cholesterol-enriched diet or a palmitic acid (PA)-enriched diet and treated with 100µM N-
Acetyl WEHD-al or untreated.  Statistical significance was determined using a Kruskall-Wallis test followed by 
a Dunn’s post test.  *** denotes p < 0.001, ** p < 0.01 and * p < 0.05.  Error bars represent 95% confidence 
intervals (CI).  Data shown for n = 1 experiments (A) and (B), and n = 2 experiments (C) – (F) (number of times 
experiments were performed). 
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As was observed with Ca-074-Me treatment (Fig 4.4A and B), a dose-dependent reduction in 
numbers of L-plastin positive cells was seen upon treatment of cholesterol-fed larvae with N-
Acetyl WEHD-al.  Similarly, only the highest concentration tested (100µM) gave a 
statistically significant difference compared to untreated larvae (~ 11 cells compared to ~ 20; 
Fig 4.4A and B).  Exposure of ZM-fed larvae to this concentration showed no difference in 
cell numbers to that of untreated ZM-fed larvae (~ 10 – 11 cells; Fig 4.4A and B) and 
repeating the experiment with only 100µM of inhibitor validated the observed result in the 
titration experiment (Fig 4.4A – D).  Larvae fed a palmitic acid-enriched diet that were 
treated with 100µM also showed a statistically significant reduction in the number of cells, 
though the level of this reduction was not quite as strong as that observed with exposure of 
larvae fed a cholesterol-enriched diet (Fig 4.4E and F).  Collectively, these results indicate 
that pharmacological inhibition of caspase-1 or caspase-5 activity results in a reduction in the 
number of L-plastin positive cells accumulating in the intestines of larvae fed diets enriched 
in either cholesterol or palmitic acid. 
 
As N-Acetyl WEHD-al primarily inhibits caspase-1 activity but also targets caspase-5 with 
much lower affinity, the use of a fluorogenic probe that is specific to caspase-1 would 
therefore allow the activity of this protease to be studied in the context of feeding on a 
cholesterol enriched-diet without the potential involvement of caspase-5.  Two such probes 
were available to do this.  One was a fluorogenic substrate of caspase-1, Z-YVAD-AFC, and 
the other a FLICA, FAM-YVAD-FMK, that binds to activated caspase-1.  Larvae were 
treated with Z-YVAD-AFC, DMSO or were untreated, and then imaged.  In order to visualise 
caspase-1 activity with FAM-YVAD-FMK, larvae were fed for 6h and then immediately 
following this, were treated with FAM-YVAD-FMK for 30 mins, followed by a 30 min wash 
in PBS.  Larvae were then imaged. 
 
The levels of fluorescence in the intestines of larvae treated with all concentrations of Z-
YVAD-AFC were equivalent to those of DMSO treated larvae and untreated larvae, 
indicating that it was not possible to distinguish between fluorescence associated with 
potential caspase-1 activity and autofluorescence in the intestine (Fig 7.2Ai – iii; Appendix).  
In contrast, when using FAM-YVAD-FMK, untreated larvae showed no detectable 
fluorescence in the intestine, indicating absence of autofluoresence in this region (Fig 7.2Bi; 
Appendix).  Approximately 50% of larvae fed either ZM or a cholesterol-enriched diet and 
treated with FAM-YVAD-FMK showed very little or no detectable fluorescence in the 
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intestine (Fig 7.2Bii and Biv; Appendix).  The remaining 50% showed a stronger green 
fluorescence in the intestine that was easily detectable (Fig 7.2Biii and Bv; Appendix).  In all 
cases, there appeared to be detectable fluorescence in the gallbladder of the larvae.  Given 
that the untreated larvae showed no detectable autofluorescence, the fluorescence observed in 
the treated larvae was due to FAM-YVAD-FMK.  These results demonstrate that it was not 
possible to distinguish between fluorescence observed with Z-YVAD-AFC treatment and 
autofluorescence in the intestine.  The results also show that whilst the fluorescence observed 
with FAM-YVAD-FMK treatment is detectable, there are variations in the intensity of this 
fluorescence in treated larvae fed either ZM or a cholesterol-enriched diet. 
 
To further investigate the differences in fluorescence intensity within ZM-fed and 
cholesterol-fed larvae treated with FAM-YVAD-FMK, larvae were segregated into those that 
had bright intestines and those with dim intestines after feeding and treatment with FAM-
YVAD-FMK 3h after removal from the diet.  Following this, numbers of L-plastin positive 
cells were counted in the intestines of larvae.  However, there were no detectable differences 
in numbers of cells in larvae that had bright intestines or those with dim intestines for both 
feeding conditions (Fig 7.3; Appendix).  These results demonstrate that there is no 
correlation between the numbers of L-plastin positive cells accumulating in the intestines of 
larvae and the brightness of the intestines.   
 
To validate whether the fluorescence observed in the intestines of larvae treated with FAM-
YVAD-FMK was associated with caspase-1 activity, inhibitors of caspase-1 and cathepsin B, 
N-Acetyl-WEHD-al and Ca-074-Me, respectively, were used to block caspase-1 activity 
either directly or through inhibition of an upstream target.  Larvae were treated with 
inhibitors and fed as previously described.  3h following removal, they were treated with 
FAM-YVAD-FMK and levels of fluorescence intensity in the intestines were then quantified.  
The fluorescence intensity observed in the intestines of untreated larvae was higher in ZM-
fed larvae compared to cholesterol-fed larvae in one experiment but approximately the same 
in another.  Furthermore, DMSO treatment resulted in an increase in fluorescence intensity 
compared to untreated larvae and there was no meaningful decrease following treatment with 
either N-Acetyl-WEHD-al or Ca-074-Me (Fig 7.4; Appendix).     
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4.3.4  The Effect of Treating Larvae with Morpholinos against ASC on the 
Accumulation of L-Plastin Positive Cells in the Intestines of Cholesterol-fed Larvae 
 
 
Localisation of FITC Fluorescence in the Inner Region of the Intestine of a 7 dpf Larva 
Following Administration of a Fluorescently Conjugated Morpholino into the Water. 
 
In order to validate the potential role of the NLRP3 inflammasome in the inflammation 
associated with feeding on a cholesterol-enriched diet, the outcome of reduced expression of 
ASC on the inflammatory cell infiltrate was investigated.  ASC associates with NLRP3 and 
recruits the pro-form of caspase-1 prior to its activation (Masumoto et al, 2003; Schroder et 
al, 2010; Tschopp and Schroder, 2010).  Given that ASC is not activated in the signalling 
transduced through the NLRP3 inflammasome, but functions as an adaptor bridging between 
NLRP3 and caspase-1, a pharmacological inhibitor-based approach to study the role of ASC 
was not feasible.  An alternative approach was to utilise a MO to transiently knock down 
gene expression of ASC and observe the effect of this knockdown on the inflammation 
associated with feeding on a cholesterol-enriched diet.  A splice-blocking MO that targets the 
first exon and intron boundary sequence of ASC was chosen, as the effect of the knockdown 
could be determined by qRT-PCR.  The effect of this MO is that the first intron is retained 
following splicing, instead of being removed.  A translation-blocking MO was also used that 
targets the translation initiation site.  Firstly, the ability for zebrafish larvae to take up a MO 
into the intestine needed to be examined.  To achieve this, larvae were treated for 24h with a 
standard control MO conjugated to FITC or untreated and imaged by confocal microscopy. 
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Figure 4.5: Localisation of FITC Fluorescence in the Inner Region of the Intestine of a 7 dpf Larva 
Following Administration of a Fluorescently Conjugated Morpholino into the Water.  6 dpf WT larvae 
were treated with either 20µM FITC-conjugated control MO or were untreated for 24h.  Following this, larvae 
were anaesthetised and then imaged on a confocal microscope for presence of green (FITC) fluorescence in the 
intestine.  Images shown are individual slices taken from a Z-stack.  Inner slices represent those taken from the 
interior of the intestine, near the lumen.  Outer slices represent those taken near the exterior of the intestine, 
where the muscularis is located.  Inner slice taken from a MO-treated larva at 10x magnification (A) and 63x 
magnification (B).  Outer slice taken from a MO-treated larva at 10x magnification (C) and 63x magnification 
(D).  (E) Inner slice and (F) outer slice taken from an untreated larva at 10x magnification.  (G) Schematic 
representation of a transverse section of the intestine indicating the relative positions in the intestine, where 
inner and outer slices are taken.  l denotes lumen, e epithelial layer and m muscularis.  Larvae are oriented 
sagitally from anterior (left) to posterior (right).  Slices taken at intervals of 1.6µm at 10x magnification and at 
intervals of 0.9µm at 63x magnification.  Scale bar (black) represents 0.4mm and red represents 0.1mm.  Data 
shown for n = 1 experiments (number of times experiment was performed). 
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Administration of a fluorescently conjugated MO led to an accumulation of FITC 
fluorescence in the inner, but not in the outer layer of the intestine (Fig 4.5A – D).  In the 
absence of a MO, there was no detectable fluorescent signal in the intestines of larvae in 
either the outer layer of the intestine, near the muscularis, or the inner layer, near the lumen 
(Fig 4.5E and F)   Given that there was no fluorescent signal observed in the absence of a 
MO, the fluorescent signal seen in the MO treated larvae is due to the FITC of the MO and 
not autofluorescence in the intestine.  These results show that administration of a 
fluorescently conjugated MO into the water leads to an accumulation of fluorescence in the 
inner region of the intestine but not the outer region.  However, the fluorescence may 
correspond to just the FITC and not the MO as the two may no longer be conjugated 
following the uptake of the MO into the intestine. 
 
 
Prior Administration of a Splice-Blocking or Translation Blocking Morpholino Against ASC 
into the Water Reduces the Accumulation of L-Plastin Positive Cells in the Intestine 
Following Feeding on a Cholesterol-enriched Diet 
 
The next step was to use a MO against ASC and determine its effect on cholesterol-induced 
cell recruitment in the intestine.  Larvae were firstly pre-treated for 24h with MO or were 
untreated and following this treatment period, were fed for 6h whilst in the presence of the 
MO.  18h following removal from the diet, larvae were fixed, stained and L-plastin positive 
cells enumerated. 
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Figure 4.6: Prior Administration of a Splice-Blocking or Translation Blocking Morpholino Against ASC 
into the Water Reduces the Recruitment of L-Plastin Positive Cells to the Intestine Following Feeding on 
a Cholesterol-enriched Diet.  6 dpf WT larvae were pre-treated with MO, or were untreated for 24h.  
Following this, larvae were either fed a cholesterol-enriched diet or a standard diet (ZM) for 6h, whilst in the 
presence of the MO.  18h following removal from the diet, larvae were fixed, stained and numbers of L-plastin 
positive cells were counted in the intestines.  Comparison of the numbers of cells in the intestines of individual 
larvae (A) and mean numbers of cells in larvae (B) treated with varying concentrations of the splice-blocking 
and control MO.  Comparison of the numbers of cells in individual larvae (C) and mean numbers of cells in 
larvae (D) treated with 20µM splice-blocking MO, or control MO or untreated.  Comparison of the numbers of 
cells in individual larvae (E) and mean numbers of cells in larvae (F) treated with 20µM splice-blocking MO, 
translation-blocking MO, specificity control MO, control MO or untreated.  Statistical significance was 
determined using a Kruskall-Wallis test followed by a Dunn’s post test.  ** denotes p < 0.01 and * p < 0.05.  
Error bars represent 95% confidence intervals.  Data shown for n = 1 experiments (A) and (B), (E) and (F), and 
n = 2 experiments (C) and (D) (number of times experiments were performed). 
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Treating larvae with a splice-blocking MO against ASC led to a dose-dependent reduction in 
the number of L-plastin positive cells in the intestine.  A concentration of 20µM gave a 
statistically significant reduction in the cell numbers to an equivalent level to that of ZM-fed 
larvae, whereas lower concentrations showed a non-significant trend towards a reduction.  
The standard control MO, however, had no effect at any concentration, as expected (Fig 4.6A 
and B).  ZM-fed larvae exposed to 20µM of the splice-blocking MO showed no reduction in 
cell numbers, unlike cholesterol-fed larvae, validating the result in the previous experiment 
(Fig 4.6 A – D).  Treatment with either a splice-blocking or a translation blocking MO 
against ASC resulted in a statistically significant reduction in the number of cells in 
cholesterol-fed larvae to a level similar to that of ZM-fed larvae.  However, a standard 
control or a specificity control did not have this effect, as expected (Fig 4.6E and F).  Taken 
together, these results indicate that prior administration of a splice-blocking or translation 
blocking MO against ASC reduces the recruitment of L-plastin positive cells to the intestine 
following feeding on a cholesterol-enriched diet. 
 
 
Microinjection of a Splice-Blocking or a Translation-Blocking Morpholino into Single-Cell 
Zebrafish Embryos Does Not Affect L-plastin Positive Cell Accumulation in the Intestine 
Following Feeding on a Cholesterol-enriched Diet 
 
In an attempt to confirm the effects of feeding the ASC-specific MO, it was administered by 
microinjection.  Embryos were microinjected at the single-cell stage with either a splice-
blocking MO against ASC, a standard control MO, or were non-injected.  At 6 dpf, larvae 
were fed either a cholesterol-enriched diet or ZM for 6h.  In a separate experiment, embryos 
were microinjected with either translation-blocking MO against ASC, standard control MO, 
or were non-injected and fed as in the previous experiment.  In both experiments, 18h 
following removal from the diet, larvae were fixed, stained and numbers of L-plastin positive 
cells were counted in the intestines. 
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Figure 4.7: Microinjection of a Splice-Blocking or a Translation-Blocking Morpholino into Single-Cell 
Zebrafish Embryos Does Not Affect L-plastin Positive Cell Recruitment to the Intestine Following 
Feeding on a Cholesterol-enriched Diet.  WT embryos at the single-cell stage were micro-injected with either 
a splice-blocking MO against ASC, control MO (both at 0.1mM), or were not injected.  In a separate 
experiment, single-cell stage WT embryos were micro-injected with either a translation-blocking MO against 
ASC, control MO (both at 0.1mM) or were not injected.   In both experiments, at 6 dpf, the larvae were fed 
either a standard diet (ZM) or a cholesterol-enriched diet for 6h.  18h following removal from the diet, larvae 
were fixed, stained and numbers of L-plastin positive cells were counted in the intestines.  Comparison of the 
numbers of cells in individual larvae (A) and mean numbers of cells in larvae (B) injected with either the splice-
blocking morpholino, control morpholino or non-injected.  Comparison of the numbers of cells in individual 
larvae (C) and mean numbers of cells in larvae (D) injected with either the translation-blocking morpholino, 
control morpholino or non-injected.  Statistical significance was determined using a Kruskall-Wallis test 
followed by a Dunn’s post test, (A) and (B), or a one way ANOVA followed by a Bonferroni post test, (C) and 
(D).  *** denotes p < 0.001 and ** p < 0.01.  Error bars represent 95% confidence intervals.  Data shown for n = 
2 experiments (number of times experiment was performed). 
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Feeding larvae a cholesterol-enriched diet following microinjection with a splice-blocking 
MO against ASC at the single-cell stage did not result in a reduction in the number of L-
plastin positive cells accumulating in the intestine compared to larvae that were injected with 
a standard control MO or were non-injected.  Such larvae still showed a statistically 
significant difference in the number of cells compared to ZM-fed larvae injected with the 
same MO (~ 19 – 20 cells compared to ~ 12 – 13 cells; Fig 4.7A and B).  Feeding larvae a 
cholesterol-enriched diet following microinjection with a translation-blocking MO against 
ASC also did not reduce the inflammatory infiltrate compared to controls and such larvae 
also showed a statistically significant difference (p < 0.001) compared to ZM-fed larvae 
injected with the same MO (~ 14 cells compared to ~ 7 – 8 cells; Fig 4.7C and D).  
Collectively, these results demonstrate that feeding on a cholesterol-enriched diet following 
microinjection of either a splice-blocking or a translation-blocking MO against ASC at the 
single-cell stage does not reduce the number of L-plastin positive cells accumulating in the 
intestine.  This is not consistent with the observed reduction in the previous experiments 
when these MO were administered into the water. 
 
 
4.3.5  The Effect of Treating Larvae with a Splice-Blocking Morpholino Against ASC on 
the Expression of ASC in the Intestine 
 
 
To try to resolve the different outcomes of MO feeding to that of microinjection, ASC 
expression was measured by qRT-PCR to assess whether or not both routes of delivery had 
indeed knocked down gene expression.  
 
 
Administration of a Splice-Blocking MO Against ASC into the Water Does Not Result in a 
Detectable Knockdown of ASC Expression 
 
6 dpf larvae were treated with a splice-blocking MO against ASC, a standard control MO or 
were untreated for 30h.  Following this, larvae had their intestines dissected and the 
remaining carcasses were also kept.  RNA was extracted from the intestines and carcasses, 
cDNA was generated and changes in ASC expression were measured by qRT-PCR.  A probe 
against ASC that targets the boundary sequence between exon 1 and 2 was used.  Expression 
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changes were normalized against the housekeeping genes EF1a (Fig 4.8), actin (Fig 4.9) and 
18S (Fig 4.10). 
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Figure 4.8: Administration of a Splice-Blocking Morpholino Against ASC into the Water Does Not Result 
in a Detectable Knockdown of ASC Expression.  6 dpf WT larvae were treated with either 20µM splice-
blocking MO against ASC, 20µM control MO, or were untreated for 30h.  Following this treatment, larvae were 
killed and the intestines dissected from the larvae (20 intestines/condition) with the remaining carcasses also 
being kept.  RNA was extracted from the intestines and carcasses, and cDNA generated.   Changes in ASC 
expression was measured by qRT-PCR and calibrated against the non-injected intestine readings.  Fold changes 
in expression of ASC in both pooled larval intestines (20 intestines/pool) and 4 pooled carcasses (Rest, 5 
carcasses/pool) for each of the treatment conditions for two separate experiments (A) and (B).   Mean fold 
changes in expression of ASC in pooled larval intestines and carcasses for the different treatment conditions for 
two separate experiments (C) and (D).   ASC expression normalised to EF1a.  Error bars represent standard 
error of the mean.  CT values for ASC in Experiment 1 ((A) and (C)) ranged from 27.5 – 28.5 (Intestine) and 28 
– 30 (Rest), and in Experiment 2 ((B) and (D)) from 27.5 – 28 for both intestines and remaining carcasses.  CT 
values for EF1a in Experiment 1 ranged from 19 – 20 (Gut) and 20.5 – 22 (Rest), and in Experiment 2 from 18.5 
– 19.5 (Intestine) and 19 – 20 (Rest).  Data shown for n =1 experiements (number of times experiment was 
performed).    
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Administering a splice-blocking MO against ASC into the water did not result in a reduction 
in gene expression of ASC in either the intestines or the remaining carcasses of larvae from 
Experiment 1 (Fig 4.8A and C).  In Experiment 2, treatment with both the ASC and control 
MO decreased ASC expression levels in the intestines and the remaining carcasses, indicating 
no reduction in expression solely due to the effect of the ASC MO (Fig 4.8B and D).  Taken 
together, these results suggest that there is no detectable decrease in ASC expression levels in 
either the intestines or the remaining carcasses of larvae pre-treated with a MO against ASC 
administered into the water. 
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Figure 4.9: Administration of a Splice-Blocking Morpholino Against ASC into the Water Does Not Result 
in a Detectable Knockdown of ASC Expression.  6 dpf WT larvae were treated with either 20µM splice-
blocking MO against ASC, 20µM control MO, or were untreated for 30h.  Following this treatment, larvae were 
killed and the intestines dissected from the larvae (20 intestines/condition) with the remaining carcasses also 
being kept.  RNA was extracted from the intestines and carcasses, and cDNA generated.   Changes in ASC 
expression was measured by qRT-PCR and calibrated against the non-injected intestine readings.  Fold changes 
in expression of ASC in both pooled larval intestines (20 intestines/pool) and 4 pooled carcasses (Rest, 5 
carcasses/pool) for each of the treatment conditions for two separate experiments (A) and (B).   Mean fold 
changes in expression of ASC in pooled larval intestines and carcasses for the different treatment conditions for 
two separate experiments (C) and (D).   ASC expression normalised to actin.  Error bars represent standard error 
of the mean.  CT values for ASC in Experiment 1 ((A) and (C)) ranged from 27.5 – 28.5 (Intestine) and 28 – 30 
(Rest), and in Experiment 2 ((B) and (D)) from 27.5 – 28 for both intestines and remaining carcasses.  CT values 
for actin in Experiment 1 ranged from 24.5 – 25.5 (Intestine) and 26.5 – 27.5 (Rest), and in Experiment 2 from 
25 – 25.5 (Intestine) and 25.5 – 27 (Rest).  Data shown for n =1 experiements (number of times experiment was 
performed). 
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Administering a splice-blocking MO against ASC into the water failed to decrease ASC 
expression levels in both larval intestines and remaining carcasses compared to untreated 
larvae in Experiment 1 as judged by qRT-PCR (Fig 4.9A and C).  In Experiment 2, there 
appeared to be no reduction in ASC expression levels in the intestines of larvae treated with 
the ASC MO compared to untreated but a 20% decrease in expression levels of ASC in larvae 
treated with the control MO relative to untreated larvae.  In contrast, in the remaining 
carcasses, there appeared to be ~ 2 fold increase in ASC expression levels in larvae treated 
with either the ASC or control MO compared to untreated larvae (Fig 4.9B and D).  
Collectively, these results also suggest that there is no detectable decrease in ASC expression 
levels in either the intestines or the remaining carcasses of larvae pre-treated with a MO 
against ASC administered into the water. 
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Figure 4.10: Administration of a Splice-Blocking Morpholino Against ASC into the Water Does Not 
Result in a Detectable Knockdown of ASC Expression.  6 dpf WT larvae were treated with either 20µM 
splice-blocking MO against ASC, 20µM control MO, or were untreated for 30h.  Following this treatment, 
larvae were killed and the intestines dissected from the larvae (20 intestines/condition) with the remaining 
carcasses also being kept.  RNA was extracted from the intestines and carcasses, and cDNA generated.  Changes 
in ASC expression were measured by qRT-PCR and calibrated against the non-injected intestine readings.  Fold 
changes in expression of ASC in both pooled larval intestines (20 intestines/pool) and 4 pooled carcasses (Rest, 
5 carcasses/pool) for each of the treatment conditions for two separate experiments (A) and (B).   Mean fold 
changes in expression of ASC in pooled larval intestines and carcasses for the different treatment conditions for 
two separate experiments (C) and (D).   ASC expression normalised to 18S.  Error bars represent standard error 
of the mean.  CT values for ASC in Experiment 1 ((A) and (C)) ranged from 27.5 – 28.5 (Intestine) and 28 – 30 
(Rest), and in Experiment 2 ((B) and (D)) from 27.5 – 28 for both intestines and remaining carcasses.  CT values 
for 18S in Experiment 1 ranged from 11.5 – 12.5 (Intestine) and 12.5 – 13.5 (Rest), and in Experiment 2 from 
11 – 12 for both intestines and remaining carcasses.  Data shown for n =1 experiements (number of times 
experiment was performed).  
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Administering a splice-blocking MO against ASC into the water resulted in an approximate 
25% decrease in ASC expression in the intestines of larvae compared to untreated larvae in 
Experiment 1.  However, since there was also a 50% reduction in expression levels in the 
larvae treated with the control MO, this reveals that the ASC MO does not specifically reduce 
expression.  Similarly, both the ASC and the control MO reduced expression in the remaining 
carcasses (Fig 4.10A and C).  The changes in ASC expression in the intestines of larvae in 
Experiment 2 are very similar to that of Experiment 1.  However, there is no change in ASC 
expression levels in the remaining carcasses of larvae treated with the ASC MO compared to 
untreated larvae (Fig 4.10B and D).  Collectively, these results confirm that that there is no 
marked or specific decrease in ASC expression levels in larvae pre-treated with an ASC-
specific MO administered into the water. 
 
 
Microinjection of a Splice-Blocking MO Against ASC into Embryos Results in an Observed 
Reduction of ASC Expression 
 
The results from the previous experiments failed to demonstrate mechanistically that the 
reduction in inflammatory cells following cholesterol feeding correlated with reduced gene 
expression.  Therefore, the biological activity of the ASC MO by microinjection was 
examined.  Embryos were microinjected with either a splice-blocking MO against ASC, a 
standard control MO or were non-injected.  At 7dpf, larvae were processed for cDNA and 
ASC expression levels analysed by qRT-PCR as for the previous experiments. 
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Figure 4.11: Microinjection of a Splice-Blocking Morpholino Against ASC into Embryos Results in an 
Observed Reduction of ASC Expression.  WT larvae at the single-cell stage were micro-injected with either 
0.1mM splice-blocking MO against ASC, 0.1µM control MO, or were non-injected.  At 7 dpf, larvae were 
killed and the intestines dissected from the larvae (20 intestines/condition) with the remaining carcasses also 
being kept.  RNA was extracted from the intestines and carcasses, and cDNA generated.  Changes in ASC 
expression was measured by qRT-PCR and calibrated against the non-injected intestine or carcass readings.  
Fold changes in expression of ASC in both pooled larval intestines (20 intestines/pool) (A) and 4 pooled 
carcasses (Rest, 5 carcasses/pool) (B) for each of the treatment conditions.   Mean fold changes in expression of 
ASC in pooled larval intestines (C) and carcasses (D) for the different treatment conditions.   Numbers in (D) 
represent fold changes relative to mean of non-injected carcasses.  ASC expression normalised to 18S.  Error 
bars represent standard error of the mean.  Statistical significance was determined using a Kruskall-Wallis test 
followed by a Dunn’s post test.  ** denotes p < 0.01.  CT values for ASC ranged from 27 – 28 (Intestine) and 27 
- 29 (Rest).  Ct values for 18S ranged from 11.5 - 12 for both intestine and remaining carcasses.  Data shown for 
n = 1 experiments (number of times experiment was performed). 
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Microinjection of the control MO led to an approximate 25% reduction in expression levels 
of ASC in the intestines of larvae compared to non-injected larvae.  However, microinjection 
of a splice-blocking MO against ASC resulted in a 60% reduction in expression levels 
compared to non-injected larvae and a 45% reduction compared to control MO injected 
larvae.  Thus, there is a decrease in ASC expression levels following injection of the ASC 
MO confirming its activity, but there was also a reduction in ASC expression levels 
following injection of the control MO (Fig 4.11A and C).  In the remaining carcasses, 
microinjection of a control MO led to a 35% reduction in expression levels of ASC compared 
to non-injected larvae whereas injection of the ASC MO resulted in a 65% reduction.  The 
trend was similar to that observed in the intestine, although the effect of the control MO was 
more marked.  Overall, the ASC MO had greater effects than the control on gene expression 
in the remaining carcasses (Fig 4.11B and D).  These results indicate that microinjection of a 
splice-blocking MO against ASC leads to a reduction in ASC expression levels in both the 
intestines and remaining carcasses. 
 
To validate the effect of the MO further, 5 dpf and 7 dpf larvae that had either been micro-
injected with the splice-blocking MO, control MO or non-injected and processed as 
previously described, except RNA was extracted from whole larvae. 
 
 
 
  4.  NLRP3 Inflammasome 
155 
 
 
 
 
Figure 4.12: Microinjection of a Splice-Blocking Morpholino Against ASC into Embryos Results in an 
Observed Reduction of ASC Expression.  WT larvae at the single-cell stage were microinjected with either 
0.1mM splice-blocking MO against ASC, 0.1µM control MO, or were non-injected.  At 5 dpf and 7 dpf, larvae 
were killed and grouped into pools (5 larvae/pool).  RNA was extracted from whole larvae and cDNA 
generated.   Changes in ASC expression was measured by qRT-PCR and calibrated against the non-injected 
readings.  Fold changes in expression of ASC in 5 dpf larvae (A) and 7 dpf larvae (B) for each of the treatment 
conditions.   Mean fold changes in expression of ASC in 5 dpf larvae (C) and 7 dpf larvae (D) for the different 
treatment conditions.   Numbers in (C) and (D) represent fold changes relative to mean of non-injected 
carcasses.  ASC expression normalised to EF1a.  Error bars represent standard error of the mean.  Statistical 
significance was determined using a Kruskall-Wallis test followed by a Dunn’s post test.  * denotes p < 0.05.  
CT values for ASC ranged from 28 – 30 for both 5dpf and 7dpf larvae.  Ct values for EF1a ranged from 20 - 21 
for 5 dpf larvae and from 19.5 – 21 for 7 dpf larvae.  Data shown for n = 1 experiments (number of times 
experiment was performed). 
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Microinjection of a splice-blocking ASC MO reduced gene expression by ~ 70% compared 
to non-injected larvae at both 5dpf and 7dpf (p < 0.05).  However, at 5dpf and 7dpf, the 
control MO gave a 10% and 25% reduction in ASC expression, respectively (Fig 4.12).  
These results validate the findings of the previous experiment and confirm that microinjection 
of a splice-blocking MO against ASC leads to a reduction in ASC expression levels in whole 
larvae.     
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4.4  Discussion 
 
 
In brief, inhibition of cathepsin B, NADPH oxidase and caspase-1 activity reduces the 
number of L-plastin positive cells in the intestines of larvae fed a cholesterol-enriched diet.  
The caspase-1, but not the cathepsin B, inhibitor also reduced the inflammatory response to a 
palmitic acid diet.  Furthermore, administration of a fluorescently conjugated MO into the 
water results in an accumulation of fluorescence in the inner layer of the intestine near the 
lumen, but not the outer layer.  Feeding of a splice-blocking ASC-specific MO leads to a 
decrease in the number of L-plastin positive cells in the intestines of cholesterol-fed larvae 
but has no detectable effect on ASC expression.  In contrast, following microinjection of this 
MO, ASC expression was reduced but there was no detectable change in the inflammatory 
cell infiltrate. 
 
 
4.4.1  The Accumulation of L-Plastin Positive Cells in the Intestine Following Feeding 
on a Cholesterol-enriched Diet Appears to be Dependent on the Activities of Cathepsin 
B, NADPH Oxidase and Caspase-1 
 
One potential explanation for the difference in effects of cathepsin B inhibition observed 
following feeding on a cholesterol-enriched diet compared to a diet enriched in palmitic acid 
may be due to the manner in which cholesterol and palmitic acid are taken up by intestinal 
epithelial cells (Fig 4.2).  Cholesterol is taken up by clathrin-mediated endocytosis following 
its interaction with NPC1L1 and as such is present in the lysosome.  Thus, cholesterol could 
activate cathepsin B if the lysosomal membrane ruptures (Ge et al, 2008; Betters and Yu, 
2010; Tschopp and Schroder, 2010).  Palmitic acid however, enters intestinal epithelial cells 
either through means facilitated by fatty acid transport proteins at the cell surface or through 
passive diffusion, or a combination of both (Masson et al, 2010; Lynes and Widmaier, 2011).  
So, since palmitic acid enters the cell independently of endocytosis it is unlikely to cause 
activation of cathepsin B.  Support of this comes from in vitro studies which have shown that 
palmitic acid can induce secretion of IL-1β from bone marrow derived macrophages, but is 
independent of the lysosome (Wen et al, 2011).  It is known that not all danger signals that 
activate the NLRP3 inflammasome do so by activation of cathepsin B, nevertheless they all 
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appear to result in ROS production, including palmitic acid (Hornung et al, 2008; Schroder et 
al, 2010; Tschopp and Schroder, 2010; Wen et al, 2011).  Crystal particles of cholesterol 
have been demonstrated to activate the NLRP3 inflammasome in a cathepsin B-dependent 
manner, consistent with a similar activation by other crystalline particles, such as silica or 
alum (Hornung et al, 2008; Duewell et al, 2010; Rajamäki et al, 2010).  It is however, 
unlikely in a 6h feeding period that cholesterol crystals will have formed as such particles are 
first observed in apoE
-
/
-
 mice two weeks after initiating feeding on a cholesterol-enriched diet 
(Duewell et al, 2010).  Nevertheless, given that dietary cholesterol itself is taken up in an 
endocytic manner, it is possible that the potential cathepsin B activation observed in this data 
occurs in the lysosome following internalisation of this dietary cholesterol into the intestinal 
epithelial cells. 
 
The results also suggest that the inflammation associated with feeding on a cholesterol-
enriched diet is dependent upon NADPH oxidase activity (Fig 4.3).  It has been demonstrated 
in vivo that blocking cholesterol uptake with ezetimibe decreases expression of NADPH 
oxidases and in vitro that ezetimibe treatment reduces ROS production (Nomura et al, 2009).  
Therefore, cholesterol is likely to be involved in enhancing expression of NADPH oxidases 
and possibly stimulating ROS production by NADPH oxidases.  Crystal particles of 
cholesterol can activate the NLRP3 inflammasome and all known activators of the 
inflammasome appear to induce ROS production (Duewell et al, 2010; Rajamäki et al, 2010; 
Schroder et al, 2010; Tschopp and Schroder, 2010).  Thus, it is possible that the potential 
activation of NADPH oxidases by cholesterol may trigger NLRP3 signalling.  This suggests 
that the acute inflammatory response that is observed following cholesterol feeding may 
involve the NLRP3 inflammasome.  In support of this is the finding that a cathepsin B 
inhibitor reduces the inflammatory cellular infiltrate, since cathepsin B is an upstream 
activator of the NLRP3 inflammasome.  However, there is currently no evidence in the 
literature that supports a role for dietary cholesterol, other than in the form of crystals, in 
activating the NLRP3 inflammasome. 
 
The source of ROS involved in the activation of the NLRP3 inflammasome is currently a 
matter of controversy with findings from some groups indicating that NADPH oxidases are 
the source and not mitochondria (Dostert et al, 2008; Dostert et al, 2009).  However, findings 
from other groups indicate that ROS production occurs independently of NADPH oxidases 
and mitochondria are the potential source (van Bruggen et al, 2010; Zhou et al, 2011).  The 
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data in this thesis indicates a role of NADPH oxidases as a source of ROS production 
following feeding on a cholesterol-enriched diet.  This is in agreement with two studies by 
Dostert et al but a mitochondrial-derived source of ROS may also be involved (Dostert et al, 
2008; Dostert et al, 2009).  Whilst the results suggest a potential role for NADPH oxidase 
activity in the acute inflammatory response induced by a cholesterol-enriched diet, no 
detectable differences were observed in levels of H2O2 indicative of NADPH oxidase activity 
in the intestine following feeding on a cholesterol-enriched diet compared to a ZM-fed diet or 
unfed larvae (Fig 7.1; Appendix).  It is possible that the fluorescence observed with the 
probe is an artefact and thus not a measure of the levels of H2O2 produced.   
 
The recruitment of L-plastin positive cells to the intestines of larvae fed either a cholesterol 
or a palmitic acid-enriched diet appears to be dependent upon caspase-1 activity (Fig 4.4).  
This is in agreement with published reports that palmitic acid and crystal particles of 
cholesterol activate NLRP3 in a caspase-1-dependent manner (Duewell et al, 2010; Rajamäki 
et al, 2010; Wen et al, 2011).  Despite the findings obtained with N-Acetyl WEHD-al, no 
meaningful changes in caspase-1 activity could be detected when using a fluorogenic 
inhibitor, FAM YVAD-FMK, of active caspase-1.  An explanation for this is that the 
fluorescence observed with FAM-YVAD-FMK is an artefact and not a measure of caspase-1 
activity.  It is possible that with N-Acetyl WEHD-al treatment, there is a smaller level of 
inhibition of caspase-5 given that the inhibitor has a lower level of affinity for caspase-5 in 
addition to its primary target, caspase-1.  However, the predominant effect of inhibition is 
likely to be on caspase-1.  Studies have demonstrated that the Ki of N-Acetyl WEHD-al for 
caspase-1 is approximately 750 times lower than that of caspase-5 (0.056nM compared to 
43nM, respectively) confirming the much higher affinity of the inhibitor for caspase-1 over 
caspase-5 (Rano et al, 1997; Garcia-Calvo et al, 1998).  This is consistent with caspase-5 
having a Kcat / KM of ~ 100 times lower than caspase-1 for substrates containing the WEHD 
recognition motif (Garcia-Calvo et al, 1998).  Caspase-5 is an inflammatory caspase and 
forms part of the NLRP1 inflammasome, which also involves caspase-1 and ASC (Martinon 
et al, 2002).  However, the NLRP1 and NLRP3 inflammasomes differ in that activation of 
caspase-1 in NLRP1 is not dependent upon ASC; ASC only enhances caspase-1 activation 
(Faustin et al, 2007).  Additionally, activation of the NLRP1 inflammasome is not known to 
be dependent upon NADPH oxidase activity which appears to be involved in the 
inflammatory response to a cholesterol-enriched diet.  NLRP1 is activated by microbial 
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products and as yet appears to have no role in the response to dietary fat (Boyden and 
Dietrich, 2006; Faustin et al, 2007).     
 
As well as the NLRP3 inflammasome, components of dietary fat have been shown to activate 
TLR signalling.  Palmitic acid activates TLR4 in a MyD88-dependent manner and is likely to 
activate p38 and JNK signalling through upstream TLR4 activation (Shi et al, 2006; Kim et 
al, 2007; Håversen et al, 2009; Maloney et al, 2009).  Palmitic acid also forms ceramides, 
which directly activate p38 and JNK, although given that ceramides take a period of hours or 
days to form, it is unlikely that they are responsible for any effect observed in these results 
(Perry and Hannun, 1998; Schmitz-Peiffer et al, 1999; Håversen et al, 2009).  OxLDL has 
been demonstrated to activate a TLR4/6 heterodimer in association with CD36 and 
independently of CD14 (Stewart et al, 2010).  Similarly, mmLDL has been shown to activate 
TLR4 signalling both in a MyD88 dependent and independent manner (Cushing et al, 1990; 
Bae et al, 2009; Chávez-Sánchez et al, 2010).  Oxidised derivatives of cholesterols, known as 
oxysterols have been demonstrated to enhance IL-8 and MCP-1 in an ERK-dependent 
manner in human retinal cells (Dugas et al, 2010).  In human macrophages, oxysterols induce 
NF-κB activation and increase phosphorylation of ERK1/2 and JNK (Palozza et al, 2010).  
Nevertheless, although there is no evidence that a cholesterol-enriched diet induces 
inflammation via NLRP1, it cannot be excluded due its dependence upon caspase-1.  
Collectively, however, the reduction in intestinal inflammation that is observed with the 
cathepsin B, NADPH oxidase and caspase-1 inhibitors all point to NLRP3 playing a role in 
the acute response to a cholesterol-enriched diet. 
 
There is cross-talk between TLR signalling and the NLRP3 inflammasome in that NF-κB 
activation results in expression of the pro-form of IL-1β.  TLR4 or TLR2 signalling following 
LPS or peptidoglycan stimulation respectively, has also been demonstrated to induce 
expression of NLRP3 itself, which is necessary for its activation possibly due to its 
constitutive low level of expression (Bauernfeind et al, 2009; Qiao et al, 2012).  Given that 
components of dietary fat are known to activate TLRs, it is possible that the priming signal 
required for generation of pro-IL-1β may occur in a TLR-dependent manner in response to 
cholesterol or palmitic acid and that induction of expression of NLRP3 may also.  However, 
whether or not this is the case in zebrafish remains to be examined in light of zebrafish 
lacking CD14 and MD-2 which are required for signalling through TLR4 (Iliev et al, 2005).  
Alternatively, it is possible that the microbiota in the intestine may provide the priming signal 
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as there is a low level of inflammation occurring in the intestine during colonisation with 
microbiota, leading to neutrophil infiltration and establishment of a resident immune cell 
population (Bates et al, 2007).  However, in order to prevent an excessive inflammatory 
response against the microbiota, the induction of expression of other cytokines and 
chemokines would need to be relatively low.  Another possibility is that the priming signal 
may occur as a result of the microbiota in combination with cholesterol or palmitic acid 
feeding.  These possibilities are discussed in greater detail in Chapter 6.   
 
 
4.4.2  Administration of a Splice-Blocking Morpholino Against ASC into the Water 
May Result in a Reduction in Expression Levels of ASC in Intestinal Epithelial Cells 
that Cannot be Detected by qRT-PCR in the Entire Intestine 
 
The results suggest that the recruitment of L-plastin positive cells to the intestines of larvae 
fed a cholesterol-enriched diet appears to be dependent upon ASC expression.  Despite this, 
however, there was no detectable reduction in expression levels of ASC by qRT-PCR neither 
in the intestines nor the remaining carcasses in MO treated larvae (Figs 4.8 – 4.10).  This may 
be due to the MO localising to the inner region of the intestine where the fluorescent signal 
was detected near the lumen and where epithelial cells are present since no fluorescent signal 
was detected in the outermost region of the intestine near the muscularis (Fig 4.5).  However, 
this relies on the fluorescent signal being a measure of the MO localisation and thus the MO 
being conjugated to FITC.  If this is the case, ASC knockdown may occur in only a 
proportion of the cells in or associated with the intestinal tract.  It is unlikely that the ASC-
specific splice-blocking MO had an off target effect that prevented cell recruitment to the 
intestine, given that the specificity control MO which has only 5 mismatched bases from the 
splice-blocking MO had no effect on the numbers of cells and the ASC-specific translation-
blocking MO had the same effect as the splice-blocking MO.  Thus, it is likely that the 
reduction in cell numbers following ASC-specific MO treatment is due to an effect on ASC 
expression.  It is known that intestinal epithelial cells express the NLRP3 inflammasome and 
therefore ASC, and additionally that these cells are responsible for taking up cholesterol in 
the intestine (Altmann et al, 2004; Kummer et al, 2007; Cario, 2010).  Thus, perhaps it is 
possible that cholesterol may activate the NLRP3 inflammasome within these cells leading to 
an accumulation of L-plastin positive cells in the intestine.  Treatment of larvae with a MO 
against ASC by administration into the water could potentially decrease expression levels of 
  4.  NLRP3 Inflammasome 
162 
 
ASC in the intestinal epithelial cells in the inner region of the intestine and so prevent NLRP3 
inflammasome-dependent accumulation of L-plastin positive cells following cholesterol-
feeding. 
 
 
4.4.3  Microinjection of an ASC-specific Splice-Blocking MO May Reduce Levels of 
ASC More Efficiently in Cells Whose ASC Expression is Not Necessary in the Response 
to Feeding on a Cholesterol-enriched Diet 
 
Microinjection of a splice-blocking ASC-specific MO reduces expression of ASC in both the 
intestines and remaining carcasses of larvae compared to control larvae (Fig 4.11).  ASC has 
been shown to be expressed in mature, differentiated colonic epithelial cells near the lumen 
but is absent from immature epithelial cells near the crypts that are further from the lumen 
(Masumoto et al, 2001; Yokoyama et al, 2003).  This pattern of ASC expression in the 
mucosal epithelium is consistent with its expression in highly differentiated epithelium of 
both skin and tonsils in humans (Masumoto et al, 2001).  The full development of the 
zebrafish larval intestine occurs by ~ 120 hpf from its onset at ~ 26 – 30 hpf (Ng et al, 2005).  
During this period, the epithelium undergoes a phase of rapid proliferation until ~ 74hpf, 
followed by a differentiation phase and ASC may possibly be expressed in these cells at the 
latter stage (Wallace et al, 2005).  As this phase commences around 3 days after the MO was 
microinjected into the embryos, the effect of knockdown of gene expression in mature, 
differentiated epithelial cells may be reduced compared to a potential knockdown in these 
cells following feeding of the MO.  In this context, the MO is instantly taken up by mature 
ASC-expressing intestinal epithelial cells from the lumen in 6 dpf larvae with a fully 
developed intestine. 
 
ASC is also expressed in SMCs of the human colon and in macrophages and neutrophils 
(Masumoto et al, 2001; Kolly et al, 2010).  Macrophages and neutrophils first appear at 15.5 
and 18 hpf, respectively, and SMC progenitors at 50 hpf which is relatively early compared 
to the commencement of the differentiation program of epithelial cells (Herbomel et al, 1999; 
Bennett et al, 2001; Wallace et al, 2005).  Therefore, the effect of ASC knockdown in these 
cells in the intestine may be stronger than that occurring in the mature epithelial cells which 
might express ASC later.  Thus, despite the potential reduced knockdown in the epithelial 
cells, the possible stronger level of knockdown of expression additionally in macrophages, 
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neutrophils and SMCs would result in an overall reduction in expression in the intestine, 
which is observed in the data (Fig 4.11). 
 
However, despite the observed decrease in ASC expression, there is no reduction in the 
numbers of L-plastin positive cells recruited to the intestines of larvae fed a cholesterol-
enriched diet following microinjection of the splice-blocking MO compared to the controls 
(Fig 4.7).  An explanation for this is that ASC expression in cells that are potentially more 
greatly affected by the microinjected MO, such as SMCs, macrophages and neutrophils, may 
not be necessary for the recruitment of L-plastin positive cells to the intestine in response to a 
cholesterol-enriched diet.  Microinjection of the ASC-specific splice-blocking MO may not 
reduce ASC expression in the lumenal epithelial cells as greatly and as a result of this, there 
is no reduction in the immune cell infiltrate.  This is supported by the observation that a 
potential knockdown of ASC expression in the epithelial cells in the inner region of the 
intestine following MO feeding is sufficient to significantly reduce the numbers of L-plastin 
positive cells without any further knockdown in expression of cells in the outer region (Fig 
4.6).  SMCs form the muscularis of the intestine and L-plastin positive cells, encompassing 
both neutrophils and macrophages, are also localised in the muscularis (Fig 3.14).  As this is 
in the outermost region of the intestine, such ASC-expressing cells may not be affected by the 
MO.  This suggests that it may be the expression of ASC in the intestinal epithelial cells that 
drives the inflammatory response to feeding on a cholesterol-enriched diet.  However, in 
order to confirm the localisation of cellular ASC expression in the intestine, WISH can be 
used as discussed further in Chapter 6.                    
 
 
4.4.4  Conclusion 
 
The recruitment of L-plastin positive cells to the intestines of larvae in response to a 
cholesterol-enriched diet appears to be dependent upon the activities of cathepsin B, NADPH 
oxidase and caspase-1.  The cell recruitment may also be dependent upon the expression of 
ASC in intestinal epithelial cells.  Taken together, these results suggest that the inflammation 
associated with feeding on a cholesterol-enriched diet is at least in part dependent on the 
NLRP3 inflammasome.                                    
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CHAPTER 5: ATTEMPTING TO GENERATE A NOVEL 
STABLE TRANSGENIC LINE OF ZEBRAFISH WITH 
ABLATED LYZC EXPRESSING CELLS 
 
 
5.1  Introduction 
 
 
The optical transparency of zebrafish larvae permits live imaging at the whole organism level 
and is an advantage of this model system over mammalian ones.  This property has been 
capitalised on by a large number of research groups and led to the development of various 
transgenic strains of zebrafish that express fluorescent reporters under the influence of cell or 
tissue specific promoters, allowing temporal and spatial control of expression.  The principles 
of zebrafish transgenesis date back almost 25 years and since then, several developments 
have been made enabling this technique to become widely used today. 
 
The first attempts at generating a transgenic strain of zebrafish involved the injection of 
plasmid DNA into fertilised eggs, which resulted in stable integration of this DNA into the 
genome (Stuart et al, 1988).  However, the frequency of this occurrence was generally low 
due to the random nature by which the plasmid DNA integrated into the genome.  If the DNA 
was integrated relatively early on, then a greater level of transgene expression would be 
observed as more cells would express it.  If the integration occurred later, though, then fewer 
cells would express the transgene, resulting in a reduced level of expression (Grabher and 
Wittbrodt, 2008).  Thus, this led to variegated expression, whereby not all cells that should 
express the transgene actually did (Stuart et al, 1990).  Expression was also reduced over 
time and by adulthood there was sometimes very little expression.  Additionally, there was a 
low frequency of germline transmission which occurred in a non-Mendelian manner (Stuart 
et al, 1988).  Over the years, however, techniques that improved the rate of transgene 
integration into the genome were developed.  One of these involved the use of I-SceI 
meganuclease, which cleaves specific recognition sites (Thermes et al, 2002).  A plasmid 
vector containing the transgene flanked by these recognition sites would be injected along 
with mRNA encoding the meganuclease. The enzyme would cleave the vector at the 
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recognition sites and allow integration of the transgene into the genome.  This approach gave 
a much higher rate of germline transmission than the previously used technique of injecting 
plasmid DNA alone into the fertilised eggs (Babaryka et al, 2009). 
 
Another approach that relies on a similar principle to I-SceI meganuclease is that of 
transposon-based integration.  Transposons are mobile genetic elements that can be 
transferred from one location to another through the activity of a transposase enzyme.  The 
enzyme recognises and cleaves specific inverted repeat sequences and allows the integration 
of the excised DNA into the genome (Largaespada, 2003).  One of the most commonly used 
transposon-based systems today is the Tol2 system which utilises Tol2 transposable elements 
identified in the medaka fish (Oryzias latipes) (Koga et al, 1996).  The plasmid vector 
containing Tol2 elements and mRNA encoding the transposase are co-injected into fertilised 
eggs.  The transposase then catalyses the excision of DNA flanked by the Tol2 sequences, 
allowing integration of the excised sequence into zebrafish germ cells (Kawakami et al, 1998; 
Kawakami and Shima, 1999; Kawakami et al, 2000).  The Tol2 transposon system has a 
germline transmission rate of up to 50%, consistent with Mendelian inheritance and is, thus, 
currently the most reliable approach in terms of transmitting the transgene to progeny 
(Kawakami et al, 2004).  It has been demonstrated that the minimal sizes of the Tol2 
elements required for achieving this rate of germline transmission are 200bp (left element) 
and 150bp (right element), and that an insert of around 11kb can be effectively transmitted in 
this way (Urasaki et al, 2006). 
 
A further advantage of the Tol2 system is that unlike other systems, the DNA integrated into 
the genome in this manner does not cause rearrangements of the surrounding DNA and thus 
no silencing effect is observed.  Thus, subsequent generations continue to express the 
transgene at the same level as previous ones.  Other approaches of transgenesis, however, can 
result in concatamers of plasmid DNA forming in the genome, which leads to gene silencing 
in future generations and thus expression being reduced or lost completely (Kawakami, 
2005).  In order to allow the integration of inserts greater than 11kb, the Tol2 system can be 
utilised in bacterial artificial chromosomes, which can carry inserts up to 350kb.  However, 
the approach is exactly the same as for plasmid vectors, which has greatly enhanced the 
applicability of this technique (Suster et al, 2009).  The principles of Tol2 transgenesis are 
summarised in Fig 5.1: 
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Figure 5.1: Generation of a Transgenic Line of Zebrafish Using the Tol2 Transposon System.  Transposase 
mRNA is generated by in vitro transcription of cDNA and co-injected into fertilised eggs along with a Tol2 
vector containing plasmid DNA encoding a transgene.  The transposase catalyses the excision of the transgene 
flanked by the transposons and its integration into the genomic DNA.  Injected eggs (founders) are then raised to 
adulthood and crossed to WT fish.  The transgene is then transmitted in the germline to the progeny (F1) (Figure 
adapted from Kawakami, 2005).    
 
 
An approach that has been used to enhance transgene expression is the GAL4/UAS system, 
originally employed in Drosophila melanogaster (Halpern et al, 2008).  It involves the use of 
two components: a regulatory protein GAL4 and an upstream activation sequence (UAS), 
each present in a separate construct.  GAL4 is placed under the promoter of a gene of interest 
and an effector protein, usually a fluorescent reporter, is placed downstream of the UAS 
(Scheer and Campos-Ortega, 1999).  Each of the two constructs is microinjected into separate 
groups of fertilised eggs and the resulting embryos are raised to adulthood.  The adult lines, 
each expressing one of the two constructs, are then crossed to one another and the resulting 
progeny contain both constructs.  Transgene expression occurs by GAL4 binding to UAS and 
driving expression of the effector gene (Halpern et al, 2008).  Thus, effector gene expression 
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can be regulated in a cell or tissue specific manner by GAL4 only being able to bind UAS 
when the promoter under which GAL4 is under the influence of, is activated.  A further 
development in this approach is the use of a hybrid of GAL4 and VP16 of the herpes simplex 
virus, termed GAL4-VP16, which enhances gene expression more greatly than GAL4 alone 
(Sadowski et al, 1988).  One limitation of the GAL4/UAS technique, however, is that 
transgene expression is not initially detected until the first generation of progeny (F1) of the 
injected founder fish (F0).  This is because the constructs need to be injected into separate sets 
of eggs and raised to adulthood before crosses are carried out to obtain offspring expressing 
both constructs. 
 
The ability to perform targeted ablation in a cell or tissue specific manner is a technique that 
has gained a lot of attention recently in zebrafish research.  It allows the processes of 
development and regeneration to be studied, as well as behavioural interactions between cell 
populations in live fish.  Several applications of this approach have been used in zebrafish in 
a variety of cell types.  One method by which this technique is carried out involves the use of 
diphtheria toxin A (DTA), which encodes an ADP-ribosyl transferase that inhibits protein 
synthesis.  DTA is fused to a cell or tissue-specific promoter of interest and causes ablation of 
the target cell population.  However, undesired effects on other cells have been observed 
using this approach.  Furtherrmore, in some cases, ablation did not occur in the target cells 
and the only effect observed on these cells was reduced cell growth (Kurita et al, 2003; Wan 
et al, 2006).  Another strategy involves the use of a bacterial toxin, Kid, and an antidote 
against it, Cis.  Kid is expressed under a cell or tissue-specific promoter and thus causes 
ablation of any cells or tissues expressing it.  In contrast, Cis is expressed in the remainder of 
the organism, protecting it from the ablative effects of Kid (Slanchev et al, 2005).  However, 
both the DTA and Kid/Cis approaches have only been successfully used in transient 
expression experiments.   
 
A third technique involves using the bacterial enzyme nitroreductase (NTR), which has the 
ability to convert certain prodrugs into potent cytotoxic DNA cross-linking agents through a 
process of reduction.  NTR can be fused to a cell or tissue-specific promoter and thus only 
NTR-expressing cells will be killed following administration of the prodrug (Curado et al, 
2007).  One prodrug that was initially used in vitro was CB1954, but this was found to be 
unsuitable as the converted product was cell permeable and thus able to enter neighbouring 
cells and kill them, resulting in a ‘bystander effect’ (Bridgewater et al, 1997).  An alternative 
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prodrug that is commonly used today is metronidazole (Mtz). Unlike CB1954, the cytotoxic 
agent formed from Mtz by the action of NTR is not cell permeable and therefore is retained 
in the NTR-expressing cells.  Thus, it is not able to enter neighbouring cells and exert a 
‘bystander effect’.  Additionally, upon removal from the prodrug, the effects of cell ablation 
are reversed, making this a very useful tool in regeneration studies (Curado et al, 2007).  
Stable transgenic lines expressing NTR constructs have also been generated, unlike the DTA 
and Kid/Cis techniques which are only used for transient studies (Gray et al, 2011).  
However, prodrug-mediated targeted cell ablation does have its limitations in that certain 
tissues might not be accessible to a prodrug and the prodrug itself may also be processed by 
the body.  General limitations in targeted cell ablation are that a suitable promoter is required 
that is cell or tissue specific and some tissues might be resistant to ablation (Curado et al, 
2008). 
 
Mtz/NTR-mediated targeted cell ablation has been used to ablate cardiomyocytes, pancreatic 
beta (β) cells and hepatocytes in the context of tissue regeneration studies (Curado et al, 
2007).  It has also been used to study the effect of ablating one population of cells on the 
behaviour of another.  This has been demonstrated by Gray et al, who use this approach to 
ablate macrophages and investigate the effect of this ablation on the response of neutrophils 
to acute injury (Gray et al, 2011).  Given the apparent role of macrophages and neutrophils in 
the inflammation associated with feeding on a fat-enriched diet, it would be interesting to 
ablate one population of immune cells and study the effect this has on the behaviour of other 
immune cell populations.  As there are multiple markers of immune cells in zebrafish, such as 
MPO, Pu.1, L-plastin and LyzC, the effect of ablation of any one of these cell populations on 
the behaviour of the remainder can be observed using techniques such as wholemount 
antibody staining.  The current availability of transgenic lines for some of these immune cell 
markers means that there are therefore appropriate promoters that can be used to generate a 
stable transgenic line containing the ablation construct. 
 
 
 
 
 
 
 5.  Attempting to Generate a Novel Transgenic Line 
169 
 
5.2  Aim  
 
 
The aim of this Chapter was to try to generate a stable transgenic line of zebrafish with an 
ablated population of immune cells.  This was endeavoured through: 
 
 Firstly, generating a Tol2 construct containing an ablation cassette of NTR fused to 
CFP located downstream of the LyzC promoter. 
 
 Secondly, microinjecting this construct together with Tol2 transposase mRNA into 
WT larvae and attempting to establish a stable transgenic line. 
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5.3  Results 
 
 
5.3.1  Generation of the pTol(2.4kb LyzC)CFP-NTR Construct 
 
 
The pTol(2.4kb LyzC)CFP-NTR construct was generated from the pTol(2.4kb LyzC)eGFP 
and 14xUAS CFP-NTR plasmid vectors in three steps.  The first step was restriction 
digestion of the pTol(2.4kb LyzC)eGFP vector to remove the GFP gene.  The second step 
was PCR amplification of the CFP-NTR ablation cassette from the 14xUAS CFP-NTR 
vector.  The final step was recombination of the digested vector with the PCR-amplified 
ablation cassette to generate the pTol(2.4kb LyzC)CFP-NTR construct.  These steps are 
summarised in Fig 5.2: 
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Figure 5.2: Schematic Representation of the Cloning Strategy Used for Generating the pTol(2.4kb 
LyzC)CFP-NTR Plasmid Vector.  The pTol(2.4kb LyzC)eGFP plasmid vector (A) was digested with NcoI and 
XhoI (1) to remove the GFP gene (B) and result in a vector lacking GFP (C).  The CFP-NTR ablation cassette 
(cyan) was amplified from the 14xUAS CFP-NTR plasmid vector (D) by PCR (2).  This was achieved using 
primers that introduce sequences at the 5’ and 3’ ends of the resulting product (E) that are complementary to the 
NcoI/XhoI digested pTol(2.4kb LyzC)eGFP vector (C).  The resulting PCR amplified product (E) and digested 
vector (C) were then recombined (3) to generate the pTol(2.4kb LyzC)CFP-NTR plasmid vector (F), which 
contains the CFP-NTR ablation cassette (cyan) immediately downstream of the 2.4kb LyzC promoter (red), in 
place of GFP. 
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Restriction Digestion of the pTol(2.4kb LyzC)eGFP Plasmid Vector 
 
In order to allow substitution of the CFP-NTR ablation cassette in place of GFP in the 
pTol(2.4kb LyzC)eGFP plasmid vector, the  pTol(2.4kb LyzC)eGFP vector was digested 
with NcoI and XhoI to excise the GFP gene. 
 
  
 
                                      
 
 
 
Figure 5.3: Restriction Digestion of the pTol(2.4kb LyzC)eGFP Plasmid Vector.  The 
pTol(2.4kbLyzC)eGFP plasmid vector was digested with NcoI and XhoI in order to excise GFP from the vector.  
Approximately 100ng of the DNA from the digestion reaction was run on a 1% agarose gel along with 5µl of 
ladder (MW).  Data shown for n = 1 experiments (number of times experiment was performed). 
 
 
Restriction digestion of the pTol(2.4kb LyzC)eGFP plasmid vector with NcoI and XhoI 
resulted in the generation of two bands: one at approximately 700bp and another at 
approximately 6000 bp (Fig 5.3).  The 700bp band corresponds to GFP and the 6000 bp band 
to that of the remaining vector.  These results demonstrate that digestion of the pTol(2.4kb 
LyzC)eGFP with NcoI and XhoI vector results in excision of the GFP gene, as expected. 
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PCR Amplification of the CFP-NTR Ablation Cassette 
 
After successfully excising GFP from the pTol(2.4kb LyzC)eGFP vector, the next step was to 
replace the excised GFP with the CFP-NTR ablation cassette.  To achieve this, FWD and 
REV primers that introduced sequences complementary to the digested pTol(2.4kb 
LyzC)eGFP vector at the 5’ and 3’ ends of the generated product were used to amplify the 
CFP-NTR ablation cassette from the 14xUAS CFP-NTR vector. 
 
 
                            
 
 
 
Figure 5.4: PCR Amplification of the CFP-NTR Ablation Cassette.  The CFP-NTR ablation cassette was 
amplified by PCR using forward and reverse primers that introduce sequences to the 5’ and 3’ ends of the 
cassette that are complementary to the NcoI/XhoI digested pTol(2.4kbLyzC)eGFP plasmid vector.  Three 
different primer concentrations were used (1µM, 0.5µM and 0.1µM) and 5µl of the PCR reaction was loaded 
onto a 1% agarose gel along with 5µl of ladder (MW).  Data shown for n = 1 experiments (number of times 
experiment was performed). 
 
 
Whilst a product at 1400bp, consistent with the expected size of the amplified sequence, was 
detected using all three concentrations of primers, a 1µM concentration produced primer-
dimers observed at the bottom of the gel at around 100-200bp.   However, 0.5µM and 0.1µM 
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did not produce primer-dimers.  A concentration of 0.1µM primers appeared to give the 
clearest band at 1400bp, although the intensity of the band was lower than that of the product 
obtained using 0.5µM primers indicating a smaller amount of product (Fig 5.4).  These 
results show that 0.1µM primer concentration gives the clearest quality band but results in a 
smaller amount of product than a concentration of 0.5µM. 
 
 
Recombination of the Digested Vector and PCR-amplified Insert 
 
Having obtained both the digested vector lacking GFP and the CFP-NTR ablation cassette 
containing complementary sequences at the 5’ and 3’ ends to that of the digested vector, 
recombination was required to anneal the digested vector and complementary insert.  This 
was carried out using the InFusion kit and following this, a restriction digest was performed 
from minprepped DNA of positive colonies to confirm the presence of the CFP-NTR ablation 
cassette in the pTol(2.4kb LyzC)eGFP vector. 
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Figure 5.5: Restriction Digest of the Recombined Vector and Insert to Confirm the Presence of the Insert.   
Competent DH5α cells were transformed with the Infusion reaction containing the linearised vector and insert.  
Positive colonies were then picked and grown overnight in LB media.  The following day, DNA was 
miniprepped from the bacterial cultures and then digested with EcoRV.  Additionally, the original 
pTol(2.4kbLyzC)eGFP  plasmid vector was digested with EcoRV as a control (C).  Approximately 100ng of 
DNA from the restriction digests were loaded onto a 1% agarose gel along with 5µl of ladder (MW).  * denotes 
colonies that were positive for the presence of the recombined vector and insert.  Data shown for n = 1 
experiments (number of times experiment was performed). 
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Restriction digestion with EcoRV resulted in three bands for 12 out of 17 lanes (denoted by *) 
(Fig 5.5).  This is consistent with the presence of the CFP-NTR ablation cassette, as there is a 
single EcoRV site approximately 750bp from the 5’ end of the cassette, which is observed as 
a band in these 12 lanes.  The 2100bp band corresponds to two EcoRV sites contained within 
the 2.4kb LyzC promoter (one approximately 300bp from the 5’ end and another at the 3’ 
end) and the 4600bp band is the remaining vector.  Thus, the total size of the product is 
approximately 7.4kb, which is consistent with the expected size (Fig 5.2F).  Digestion of the 
original pTol(2.4kb LyzC)eGFP vector with EcoRV (denoted by C) produced two bands, as 
expected: one at 2100bp corresponding to the digestion at two EcoRV sites within the LyzC 
promoter and a band at 4600bp corresponding to the remaining vector (Fig 5.5).  The absence 
of an additional band at 750bp is consistent with the lack of the CFP-NTR cassette in this 
vector.  However, 4 lanes which were from positive colonies gave a digestion profile 
identical to that of the original vector (C) (Fig 5.5).  An explanation for this is that the 
excised GFP may have recombined back into the digested vector during the InFusion reaction 
instead of the CFP-NTR cassette and thus regenerated the original pTol(2.4kb LyzC)eGFP 
vector.  As the NcoI/XhoI digestion reaction was column purified, both the excised GFP and 
the remaining vector would have been present in the InFusion reaction.  However, given that 
only 4 out of the 16 positive colonies showed this profile, the GFP may not have been present 
in the optimum amount required for annealing back into the vector.  This accounts for why 12 
out of the 16 positive colonies contain the CFP-NTR cassette and not GFP.  These results 
indicate that 12 out of the 16 positive colonies contain the CFP-NTR ablation cassette and 
thus have been transformed with the pTol(2.4kb LyzC)CFP-NTR vector. 
 
 
5.3.2  Attempting to Establish a Stable Transgenic Line of LyzC CFP-NTR Zebrafish 
 
 
Assessing the Presence of CFP Positive Cells in F0 Founder Larvae 
 
Following the successful generation of the pTol(2.4kb LyzC)CFP-NTR vector containing the 
CFP-NTR ablation cassette downstream of the LyzC promoter, which was confirmed by 
sequencing, the next step was to microinject this construct together with previously 
synthesised Tol2 mRNA into embryos at the single-cell stage.  Larvae were microinjected 
and then at 3 dpf, the presence of CFP expressing cells was assessed. 
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Figure 5.6: Assessing the Presence of CFP Positive Cells in F0 Founder Larvae.  Tra/Nac embryos were co-
injected at the single cell stage with 25ng/µl of ablation construct and 25ng/µl Tol2 mRNA into the single cell.  
At 3 dpf, larvae were screened for the presence of LyzC positive cells in the posterior blood island.  (A) 3dpf 
Tra/Nac larva co-injected with the ablation construct and Tol2 mRNA.  (B) 3dpf non-injected Tra/Nac larva.  
The red rectangle outlines the area of interest and examples pigment cells are highlighted with a white arrow.  
Scale bar represents 0.4mm.  Data shown for n =1 experiments (experiment performed 4 times).  
 
 
Within the PBI, there was autofluorescence in the pigment cells of both 3 dpf larvae injected 
with the construct and non-injected 3 dpf larvae (white arrows).  However, there were no 
observable CFP-expressing cells in the PBI of larvae injected larvae compared to non-
injected larvae indicating a lack of detectable expression of the injected construct in the F0 
founder larvae (Fig 5.6). 
 
 
Tail Transection of LyzC Transgenic Larvae to Assess the Expression of LyzC Positive Cells 
 
After observing a lack of detectable expression of CFP positive cells in the F0 founder larvae, 
all injected larvae were raised to adulthood and then crossed to WT fish.  3 dpf offspring of 
such crosses were then tail transected together with 3dpf LyzC GFP and LyzC dsRed larvae 
to observe the presence of LyzC positive cells in the injured tails.  This was to confirm 
whether the expression of the construct may have been very weak in the F0 generation, but 
could increase in the F1 generation through germline transmission. 
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Figure 5.7: Tail Transection of LyzC Transgenic Larvae to Assess the Expression of LyzC Positive Cells.  
3 dpf LyzC dsRed, LyzC GFP and potential F1 LyzC CFP-NTR transgenic larvae had their tails transected.  5h 
post-transection, larvae were anaesthetised and imaged under a wide-field microscope to visualise the 
recruitment of LyzC positive cells to the site of injury.  Transected tail of a LyzC dsRed transgenic larva (A), a 
LyzC GFP transgenic larva (B), the LyzC GFP transgenic larva in (B) visualised in the CFP channel (C), and  a 
potential F1 LyzC CFP-NTR transgenic larva (D).  Examples of recruited cells are marked with an arrow.  Scale 
bar represents 0.2mm.  Dat shown for n = 1 experiments (number of times experiment was performed). 
 
 
Carrying out a tail transection on 3 dpf LyzC dsRed or LyzC GFP larvae resulted in the 
recruitment of fluorescent cells to the injury site 5h post-transection (Fig 5.7A and B).  
However, there was no observed recruitment of fluorescent cells to the wounded tails of F1 
LyzC CFP-NTR larvae (Fig 5.7D).  Additionally, GFP expressing cells of a tail transected 
LyzC GFP larvae could be observed in the CFP channel, excluding the possibility of a high 
level of autofluorescence in this channel obscuring the visualisation of fluorescent cells (Fig 
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5.7C).  Taken together, these results suggest a lack of detectable expression of CFP-
expressing cells in the F1 generation. 
 
 
Analysis of LyzC Expression in Transgenic Larvae by Flow Cytometry 
 
Unable to detect any CFP positive cells in either the F0 founder larvae or the F1 offspring, the 
expression of CFP in myeloid cells of adult potential transgenics was then analysed by flow 
cytometry. 
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Figure 5.8: Analysis of LyzC Expression in Transgenic Larvae by Flow Cytometry.  Potential adult 
transgenic LyzC CFP-NTR fish, along with LyzC dsRed and Tra/Nac fish, were killed and had their kidneys 
removed.  The kidneys were homogenised in PBS containing foetal calf serum to obtain a single-cell suspension 
and centrifuged.  The resulting pellets were resuspended in PBS and then analysed by flow cytometry using both 
a 405/450 excitation/emission channel for analysis of Tra/Nac and potential LyzC CFP-NTR fish, and a 488/530 
excitation/emission channel for analysis of LyzC dsRed fish.  Profile for a Tra/Nac fish (A), a LyzC dsRed 
transgenic fish (B), and potential LyzC CFP-NTR transgenic fish (C) and (D).  Data shown for n = 1 
experiments (experiment was performed 3 times).  Figure obtained courtesy of Fränze Progratzky. 
 
 
Of the gated myeloid cell population, approximately 4% of cells in the Tra/Nac fish were 
CFP positive, indicating a low level of background fluorescence (Fig 5.8A) and 
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approximately 85% of cells were dsRed positive in the LyzC dsRed fish, as expected (Fig 
5.8B).  The majority of potential LyzC CFP-NTR transgenic fish gave a profile where a 
similar percentage of CFP positive cells were observed to that of the Tra/Nac control (Fig 
5.8C), suggesting that these were not LyzC CFP-NTR transgenics.  However, one of the 
potential LyzC CFP-NTR transgenic fish displayed a profile where 20% of gated myeloid 
cells were CFP positive, suggesting a potential transgenic (Fig 5.8D).  These results suggest 
that the majority of the potential LyzC CFP-NTR fish are not transgenic. 
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5.4  Discussion 
 
 
The results have demonstrated that whilst the pTol(2.4kb LyzC)CFP-NTR construct has been 
successfully generated, neither the injected F0 founder larvae nor the F1 larvae show any CFP 
positive cells consistent with LyzC expression.  The majority of adult fish microinjected with 
the construct do not show any CFP positive cells within the myeloid population that is 
different to that of the Tra/Nac control fish when analysed by flow cytometry. 
 
The approach used for attempting to generate the transgenic line involved application of the 
Tol2 system which results in a high level of stable integration of the transgene into the 
genome and germline transmission consistent with Mendelian inheritance, in that 50% of 
progeny from a positive founder crossed to a WT should be CFP positive (Kawakami et al, 
2004).  However, neither the founder larvae nor the F1 offspring of the founder-WT cross 
displayed any CFP-positive cells.  LyzC is a marker of myeloid cells and is expressed at 3dpf 
as shown by the recruitment of fluorescent cells to the site of injury in both LyzC GFP and 
LyzC dsRed larvae.  However, no such recruitment was observed in the potential LyzC CFP-
NTR transgenics, suggesting a lack of expression of the transgene in these larvae (Fig 5.7).  
The lack of observable expression was confirmed by the absence of CFP positive cells within 
the myeloid population in the majority of the potential adult LyzC CFP-NTR transgenics (Fig 
5.8).  The high level of stable integration of transgenes into zebrafish germ cells with the 
Tol2 approach is due to the co-injection of Tol2 mRNA along with the plasmid containing 
the transgene.  The transposase encoded within the mRNA catalyses the excision of the 
transgene from the plasmid vector and its integration into the genome (Largaespada, 2003).  
Thus, the genomic integration of the transgene is an active process and not random, unlike 
approaches which involve the injection of plasmid DNA alone (Stuart et al, 1988; Stuart et 
al, 1990).  Additionally, with the Tol2 system, there is no silencing effect observed with 
transgene expression over time due to the avoidance of rearrangements of surrounding 
genomic DNA.  As a consequence of this, there is a high level of germline transmission to the 
offspring (Kawakami, 2005).  Therefore, the results observed in using the Tol2 system in this 
case are not consistent with its reported success in the literature. 
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A possible explanation for the lack of observed expression of CFP in the F0 founder larvae 
may be that the transgene integrated relatively late into the genome following microinjection.  
Thus, only a small number of cells would express it, resulting in a very low, non-detectable 
level of expression.  Alternatively, it is possible that the transgene may have failed to express 
following its genomic integration, resulting in no observable CFP-fluorescent cells or the 
integration into the genome may have failed completely.  However, given the reported 
success of genome integration and germline transmission of transgenes using the Tol2 
system, it is more likely that the lack of observable CFP fluorescence is due to a failure of 
expression rather than a failure of genome integration or genome integration occurring 
relatively late.  Nevertheless, the latter two possibilities cannot be completely excluded. 
 
The CFP-NTR ablation cassette has been previously used in combination with the Tol2 
system by Curado et al to successfully generate stable transgenic lines of zebrafish 
expressing the cassette under the control of the cmlc2 promoter (cardiomyocytes) and the L-
FABP promoter (hepatocytes) (Curado et al, 2007).  A construct composed of NTR fused to 
mCherry under the influence of the insulin promoter has also been used to generate a 
transgenic line of zebrafish using the Tol2 system (Pisharath et al, 2007).  Thus, the NTR 
ablation cassette has been used to successfully generate stable transgenic lines in the same 
way that it was used in this study.  Furthermore, the 2.4kb LyzC promoter has been 
successfully used to drive GFP expression in a stable line of transgenic LyzC GFP zebrafish, 
which too was created using the Tol2 system (Kitaguchi et al, 2009).  Therefore, the elements 
that were used to create the transgenic LyzC CFP-NTR line have been utilised in previous 
studies to generate stable transgenic lines, in that GFP expression has been driven by the 
2.4kb LyzC promoter, and the cmcl2, L-FABP and insulin promoters have been used to drive 
expression of an NTR ablation cassette.  However, this is the first time to our knowledge that 
the LyzC promoter has been used to drive expression of the CFP-NTR ablation cassette, 
which was ultimately unsuccessful. 
 
 
5.4.1  Conclusion 
 
Whilst the pTol(2.4kb LyzC)CFP-NTR construct was successfully created, it was not 
possible to generate a stable transgenic line of LyzC CFP-NTR zebrafish.  This is most likely 
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due to a failure of expression of the transgene but also possibly due to a failure of the 
transgene to integrate into the genome or the integration occurring relatively late. 
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CHAPTER 6: FINAL DISCUSSION 
 
 
The aims of this thesis were to establish zebrafish as a model for acute inflammation 
following feeding on a fat-enriched diet and to investigate the role of the NLRP3 
inflammasome in this inflammation.  The results have demonstrated that feeding larvae an 
enriched fat diet in the form of cream or in a more refined form as cholesterol leads to a 
recruitment of neutrophils and potentially macrophages to the intestine. Furthermore, in 
response to feeding on a cholesterol-enriched diet, the neutrophil accumulation appears to 
precede that of macrophages.  Palmitic acid is capable of causing a localised recruitment of 
immune cells to the intestine whereas UFAs are unable to do so.  Switching to a standard diet 
following feeding on a fat-enriched diet leads to an accelerated resolution of inflammation, 
possibly due to the anti-inflammatory effects of ω-3 FAs contained in the ZM.  The 
recruitment of L-plastin positive cells to the intestine of cholesterol-fed larvae appears to 
depend upon the activities of cathepsin B, NADPH oxidase and caspase-1.  Additionally, the 
expression of ASC in intestinal epithelial cells appears to drive the inflammatory infiltrate to 
the intestine, suggesting that the inflammation associated with feeding on a cholesterol-
enriched diet is at least partly dependent upon signalling through the NLRP3 inflammasome.    
 
Very little is known about the acute inflammation associated with diseases such as obesity, 
type II diabetes and atherosclerosis, and the findings of this thesis potentially shed some light 
on this.  It is known that neutrophils transiently infiltrate AT of mice after 3 days of feeding 
on a high fat diet and then disappear after 14 days, following which macrophages appear 
(Elgazar-Carmon et al, 2008).  These findings indicate a role of neutrophils and potentially 
macrophages following a 6h feeding period on a fat-enriched diet, which suggests that even 
after a period of a few hours, localised inflammation in the intestine has already begun.  The 
peak accumulation of neutrophils appears to precede that of macrophages, consistent with an 
initial infiltration of neutrophils followed by macrophages in AT following high fat feeding 
and in other known cases of inflammation (Elgazar-Carmon et al, 2008; Soehnlein and 
Lindbom, 2010). 
 
To further investigate the role of macrophages recruited to the intestine 18h following 
removal from the cholesterol-enriched diet, the phenotype of these immune cells could be 
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studied by examining the expression of markers associated with M1 and M2 macrophages.  
This would provide information as to whether these macrophages are responding to the 
cholesterol or to apoptotic neutrophils as part of the resolution phase.  A marker of M1 
macrophages is TNF-α and arginase is an M2 macrophage marker.  Wholemount triple 
antibody staining can be carried out using antibodies against L-plastin, TNF-α and arginase, 
which are each stained with secondary antibodies conjugated to different, non-overlapping 
fluorophores.  L-plastin positive cells positive for TNF-α are M1, those that are positive for 
arginase are M2 and any L-plastin positive cells that are negative for both TNF-α and 
arginase are neutrophils.  This approach has been used by Feng et al in 7dpf larvae but in 
place of an arginase antibody, a fluorescent in situ probe was used (Feng et al, 2010).  The 
inability to detect certain cytokines at all in the zebrafish larval intestine through qRT-PCR 
greatly hinders the understanding of the inflammation associated with feeding on a fat-
enriched diet.  To circumvent this, WISH could be used to detect changes in expression of 
cytokines in the intestine of larvae fed a fat-enriched diet compared to control larvae.  This 
could be carried out at various time points both during the feeding period itself and following 
removal from the diet to investigate the inflammatory and resolution phases of the response 
to feeding on a fat-enriched diet.  
 
The results suggest that both cholesterol uptake into intestinal epithelial cells and the 
expression of ASC in these cells may be required for localised inflammation in the intestine 
to occur.  Thus, it is possible that cholesterol uptake into epithelial cells may activate the 
NLRP3 inflammasome leading to IL-1β release.  The receptor through which IL-1β exerts its 
pro-inflammatory effects, IL-1RI, is expressed on epithelial cells in the intestine and 
potentially SMCs due to IL-1β inducing IL-6 release in these cells (Khan et al, 1995; McGee 
et al, 1996).  Therefore, it is possible that the released IL-1β may engage its receptor on these 
cells resulting in the production of chemokines such as IL-8 and MCP-1, leading to the 
recruitment of further immune cells (Stienstra et al, 2012).  Given the dependence of immune 
cell recruitment upon cathepsin B activity, it appears that cholesterol activates the 
inflammasome in a lysosomal-dependent manner, consistent with its mechanism of uptake 
into intestinal epithelial cells (Betters and Yu, 2010). 
 
To gain further insight into the expression of ASC in the intestine, WISH could be used with 
an RNA probe against zebrafish ASC.  This can be combined with transverse sectioning to 
examine the localisation of ASC expression in the cells of the intestine at the histological 
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level.  In order to investigate ASC expression in intestinal macrophages and neutrophils, 
WISH can be carried out with L-plastin antibody staining.  The expression of other 
components of the NLRP3 inflammasome can also be examined in this way.  The possibility 
of ASC knockdown occurring in the intestinal epithelial cells assumes that the FITC 
fluorescence is a measure of the localisation of the MO and thus the FITC and MO are still 
conjugated following feeding.  To see if this is the case, the effect of feeding the ASC-
specific splice-blocking MO on expression of ASC studied with WISH can be compared to 
that of untreated larvae and provide further information as to where the MO is localising 
when administered in this way.  If the MO is localising in the region where the FITC 
fluorescence is observed, then this region should display a reduced level of ASC expression.  
Thus, information that could not be gained from the qRT-PCR experiments studying ASC 
expression in the intestine following MO feeding could potentially be obtained in this 
manner.  Additionally, the effects of MO feeding on ASC expression in the intestine can be 
compared to that of MO microinjection in terms of the cell types that are affected by both 
methods of delivery.  This may help to resolve the different outcomes observed in terms of 
recruitment of L-plastin positive cells and detection of expression by qRT-PCR when 
delivering the MO by these two methods.  
 
Despite the proposed ability of cholesterol to activate the NLRP3 inflammasome, an 
unanswered question is the mechanism of transduction of the priming signal required to 
generate the pro-form of IL-1β following feeding on a cholesterol-enriched diet.  It is known 
that oxLDL is capable of providing this priming signal by engaging the TLR4/6 heterodimer 
in a CD36-dependent and CD14 independent manner (Stewart et al, 2010).  However, the 
possibility that activation of the NLRP3 inflammasome is occurring in the intestinal epithelial 
cells means it is unlikely dietary cholesterol will have formed oxLDL at this stage as it has 
not yet been processed by the organism.  Thus, cholesterol itself may provide this priming 
signal possibly through an unknown mechanism.  Oxysterols have been shown to induce 
secretion of IL-1β from human macrophages, suggesting that possible oxidation of the dietary 
cholesterol following ingestion by the larvae may result in generation of pro-IL-1β (Palozza 
et al, 2011).  Treatment with ezetimibe has been demonstrated to decrease IL-1β expression 
in rat livers, suggesting that cholesterol is capable of inducing IL-1β expression in 
hepatocytes (Nomura et al, 2009). 
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The inflammation associated with feeding on a palmitic acid-enriched diet also appears to be 
dependent upon caspase-1 activity, suggesting a potential dependence upon the NLRP3 
inflammasome.  Furthermore, palmitic acid is capable of activating TLR4 and thus could 
potentially provide the priming signal required to generate pro-IL-1β and the second signal 
through activation of the NLRP3 inflammasome (Kim et al, 2007; Davis et al, 2008; 
Maloney et al, 2009).  Interestingly, studies by Wen et al demonstrated that palmitic acid was 
incapable of inducing mature IL-1β release from macrophages in the absence of LPS, 
indicating that LPS was required to provide the priming signal and palmitic acid activates the 
inflammasome providing the second signal (Wen et al, 2011).  However, these results suggest 
that palmitic acid alone is capable of providing both signals as the inflammation associated 
with feeding on a palmitic acid-enriched diet appears to be dependent upon caspase-1 activity 
without any further inflammatory stimuli required.  An explanation for the requirement of 
LPS to provide the priming signal is that palmitic acid used in studies by Wen et al was 
conjugated to BSA to enhance its solubility.  This may have affected its ability to activate 
TLR4 signalling and thus provide the priming signal (Wen et al, 2011).  However, because 
activation of TLR4 by palmitic acid is likely to be dependent upon CD14 and MD-2, the 
priming signal is unlikely to occur in this manner in zebrafish and another pathway may be 
involved.  It is known that the LPS response in zebrafish occurs independently of TLR4 
signalling and MyD88, yet the expression of genes induced in response to LPS treatment are 
MyD88-dependent such as IL-1β, IL-12 and TNF-α (Sepulcre et al, 2009).  This suggests the 
involvement of another pathway that results in expression of the same genes.  A similar 
scenario may the case for the inflammation associated with feeding on diets enriched in 
cholesterol or palmitic acid. 
 
An alternative source of the priming signal may be the microbiota of the intestine.  It is 
known that there is a low level of inflammation in the intestine during its colonisation by the 
microbiota, which results in a recruitment of neutrophils.  LPS produced by the microbiota is 
responsible for this and the infiltration occurs in a MyD88 and TNF-α dependent manner.  
This is required to establish a homeostatic population of these immune cells in the intestine 
(Bates et al, 2007).  The NF-κB pathway has also been shown to be activated following 
colonisation of the zebrafish gut with microbiota (Kanther et al, 2011).  It is possible that the 
microbiota may lead to induction of expression of the pro-form of IL-1β potentially in a 
MyD88-dependent manner through TLR signalling.  Given that the expression of other pro-
inflammatory cytokines such as TNF-α and IL-6, and chemokines such as IL-8 and MCP-1 
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are also induced in this manner, the level of expression of these genes needs to be relatively 
low to prevent an overactive immune response in the resting state.  There are regulatory 
mechanisms in place to prevent an excessive inflammatory response to the microbiota.  One 
example of this is intestinal alkaline phosphatase, expressed in intestinal epithelial cells, 
dephosphorylating LPS and thereby reducing its immunogenic properties (Bates et al, 2007).  
TLR2 and TLR4 are also expressed at relatively low levels in intestinal epithelial cells to 
minimise recognition of commensal bacteria (Cario and Podolsky, 2000).  Thus, if the 
microbiota alone were to provide the priming signal, it would need to involve a predominant 
expression of pro-IL-1β compared to other cytokines and chemokines.  This is because it 
would be of no benefit to the host to have an inflammatory response against the resident 
intestinal flora.  It is also possible that the induction of pro-IL-1β expression by the 
microbiota may occur in a MyD88-independent manner as was observed by Sepulcre et al 
following LPS stimulation (Sepulcre et al, 2009).    
 
A priming signal may potentially be generated by the microbiota in combination with feeding 
diets enriched in either cholesterol or palmitic acid, reminiscent of what is observed in 
inflammatory bowel disease (IBD) whereby an inflammatory response is also mounted 
against the microbiota (Wlodarska and Finlay, 2010).  In a chemically-induced colitis model 
in zebrafish, it has been demonstrated that the inflammation observed with TNBS treatment is 
dependent upon the microbiota.  It is also proposed that TNBS may disrupt function of 
epithelial cells affecting their contact with commensal bacteria (Oehlers et al, 2011).  In 
intestinal epithelial cells taken from human patients suffering from IBD, there is an increased 
expression of TLR4 (Cario and Podolsky, 2000).  It is possible that cholesterol and palmitic 
acid may disrupt the regulatory mechanisms in place to suppress the inflammatory response 
against the microbiota, which leads to a state of intolerance of the gut flora and a 
hyperinflammatory response against it.  This may be due to interfering with intestinal alkaline 
phosphatase activity or expression, or potentially upregulating expression of TLRs.  Thus, 
this would lead to a priming signal within the intestinal epithelial cells as a result of altered 
recognition of commensal PAMPs by the epithelial cells.  IBD is also characterised by an 
alteration in the composition of the gut flora which leads to an immune response against it, 
but in the short timescale of acute feeding, it is unlikely that such a scenario is occurring 
(Peterson et al, 2008).  Therefore, it is possible that the microbiota may be responsible for 
generation of the priming signal as a result of feeding on a diet enriched in either cholesterol 
or palmitic acid given the known dependence of gastrointestinal inflammation associated 
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with IBD on the resident intestinal flora.  It is also possible that cholesterol and palmitic acid 
may generate the priming signal without any involvement of the microbiota, or the 
microbiota alone may provide the signal.  However, the data in this thesis does not indicate 
that any one of these three possibilities is more likely than the others.        
 
Studies investigating the role of microbiota in inflammation often use germ-free animals, 
which lack resident bacteria in the gastrointestinal tract, or treatment with antibiotics to 
deplete the microbiota.  It is not however applicable to use these approaches in the context of 
an acute fat feeding model to investigate the role of the microbiota in generating the priming 
signal.  The microbiota plays an important role in regulating the proliferation of intestinal 
epithelial cells, which precedes their differentiation and is required for development of the 
larval intestine (Crosnier et al, 2005).  ASC is also expressed in mature, highly differentiated 
intestinal epithelial cells near the lumen and not immature, undifferentiated cells (Masumoto 
et al, 2001; Yokoyama et al, 2003).  Furthermore, full development of the larval intestine 
occurs by 5 dpf, which coincides with the onset of feeding (Ng et al, 2005).  Thus, depleting 
the microbiota may interfere with the development of the intestinal epithelia which could 
affect ASC expression and also the ability of intestinal epithelial cells to take up cholesterol 
or palmitic acid.  If an effect is observed following acute fat feeding as a result of depleting 
the microbiota, it may be due to absence of the microbiota-dependent priming signal or 
possibly due to a reduction or absence of ASC expression, or a reduced ability for epithelial 
cells to take up dietary fat.  Thus, there could be a number of effects of depleting the 
microbiota in addition to potentially abrogating the priming signal, which may also be 
responsible. 
 
However, given the possible dependence on TLRs in providing the priming signal, an 
approach to investigate this could involve MO knockdown of zebrafish TLRs.  As both NF-
κB and MAPK signalling occur downstream of IL-1β signalling as well as through TLR 
signalling, it would not be possible to distinguish whether NF-κB and MAPK signalling are 
required for the priming signal as well as the downstream signalling through IL-1β, or just 
the downstream IL-1β signalling, if these two signalling pathways were targeted.  Thus, the 
targeting of the TLRs ensures that only a pathway that occurs potentially in parallel to 
NLRP3 signalling, and not downstream of it as well, is affected.  This could potentially 
provide information about whether the priming signal is occurring in a TLR-dependent 
manner by observing the effect of gene knockdown on immune cell recruitment to the 
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intestine.  Furthermore, the effect of MO knockdown of TLRs on IL-1β expression in the 
intestine can be examined using WISH. 
 
Whilst feeding on a palmitic acid-enriched diet results in recruitment of immune cells to the 
intestine, feeding on diets enriched in UFAs such as linoleic acid and oleic acid do not, 
suggesting that these FAs are non-inflammatory.  This is consistent with the inability of oleic 
acid to impair insulin signalling or induce TNF-α expression or secretion, and the failure of 
linoleic acid to induce MCP-1 and IL-6 expression compared to palmitic acid (Chavez and 
Summers, 2003; Bradley et al, 2008; Wang et al, 2009).  Oleic acid and linoleic acid are also 
capable of antagonising the inflammatory effects of palmitic acid, suggesting an anti-
inflammatory effect of these UFAs (Weigert et al, 2004; Kennedy et al, 2009).  This is 
further supported by the observation of switching to a standard diet enriched in ω-3 FAs 
following feeding on a fat-enriched diet results in an accelerated resolution of inflammation.  
ω-3 FAs are converted to protectins and resolvins which are involved in the resolution of 
inflammation through blocking neutrophil transmigration and promoting the phagocytosis of 
neutrophils by macrophages (Schwab et al, 2007; Serhan et al, 2008; Soehnlein and 
Lindbom, 2010).  Thus, supplying such FAs in the diet immediately following feeding on a 
fat-enriched diet means that the processes involved in resolving inflammation occur more 
quickly.  Therefore, FAs vary in their ability to induce acute inflammation in the intestine and 
this may have consequences on chronic inflammation associated with metabolic diseases.   
For instance, obese patients have high levels of SFAs such as palmitic acid which can 
predispose to type II diabetes through interference with insulin signalling (Reynoso et al, 
2003; Yerlikaya et al, 2011).   
 
The chronic inflammation associated with diseases of the metabolic syndrome is well 
established and interconnected in that inflammation resulting from obesity can pre-dispose to 
type II diabetes and atheroscelerosis.  These disorders are increasingly prevalent today with a 
lifestyle heavily influenced by an unhealthy diet and a lack of exercise.  The inflammation is 
systemic and affects multiple sites in the body, such as AT, muscle, liver and the vasculature.  
The results of this thesis demonstrate an acute inflammation localised to the gastrointestinal 
tract after feeding on a fat-enriched diet for a period of a few hours.  Thus, it appears that this 
highly localised inflammation precedes the systemic chronic inflammation associated with 
the metabolic syndrome.  As very little is known about the acute inflammation associated 
with feeding on a fat-enriched diet, the findings of this thesis may open up avenues for 
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therapeutic potential.  The results suggest that the NLRP3 inflammasome is at least partly 
responsible for the inflammation observed in feeding on a cholesterol-enriched diet through 
the use of pharmacological inhibitors.  As the targets of inhibition are conserved in 
mammalian systems, possible drugs could be designed against the human orthologues of 
these.  The inflammatory effect resulting from feeding on a fat-enriched diet is resolved more 
quickly upon switching to a standard diet which also may have therapeutic potential in 
preventing the chronic inflammation associated with obesity.  Western diets typically have a 
high content of SFAs and are often lacking in UFAs.  Thus, switching to healthier diets 
especially high in ω-3 FAs may reduce the incidence of obesity and the metabolic 
complications arising from it.  Given the similarity in both the development and function of 
the innate immune system in zebrafish together with the manner in which dietary fat is taken 
up and processed in zebrafish compared to mammalian systems, the findings of this thesis 
may well be relevant to human disease.  Complications arising from type II diabetes and 
atherosclerosis claim many lives each year and being able to target possible early causes of 
the inflammation associated with these diseases at the molecular level could be of great 
benefit to global health.   
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APPENDIX 
 
 
 
 
 
  
 
 
Figure 7.1: Attempting to Detect H2O2 in the Intestines of Cholesterol-Fed Larvae.  6 dpf WT larvae were 
treated with either 50µM fluorogenic H2O2 probe or DMSO for 1h.  They were then fed either a standard diet 
(ZM), or a cholesterol-enriched diet or were unfed for 10 mins.  Following this, larvae were anaesthetised and 
imaged under an epifluorescent microscope for fluorescence in the intestine.  (A) Cholesterol-fed larva pre-
treated with DMSO.  (B) Unfed, (C) ZM-fed and (D) cholesterol-fed larvae pre-treated with fluorogenic H2O2 
probe.  Larvae are oriented from anterior (left) to posterior (right).  Scale bar represents 0.4mm.  Data shown for 
n = 1 experiments (number of times experiment was performed). 
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Figure 7.2: Attempting to Detect Caspase-1 Activity in the Intestines of 7dpf Larvae.  (A) 6 dpf WT larvae 
were treated with either 10µM, 40µM or 100µM fluorogenic caspase-1 substrate (Z-YVAD-AFC) for 1h.  They 
were then anaesthetised and imaged under a wide-field microscope for fluorescence in the intestine.  (i) 
Untreated, (ii) DMSO-treated and (iii) 10 µM Z-YVAD-AFC-treated larvae.  (B) In a separate experiment, 6 dpf 
WT larvae were fed for 6h on either a standard diet (ZM) or a cholesterol-enriched diet.  At the end of this 
feeding period, larvae were anaesthetised and then treated for 30 mins in 1 x FLICA, followed by a 30 min wash 
in PBS.  Larvae were then imaged for fluorescence in the intestine.  (i) Untreated larva.  (ii) and (iii) ZM-fed 
larva treated with FLICA.  (iv) and (v) cholesterol-fed larva treated with FLICA.  Larvae are oriented sagitally 
from anterior (left) to posterior (right).  Scale bar represents 0.4mm.  Data shown for n = 1 experiments (number 
of times experiment was performed). 
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Figure 7.3: Lack of a Correlation Between Fluorescence Intensity of FLICA and Recruitment of L-Plastin 
Positive Cells to the Intestine.   6 dpf WT larvae were fed for 6h on either a standard diet (ZM) or a 
cholesterol-enriched diet.  3h after removal from the diet, larvae were anaesthetised and then treated for 30 mins 
in 1 x FLICA, followed by a 30 min wash in PBS.  One group of cholesterol-fed larvae were not treated with 
FLICA (Untreated).  Larvae were then imaged for fluorescence in the intestine and scored on the brightness of 
this fluorescence.  The larvae were fixed and stained, and numbers of L-plastin positive cells in the intestine 
were then counted in each of the groups.  Comparison of the numbers of cells in individual larvae (A) and mean 
numbers of cells in larvae (B) fed either ZM or a cholesterol-enriched diet and scored on the brightness of the 
intestine.  Data shown for n = 1 experiments (number of times experiment was performed). 
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Figure 7.4: Quantifying the Fluorescence Intensity of FLICA Following Treatment with Inhibitors of the 
NLRP3 Inflammasome.  6 dpf WT larvae were pre-treated with either DMSO, 100µM caspase-1 and 5 
inhibitor (N-Acetyl WEHD-al), 100µM cathepsin B inhibitor (Ca-074-Me) or were untreated for 30 mins.  
Following the pre-treatment, larvae were either fed for 6h on a standard diet (ZM) or a cholesterol-enriched diet 
in the presence of the inhibitors.  At the end of this feeding period, larvae were removed from the diet and 3h 
following removal were anaesthetised and then treated for 30 mins in 1 x FLICA, followed by a 30 min wash in 
PBS.  Larvae were then imaged for fluorescence in the intestine which was quantified.  Comparison of the 
fluorescence intensity in individual larvae (A) and mean fluorescence intensity in larvae (B) fed either ZM or a 
cholesterol-enriched diet under the different pre-treatment conditions.  Comparison of the fluorescence intensity 
in individual larvae (C) and mean fluorescence intensity in larvae (D) fed either ZM or a cholesterol-enriched 
diet and untreated or pre-treated with DMSO.  Statistical significance was determined using a Kruskall-Wallis 
test followed by a Dunn’s post test.  *** denotes p < 0.001, and * p < 0.05.  Error bars represent 95% 
confidence intervals.  Data shown for n = 1 experiments (number of times experiment was performed). 
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